[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 131
1. Tan AY, Manley JL: The TET family of proteins: functions and roles in disease. J Mol Cell Biol; 2009 Dec;1(2):82-92
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Translocated in liposarcoma, Ewing's sarcoma and TATA-binding protein-associated factor 15 constitute an interesting and important family of proteins known as the TET proteins.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Genet. 1999 Oct;23(2):222-7 [10508522.001]
  • [Cites] Oncogene. 1999 Sep 30;18(40):5592-7 [10523836.001]
  • [Cites] Nature. 2004 Nov 11;432(7014):235-40 [15531877.001]
  • [Cites] Nucleic Acids Res. 2005;33(4):1323-31 [15743974.001]
  • [Cites] Curr Biol. 2005 Mar 29;15(6):587-93 [15797031.001]
  • [Cites] Semin Cancer Biol. 2005 Jun;15(3):189-96 [15826833.001]
  • [Cites] Semin Cancer Biol. 2005 Jun;15(3):197-205 [15826834.001]
  • [Cites] Neurosci Lett. 2005 May 13;379(3):152-7 [15843054.001]
  • [Cites] Curr Opin Cell Biol. 2005 Jun;17(3):251-6 [15901493.001]
  • [Cites] Stem Cells. 2005 Jun-Jul;23(6):738-51 [15917470.001]
  • [Cites] Proteins. 2005 Oct 1;61(1):164-75 [16044463.001]
  • [Cites] Nature. 2005 Oct 20;437(7062):1173-8 [16189514.001]
  • [Cites] Eur J Cancer. 2005 Nov;41(16):2513-27 [16213703.001]
  • [Cites] Gene. 2005 Dec 19;363:1-14 [16202544.001]
  • [Cites] J Cell Sci. 2005 Dec 15;118(Pt 24):5755-65 [16317045.001]
  • [Cites] Int J Cancer. 2006 Mar 15;118(6):1381-9 [16206264.001]
  • [Cites] Cancer Cell. 2006 May;9(5):405-16 [16697960.001]
  • [Cites] Oncologist. 2006 May;11(5):503-19 [16720851.001]
  • [Cites] Proteomics. 2006 Nov;6(22):5962-72 [17106916.001]
  • [Cites] Oncogene. 1999 Dec 9;18(52):7599-601 [10602520.001]
  • [Cites] Oncogene. 2009 Mar 5;28(9):1280-4 [19151750.001]
  • [Cites] Biochemistry. 2009 Apr 7;48(13):2849-57 [19290668.001]
  • [Cites] Exp Cell Res. 2009 Apr 15;315(7):1273-86 [19124016.001]
  • [Cites] PLoS One. 2009;4(4):e5415 [19404404.001]
  • [Cites] EMBO Rep. 2009 May;10(5):494-500 [19282884.001]
  • [Cites] Cancer Sci. 2009 Feb;100(2):200-8 [19076980.001]
  • [Cites] Biochem Biophys Res Commun. 2005 Apr 8;329(2):653-60 [15737635.001]
  • [Cites] Science. 1990 Aug 3;249(4968):505-10 [2200121.001]
  • [Cites] Nature. 1992 Sep 10;359(6391):162-5 [1522903.001]
  • [Cites] EMBO J. 1993 Feb;12(2):489-99 [8440239.001]
  • [Cites] Nature. 1993 Jun 17;363(6430):640-4 [8510758.001]
  • [Cites] Trends Biochem Sci. 1993 Jun;18(6):226-30 [7688487.001]
  • [Cites] Nat Genet. 1993 Jun;4(2):175-80 [7503811.001]
  • [Cites] EMBO J. 1993 Dec;12(12):4481-7 [8223458.001]
  • [Cites] Genes Dev. 1994 Feb 15;8(4):453-64 [8125258.001]
  • [Cites] Mol Cell Biol. 1994 May;14(5):3230-41 [8164678.001]
  • [Cites] Science. 1994 Jul 29;265(5172):615-21 [8036511.001]
  • [Cites] Oncogene. 1994 Oct;9(10):3087-97 [8084618.001]
  • [Cites] Genes Dev. 1994 Nov 1;8(21):2513-26 [7958914.001]
  • [Cites] Eur J Biochem. 2001 Jun;268(12):3483-9 [11422378.001]
  • [Cites] Oncogene. 2001 Sep 10;20(40):5747-54 [11607824.001]
  • [Cites] J Biol Chem. 2001 Nov 9;276(45):41977-84 [11553628.001]
  • [Cites] Oncogene. 2001 Oct 11;20(46):6653-9 [11709699.001]
  • [Cites] Nature. 2001 Dec 20-27;414(6866):929-33 [11780068.001]
  • [Cites] Genes Dev. 2002 Mar 15;16(6):673-5 [11963920.001]
  • [Cites] Cancer Cell. 2002 May;1(4):393-401 [12086853.001]
  • [Cites] Genome Res. 2002 Aug;12(8):1231-45 [12176931.001]
  • [Cites] Nature. 2002 Sep 12;419(6903):182-5 [12226669.001]
  • [Cites] Cancer Res. 2002 Oct 1;62(19):5408-12 [12359745.001]
  • [Cites] Nat Struct Biol. 2002 Nov;9(11):790-1 [12402032.001]
  • [Cites] Cell. 2002 Nov 1;111(3):407-17 [12419250.001]
  • [Cites] Cancer Biol Ther. 2002 Jul-Aug;1(4):428-32 [12432261.001]
  • [Cites] Oncogene. 2002 Nov 28;21(54):8302-9 [12447693.001]
  • [Cites] Ann Hum Genet. 2002 Nov;66(Pt 5-6):331-42 [12485467.001]
  • [Cites] Mol Cell Biol. 2003 Jan;23(2):482-92 [12509448.001]
  • [Cites] Gene. 2003 Jan 16;303:11-34 [12559563.001]
  • [Cites] J Biol Chem. 2003 Feb 14;278(7):5427-32 [12459554.001]
  • [Cites] Exp Cell Res. 2003 Feb 15;283(2):184-95 [12581738.001]
  • [Cites] Exp Cell Res. 2003 Aug 15;288(2):374-81 [12915128.001]
  • [Cites] Anal Chem. 2003 Jul 1;75(13):3107-14 [12964758.001]
  • [Cites] Cancer Res. 2003 Dec 1;63(23):8338-44 [14678994.001]
  • [Cites] Cell Signal. 2004 Apr;16(4):515-20 [14709340.001]
  • [Cites] FEBS Lett. 2004 Apr 23;564(1-2):188-98 [15094065.001]
  • [Cites] EMBO J. 2004 Apr 21;23(8):1782-91 [15057275.001]
  • [Cites] J Orthop Res. 2004 Jul;22(4):910-7 [15183454.001]
  • [Cites] Mol Cell Biol. 2004 Aug;24(16):7275-83 [15282325.001]
  • [Cites] Neuron. 2004 Aug 19;43(4):513-25 [15312650.001]
  • [Cites] RNA. 2004 Oct;10(10):1489-98 [15383674.001]
  • [Cites] J Biol Chem. 2004 Oct 22;279(43):44834-40 [15299008.001]
  • [Cites] Biochemistry. 2004 Oct 26;43(42):13579-89 [15491164.001]
  • [Cites] Cell. 1977 May;11(1):127-38 [872217.001]
  • [Cites] J Clin Oncol. 1998 Apr;16(4):1248-55 [9552022.001]
  • [Cites] J Biol Chem. 1998 Jul 17;273(29):18086-91 [9660765.001]
  • [Cites] EMBO J. 1998 Aug 3;17(15):4442-55 [9687511.001]
  • [Cites] Oncogene. 1998 Aug 6;17(5):603-10 [9704926.001]
  • [Cites] Genes Dev. 1998 Oct 1;12(19):2992-6 [9765201.001]
  • [Cites] J Biol Chem. 1998 Oct 23;273(43):27761-4 [9774382.001]
  • [Cites] Oncogene. 1999 Jan 21;18(3):721-9 [9989822.001]
  • [Cites] Cancer Res. 1999 Apr 1;59(7):1428-32 [10197607.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5025-30 [10220412.001]
  • [Cites] Genes Dev. 1999 May 1;13(9):1102-15 [10323862.001]
  • [Cites] Oncogene. 1999 Aug 5;18(31):4515-21 [10442642.001]
  • [Cites] Semin Cancer Biol. 1999 Aug;9(4):303-18 [10448117.001]
  • [Cites] Int J Cancer. 1999 Sep 24;83(1):30-3 [10449603.001]
  • [Cites] Nucleic Acids Res. 1995 Mar 11;23(5):835-43 [7708500.001]
  • [Cites] Mol Cell Biol. 1995 May;15(5):2800-8 [7739561.001]
  • [Cites] Mol Cell Biol. 1995 Aug;15(8):4562-71 [7623847.001]
  • [Cites] RNA. 1995 Sep;1(7):724-33 [7585257.001]
  • [Cites] J Clin Oncol. 1996 Apr;14(4):1245-51 [8648380.001]
  • [Cites] Science. 1996 Oct 25;274(5287):605-10 [8849451.001]
  • [Cites] EMBO J. 1996 Sep 16;15(18):5022-31 [8890175.001]
  • [Cites] Genomics. 1996 Nov 15;38(1):51-7 [8954779.001]
  • [Cites] Oncogene. 1996 Dec 19;13(12):2649-58 [9000139.001]
  • [Cites] J Clin Invest. 1997 Jan 15;99(2):239-47 [9005992.001]
  • [Cites] Oncogene. 1997 Jan 30;14(4):451-61 [9053842.001]
  • [Cites] Oncogene. 1997 Mar 20;14(11):1259-68 [9178886.001]
  • [Cites] EMBO J. 1997 Jul 16;16(14):4421-32 [9250686.001]
  • [Cites] J Cell Sci. 1997 Aug;110 ( Pt 15):1741-50 [9264461.001]
  • [Cites] Oncogene. 1997 Sep;15(11):1357-62 [9315104.001]
  • [Cites] J Biol Chem. 1997 Oct 24;272(43):27369-77 [9341188.001]
  • [Cites] Nat Genet. 1997 Dec;17(4):495-7 [9398859.001]
  • [Cites] Mol Endocrinol. 1998 Jan;12(1):4-18 [9440806.001]
  • [Cites] Mol Cell Biol. 1998 Mar;18(3):1489-97 [9488465.001]
  • [Cites] J Biol Chem. 1998 Feb 27;273(9):4838-42 [9478924.001]
  • [Cites] Cancer Res. 1999 Oct 15;59(20):5064-7 [10537274.001]
  • [Cites] J Biol Chem. 1999 Nov 26;274(48):34337-42 [10567410.001]
  • [Cites] Oncogene. 1999 Dec 9;18(52):7594-8 [10602519.001]
  • [Cites] Oncogene. 1999 Dec 23;18(56):8000-10 [10637511.001]
  • [Cites] Nat Genet. 2000 Feb;24(2):175-9 [10655065.001]
  • [Cites] EMBO J. 2000 Feb 1;19(3):453-62 [10654943.001]
  • [Cites] Mol Cell Biol. 2000 May;20(10):3345-54 [10779324.001]
  • [Cites] Oncogene. 2000 May 11;19(20):2413-22 [10828883.001]
  • [Cites] Genes Dev. 2000 Jun 15;14(12):1415-29 [10859161.001]
  • [Cites] Mol Cell Biol. 2000 Aug;20(16):6159-69 [10913197.001]
  • [Cites] J Biol Chem. 2000 Jul 28;275(30):23053-8 [10767297.001]
  • [Cites] J Biol Chem. 2000 Dec 1;275(48):37612-8 [10982800.001]
  • [Cites] Oncogene. 2000 Nov 23;19(50):5821-5 [11126370.001]
  • [Cites] Lab Invest. 2000 Dec;80(12):1833-44 [11140696.001]
  • [Cites] Oncogene. 2000 Dec 7;19(52):6015-22 [11146553.001]
  • [Cites] J Biol Chem. 2001 Mar 2;276(9):6807-16 [11098054.001]
  • [Cites] Cancer Res. 2001 Mar 15;61(6):2690-5 [11289149.001]
  • [Cites] Oncogene. 2001 Mar 22;20(12):1519-24 [11313895.001]
  • [Cites] Cancer Res. 2001 May 1;61(9):3586-90 [11325824.001]
  • [Cites] J Biol Chem. 2001 Jun 1;276(22):18681-7 [11278906.001]
  • [Cites] Oncogene. 2001 May 28;20(24):3014-20 [11420716.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):479-84 [17202261.001]
  • [Cites] Cell Res. 2007 Apr;17(4):286-8 [17426699.001]
  • [Cites] J Clin Invest. 2007 May;117(5):1314-23 [17415412.001]
  • [Cites] Cancer Lett. 2007 Aug 28;254(1):1-10 [17250957.001]
  • [Cites] J Mol Med (Berl). 2007 Sep;85(9):1015-29 [17453169.001]
  • [Cites] J Pathol. 2007 Sep;213(1):4-20 [17691072.001]
  • [Cites] PLoS One. 2007;2(10):e979 [17912356.001]
  • [Cites] Carcinogenesis. 2007 Oct;28(10):2069-73 [17468515.001]
  • [Cites] J Orthop Res. 2008 Jun;26(6):886-93 [18271016.001]
  • [Cites] FEBS Lett. 2008 Jun 18;582(14):1971-6 [18435923.001]
  • [Cites] Nature. 2008 Jul 3;454(7200):126-30 [18509338.001]
  • [Cites] PLoS One. 2008;3(7):e2569 [18596980.001]
  • [Cites] BMC Cell Biol. 2008;9:37 [18620564.001]
  • [Cites] Pathology. 2008 Oct;40(6):547-52 [18752119.001]
  • [Cites] Proteins. 2008 Sep;72(4):1125-37 [18320585.001]
  • [Cites] J Androl. 2008 Sep-Oct;29(5):572-9 [18567644.001]
  • [Cites] Biochem J. 2008 Oct 15;415(2):297-307 [18620545.001]
  • [Cites] Oncogene. 2008 Oct 9;27(46):6034-43 [18591936.001]
  • [Cites] Rev Recent Clin Trials. 2009 Jan;4(1):12-26 [19149759.001]
  • [Cites] BMC Cancer. 2009;9:17 [19144156.001]
  • [Cites] Biochem J. 2009 Mar 15;418(3):625-34 [19076070.001]
  • [Cites] Science. 2009 Feb 27;323(5918):1205-8 [19251627.001]
  • [Cites] Science. 2009 Feb 27;323(5918):1208-11 [19251628.001]
  • (PMID = 19783543.001).
  • [ISSN] 1759-4685
  • [Journal-full-title] Journal of molecular cell biology
  • [ISO-abbreviation] J Mol Cell Biol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Transcription Factors
  • [Number-of-references] 120
  • [Other-IDs] NLM/ PMC2905059
  •  go-up   go-down


2. Barbaro G, Barbarini G: HIV infection and cancer in the era of highly active antiretroviral therapy (Review). Oncol Rep; 2007 May;17(5):1121-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The majority of cancers affecting HIV-infected subjects are those established as acquired immunodeficiency syndrome (AIDS)-defining: Kaposi's sarcoma (KS), non-Hodgkin's lymphoma (NHL), and invasive cervical cancer (ICC).
  • However, other types of cancer, such as Hodgkin's disease (HD), anal cancer, lung cancer and testicular germ cell tumors appear to be more common among HIV-infected subjects compared to the general population.
  • While a significant decrease in the incidence of KS has been observed, HAART has not had a significant impact on NHL incidence, particularly systemic NHL, or on ICC, HD, anal cancers and other non-AIDS-defining cancers.


3. Lyle PL, Amato CM, Fitzpatrick JE, Robinson WA: Gastrointestinal melanoma or clear cell sarcoma? Molecular evaluation of 7 cases previously diagnosed as malignant melanoma. Am J Surg Pathol; 2008 Jun;32(6):858-66
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Gastrointestinal melanoma or clear cell sarcoma? Molecular evaluation of 7 cases previously diagnosed as malignant melanoma.
  • Clear cell sarcoma (CCS) is a rare tumor classically associated with the tendons and aponeuroses of distal extremities of young adults.
  • In total, we examined 7 cases: Four with no prior history of MM, 2 with histories of cutaneous MM, and 1 with an anal MM.
  • [MeSH-major] Gastrointestinal Neoplasms / diagnosis. Melanoma / diagnosis. Sarcoma, Clear Cell / diagnosis

  • MedlinePlus Health Information. consumer health - Melanoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18408594.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


Advertisement
4. Spugnini EP, Dotsinsky I, Mudrov N, Citro G, D'Avino A, Baldi A: Biphasic pulses enhance bleomycin efficacy in a spontaneous canine genital tumor model of chemoresistance: Sticker sarcoma. J Exp Clin Cancer Res; 2008;27:58
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Biphasic pulses enhance bleomycin efficacy in a spontaneous canine genital tumor model of chemoresistance: Sticker sarcoma.
  • Sticker's sarcoma (also known as transmissible venereal tumor) is a horizontally transmitted neoplasm of the dog, that is passed with coitus.
  • [MeSH-major] Anal Gland Neoplasms / drug therapy. Antibiotics, Antineoplastic / therapeutic use. Bleomycin / therapeutic use. Dog Diseases / drug therapy. Electrochemotherapy / veterinary. Sarcoma / veterinary. Venereal Tumors, Veterinary / drug therapy

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • Hazardous Substances Data Bank. BLEOMYCIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Biochem Cell Biol. 2008;40(2):159-63 [17977058.001]
  • [Cites] J Transl Med. 2007;5:48 [17910745.001]
  • [Cites] J Exp Clin Cancer Res. 2007 Dec;26(4):483-7 [18365542.001]
  • [Cites] In Vivo. 2008 Jan-Feb;22(1):47-9 [18396781.001]
  • [Cites] In Vivo. 2008 Jan-Feb;22(1):51-3 [18396782.001]
  • [Cites] Cancer Immunol Immunother. 2008 Jul;57(7):1091-104 [18259750.001]
  • [Cites] Vet J. 2008 Nov;178(2):291-3 [17910926.001]
  • [Cites] Vet J. 2009 Jan;179(1):117-20 [17904882.001]
  • [Cites] Vet Immunol Immunopathol. 2003 May 12;92(3-4):149-62 [12730015.001]
  • [Cites] J Immunol. 2004 Feb 1;172(3):1508-14 [14734728.001]
  • [Cites] Radiology. 2004 Mar;230(3):761-7 [14990840.001]
  • [Cites] J Exp Clin Cancer Res. 2003 Dec;22(4):571-80 [15053299.001]
  • [Cites] Cancer Chemother Pharmacol. 1992;29(3):214-8 [1733554.001]
  • [Cites] IEEE Eng Med Biol Mag. 1999 Jan-Feb;18(1):62-6 [9934602.001]
  • [Cites] J Vet Med A Physiol Pathol Clin Med. 2005 Sep;52(7):366-70 [16109105.001]
  • [Cites] J Exp Clin Cancer Res. 2005 Jun;24(2):245-54 [16110758.001]
  • [Cites] Melanoma Res. 2006 Feb;16(1):23-7 [16432452.001]
  • [Cites] J Vasc Interv Radiol. 2006 Feb;17(2 Pt 1):351-8 [16517782.001]
  • [Cites] Cell. 2006 Aug 11;126(3):445-7 [16901777.001]
  • [Cites] Cell. 2006 Aug 11;126(3):477-87 [16901782.001]
  • [Cites] Vet Rec. 2006 Oct 28;159(18):598-600 [17071674.001]
  • [Cites] Cancer Chemother Pharmacol. 2007 Feb;59(3):375-81 [16807731.001]
  • [Cites] Anticancer Res. 2006 Nov-Dec;26(6B):4585-9 [17201181.001]
  • [Cites] Bioelectrochemistry. 2007 May;70(2):283-6 [17150416.001]
  • [Cites] J Exp Clin Cancer Res. 2007 Sep;26(3):343-6 [17987793.001]
  • [Cites] In Vivo. 2007 Sep-Oct;21(5):819-22 [18019417.001]
  • [Cites] In Vivo. 2007 Sep-Oct;21(5):897-9 [18019432.001]
  • [Cites] Vet Rec. 2008 Feb 9;162(6):186-8 [18263920.001]
  • (PMID = 18980687.001).
  • [ISSN] 1756-9966
  • [Journal-full-title] Journal of experimental & clinical cancer research : CR
  • [ISO-abbreviation] J. Exp. Clin. Cancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Antibiotics, Antineoplastic; 11056-06-7 / Bleomycin
  • [Other-IDs] NLM/ PMC2596090
  •  go-up   go-down


5. Beaty O 3rd, Berg S, Blaney S, Malogolowkin M, Krailo M, Knight R, Schaiquevich P, Stewart C, Chen Z, Nelson M, Voss S, Ivy SP, Adamson PC: A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer; 2010 Sep;55(3):440-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PATIENTS AND METHODS: Subjects, < or =21 years of age at original diagnosis, received oxaliplatin (130 mg/m(2)) intravenously every 21 days.
  • Histologies included: Ewing sarcoma/peripheral PNET, osteosarcoma, rhabdomyosarcoma, neuroblastoma, high and low grade astrocytoma, brain stem glioma, ependymoma, hepatoblastoma and selected rare tumors.

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Cancer in Children.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2010 Wiley-Liss, Inc.
  • (PMID = 20658614.001).
  • [ISSN] 1545-5017
  • [Journal-full-title] Pediatric blood & cancer
  • [ISO-abbreviation] Pediatr Blood Cancer
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / U10CA98413; United States / NCI NIH HHS / CA / U10CA98543; United States / NCI NIH HHS / CA / U10 CA098413; United States / NCI NIH HHS / CA / U10 CA098543-08; United States / NCI NIH HHS / CA / U10 CA098543; United States / NCI NIH HHS / CA / U10 CA098413-08
  • [Publication-type] Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Organoplatinum Compounds; 04ZR38536J / oxaliplatin
  • [Other-IDs] NLM/ NIHMS218622; NLM/ PMC4665115
  •  go-up   go-down


6. Cermák V, Kosla J, Plachý J, Trejbalová K, Hejnar J, Dvorák M: The transcription factor EGR1 regulates metastatic potential of v-src transformed sarcoma cells. Cell Mol Life Sci; 2010 Oct;67(20):3557-68
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The transcription factor EGR1 regulates metastatic potential of v-src transformed sarcoma cells.
  • To advance our understanding of metastatic cancer dissemination, we have developed a model system that is based on two v-src transformed chicken sarcoma cell lines-the highly metastatic parental PR9692 and a non-metastasizing but fully tumorigenic clonal derivative PR9692-E9.
  • [MeSH-major] Cell Transformation, Neoplastic / genetics. Early Growth Response Protein 1 / metabolism. Neoplasm Metastasis / genetics. Oncogene Protein pp60(v-src) / metabolism. Sarcoma / genetics. Sarcoma / pathology

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cardiovasc Res. 2007 Oct 1;76(1):141-8 [17631285.001]
  • [Cites] Genome Res. 1999 Nov;9(11):1106-15 [10568750.001]
  • [Cites] Nat Cell Biol. 2003 Aug;5(8):711-9 [12844144.001]
  • [Cites] Nat Rev Cancer. 2007 Jun;7(6):415-28 [17508028.001]
  • [Cites] J Biol Chem. 2002 Mar 22;277(12):10050-7 [11790779.001]
  • [Cites] Mol Cancer Res. 2008 Sep;6(9):1410-20 [18819929.001]
  • [Cites] Lab Invest. 1996 Jul;75(1):55-66 [8683940.001]
  • [Cites] Cell Res. 2009 Jan;19(1):89-102 [19050696.001]
  • [Cites] Cancer Metastasis Rev. 2006 Mar;25(1):9-34 [16680569.001]
  • [Cites] Mol Cell Biol. 1996 May;16(5):2418-30 [8628310.001]
  • [Cites] Cancer Res. 2007 Dec 15;67(24):11476-9; discussion 11479-80 [18089773.001]
  • [Cites] Am J Physiol. 1997 Sep;273(3 Pt 2):H1415-26 [9321833.001]
  • [Cites] Endocr Relat Cancer. 2007 Jun;14(2):279-92 [17639044.001]
  • [Cites] J Biol Chem. 2009 Feb 20;284(8):5119-27 [19098287.001]
  • [Cites] J Cell Biol. 2000 Aug 21;150(4):797-806 [10953004.001]
  • [Cites] J Biol Chem. 2006 Aug 25;281(34):24381-9 [16807238.001]
  • [Cites] Dev Cell. 2004 Oct;7(4):585-95 [15469846.001]
  • [Cites] J Cell Biol. 2003 Jan 20;160(2):267-77 [12527751.001]
  • [Cites] Cell. 2004 Jun 25;117(7):927-39 [15210113.001]
  • [Cites] Immunogenetics. 1992;35(5):309-15 [1348493.001]
  • [Cites] Exp Cell Res. 2005 Aug 15;308(2):422-38 [15950966.001]
  • [Cites] Oncogene. 2009 Mar 12;28(10):1285-97 [19151753.001]
  • [Cites] J Biol Chem. 2006 Jul 28;281(30):21183-97 [16702209.001]
  • [Cites] J Virol. 1990 Mar;64(3):1070-8 [2154593.001]
  • [Cites] Carcinogenesis. 2000 Mar;21(3):497-503 [10688870.001]
  • [Cites] Folia Biol (Praha). 1984;30(3):189-201 [6090232.001]
  • [Cites] Anal Biochem. 1993 Mar;209(2):375-6 [8470813.001]
  • [Cites] Nat Rev Mol Cell Biol. 2008 Jun;9(6):446-54 [18464790.001]
  • [Cites] Virology. 1986 Sep;153(2):314-7 [3016994.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1846-51 [9050867.001]
  • [Cites] Mol Carcinog. 2000 Jun;28(2):63-9 [10900462.001]
  • [Cites] Genome Biol. 2004;5(10):R80 [15461798.001]
  • [Cites] Cancer Res. 1997 Dec 1;57(23 ):5226-31 [9393739.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12411-6 [16894163.001]
  • [Cites] Exp Cell Res. 1993 Jan;204(1):130-5 [7677984.001]
  • [Cites] Acta Histochem. 2010;112(1):3-25 [19162308.001]
  • [Cites] Biotechniques. 2003 Feb;34(2):374-8 [12613259.001]
  • [Cites] Stat Appl Genet Mol Biol. 2004;3:Article3 [16646809.001]
  • [Cites] J Cell Biol. 2008 Nov 3;183(3):543-54 [18955554.001]
  • [Cites] Clin Exp Metastasis. 2009;26(4):273-87 [18498004.001]
  • [Cites] Anticancer Res. 2002 Nov-Dec;22(6C):3963-70 [12553019.001]
  • [Cites] Am J Physiol Cell Physiol. 2007 Jan;292(1):C70-81 [16928770.001]
  • [Cites] Nat Cell Biol. 2002 Mar;4(3):246-50 [11854753.001]
  • [Cites] J Biol Chem. 1994 Dec 23;269(51):32551-7 [7798257.001]
  • [Cites] EMBO J. 2008 Oct 8;27(19):2603-15 [18772882.001]
  • [Cites] Ann Surg. 1993 Dec;218(6):705-12 [8257219.001]
  • [Cites] Biochem Biophys Res Commun. 2004 Jun 18;319(1):214-20 [15158464.001]
  • [Cites] Cancer Res. 2005 Jul 15;65(14 ):6139-50 [16024615.001]
  • [Cites] Nat Cell Biol. 2009 Mar;11(3):257-68 [19198601.001]
  • [Cites] Nucleic Acids Res. 2003 Feb 15;31(4):e15 [12582260.001]
  • [Cites] Cancer Metastasis Rev. 2009 Jun;28(1-2):15-33 [19169796.001]
  • [Cites] Sarcoma. 2003;7(2):63-7 [18521370.001]
  • (PMID = 20505979.001).
  • [ISSN] 1420-9071
  • [Journal-full-title] Cellular and molecular life sciences : CMLS
  • [ISO-abbreviation] Cell. Mol. Life Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Early Growth Response Protein 1; EC 2.7.10.2 / Oncogene Protein pp60(v-src)
  •  go-up   go-down


7. Butler LM, Osmond DH, Jones AG, Martin JN: Use of saliva as a lubricant in anal sexual practices among homosexual men. J Acquir Immune Defic Syndr; 2009 Feb 1;50(2):162-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Use of saliva as a lubricant in anal sexual practices among homosexual men.
  • OBJECTIVES: Compared with other sexually active adults, men who have sex with men (MSM) are more frequently infected with several pathogens including cytomegalovirus, hepatitis B virus, and Kaposi sarcoma-associated herpesvirus.
  • Because one common element between these organisms is their presence in saliva, we evaluated saliva exposure among MSM in a heretofore relatively unrecognized route-via use of saliva as a lubricant in anal sex.
  • METHODS: MSM in a San Francisco population-based cohort were interviewed regarding use of saliva by the insertive partner as a lubricant in various anal sexual practices.
  • RESULTS: Among 283 MSM, 87% used saliva as a lubricant in insertive or receptive penile-anal intercourse or fingering/fisting at some point during their lifetime; 31%-47% did so, depending upon the act, in the prior 6 months.
  • Even among MSM following safe sex guidelines by avoiding unprotected penile-anal intercourse, 26% had anal exposure to saliva via use as a lubricant.
  • CONCLUSIONS: Among MSM, use of saliva as a lubricant is a common, but not ubiquitous, practice in anal sex.

  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Epidemiol. 2000 Feb 1;151(3):225-9; discussion 230 [10670546.001]
  • [Cites] Sex Transm Dis. 2008 Dec;35(12):1011-4 [18665016.001]
  • [Cites] N Engl J Med. 2000 Nov 9;343(19):1369-77 [11070101.001]
  • [Cites] AIDS. 2001 Jan 26;15(2):245-50 [11216934.001]
  • [Cites] Clin Infect Dis. 2001 Oct 15;33(8):1406-11 [11550116.001]
  • [Cites] MMWR Recomm Rep. 2002 Jun 14;51(RR-8):1-52 [12081007.001]
  • [Cites] J Acquir Immune Defic Syndr. 2002 Aug 1;30(4):413-20 [12138348.001]
  • [Cites] J Infect Dis. 2004 Sep 15;190(6):1068-75 [15319855.001]
  • [Cites] JAMA. 1977 Dec 12;238(24):2625-6 [579199.001]
  • [Cites] J Infect Dis. 1980 Jul;142(1):67-71 [7400629.001]
  • [Cites] J Infect Dis. 1981 Feb;143(2):188-92 [6260871.001]
  • [Cites] Br Med J (Clin Res Ed). 1985 Jun 22;290(6485):1853-5 [3924282.001]
  • [Cites] JAMA. 1987 Jan 16;257(3):321-5 [3540327.001]
  • [Cites] J Hepatol. 1987 Feb;4(1):37-44 [3571932.001]
  • [Cites] J Infect Dis. 1987 Aug;156(2):299-307 [3598231.001]
  • [Cites] J Med Virol. 1993 Feb;39(2):156-62 [8387571.001]
  • [Cites] Am J Public Health. 1994 Dec;84(12):1933-7 [7998633.001]
  • [Cites] J Infect Dis. 1997 Jul;176(1):94-102 [9207354.001]
  • [Cites] N Engl J Med. 1998 Apr 2;338(14):948-54 [9521982.001]
  • [Cites] Am J Epidemiol. 1998 Mar 1;147(5):478-87 [9525535.001]
  • [Cites] Int J STD AIDS. 1998 Jun;9(6):330-5 [9671246.001]
  • [Cites] Clin Infect Dis. 1998 Jul;27(1):137-41 [9675467.001]
  • [Cites] J Infect Dis. 1999 Sep;180(3):600-6 [10438345.001]
  • [Cites] Eur J Gastroenterol Hepatol. 2005 Nov;17(11):1173-9 [16215428.001]
  • [Cites] Sex Transm Infect. 2006 Jun;82(3):229-35 [16731675.001]
  • [Cites] J Clin Microbiol. 2006 Jul;44(7):2409-15 [16825357.001]
  • [Cites] AIDS Behav. 2008 May;12(3):476-82 [17594139.001]
  • [Cites] J Med Virol. 2000 Aug;61(4):433-8 [10897060.001]
  • (PMID = 19131893.001).
  • [ISSN] 1525-4135
  • [Journal-full-title] Journal of acquired immune deficiency syndromes (1999)
  • [ISO-abbreviation] J. Acquir. Immune Defic. Syndr.
  • [Language] ENG
  • [Grant] United States / NIMH NIH HHS / MH / P30 MH062246; United States / NCI NIH HHS / CA / U01 CA078124; United States / NIMH NIH HHS / MH / T32 MH019105; United States / NIMH NIH HHS / MH / T32 MH19105; United States / NICHD NIH HHS / HD / K01 HD052020; United States / NIAID NIH HHS / AI / P30 AI027763; United States / NCI NIH HHS / CA / R01 CA119903; United States / NICHD NIH HHS / HD / K01 HD052020-01
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Lubricants
  • [Other-IDs] NLM/ NIHMS130804; NLM/ PMC3975591
  •  go-up   go-down


8. Rennel E, Waine E, Guan H, Schüler Y, Leenders W, Woolard J, Sugiono M, Gillatt D, Kleinerman E, Bates D, Harper S: The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice. Br J Cancer; 2008 Apr 08;98(7):1250-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here we show that overexpression of VEGF165b by tumour cells inhibits the growth of prostate carcinoma, Ewing's sarcoma and renal cell carcinoma in xenografted mouse tumour models.
  • [MeSH-minor] Alternative Splicing. Animals. Carcinoma, Renal Cell / pathology. Cell Movement / drug effects. Cell Proliferation / drug effects. Down-Regulation. Endothelial Cells / drug effects. Male. Mice. Mice, Nude. Neoplasm Transplantation. Neovascularization, Pathologic. Prostate / cytology. Prostate / drug effects. Prostatic Neoplasms / pathology. Protein Isoforms. Sarcoma, Ewing / pathology. Transfection

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Am Soc Nephrol. 2007 Mar;18(3):719-29 [17267748.001]
  • [Cites] Cell Mol Life Sci. 2006 Sep;63(17):2067-77 [16909199.001]
  • [Cites] Br J Cancer. 2007 Jul 16;97(2):223-30 [17595666.001]
  • [Cites] Oncogene. 2007 Aug 23;26(39):5808-15 [17353901.001]
  • [Cites] Biomed Pharmacother. 2008 Mar;62(3):158-63 [17851027.001]
  • [Cites] Int J Cancer. 2000 Jun 15;86(6):768-76 [10842189.001]
  • [Cites] Cancer Res. 2002 Jul 15;62(14):4123-31 [12124351.001]
  • [Cites] Semin Oncol. 2002 Dec;29(6 Suppl 16):10-4 [12516033.001]
  • [Cites] N Engl J Med. 2004 Jun 3;350(23):2335-42 [15175435.001]
  • [Cites] Endocr Rev. 2004 Aug;25(4):581-611 [15294883.001]
  • [Cites] Anal Biochem. 1987 Apr;162(1):156-9 [2440339.001]
  • [Cites] Mol Endocrinol. 1991 Dec;5(12):1806-14 [1791831.001]
  • [Cites] Nature. 1992 Oct 29;359(6398):843-5 [1279431.001]
  • [Cites] Cancer Res. 1995 Oct 15;55(20):4575-80 [7553632.001]
  • [Cites] J Urol. 1997 Jun;157(6):2323-8 [9146664.001]
  • [Cites] J Urol. 1997 Jun;157(6):2329-33 [9146665.001]
  • [Cites] Cancer Res. 2004 Nov 1;64(21):7647-54 [15520162.001]
  • [Cites] Cancer Res. 2004 Nov 1;64(21):7822-35 [15520188.001]
  • [Cites] N Engl J Med. 2004 Dec 30;351(27):2805-16 [15625332.001]
  • [Cites] Oncogene. 2005 Jan 27;24(5):889-901 [15580293.001]
  • [Cites] Diabetologia. 2005 Nov;48(11):2422-7 [16193288.001]
  • [Cites] Urology. 2006 Aug;68(2):244-8 [16904427.001]
  • [Cites] Cancer Lett. 2007 May 8;249(2):133-42 [17027147.001]
  • (PMID = 18349828.001).
  • [ISSN] 0007-0920
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Grant] United Kingdom / Cancer Research UK / / A5047; United Kingdom / British Heart Foundation / / BS/06/005/20340; United Kingdom / British Heart Foundation / / BB2000003; United Kingdom / British Heart Foundation / / BS06/005
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Protein Isoforms; 0 / VEGFA protein, human; 0 / Vascular Endothelial Growth Factor A
  • [Other-IDs] NLM/ PMC2359649; NLM/ UKMS3369
  •  go-up   go-down


9. Lagier-Tourenne C, Polymenidou M, Cleveland DW: TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet; 2010 Apr 15;19(R1):R46-64
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Landmark discoveries of mutations in the transactive response DNA-binding protein (TDP-43) and fused in sarcoma/translocated in liposarcoma (FUS/TLS) as causative of ALS and FTLD, combined with the abnormal aggregation of these proteins, have initiated a shifting paradigm for the underlying pathogenesis of multiple neurodegenerative diseases.

  • MedlinePlus Health Information. consumer health - Amyotrophic Lateral Sclerosis.
  • COS Scholar Universe. author profiles.
  • FlyBase. FlyBase .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 2008 Oct 24;283(43):28852-9 [18703504.001]
  • [Cites] J Biol Chem. 2008 Oct 31;283(44):30289-99 [18715868.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 2009 Mar;80(3):354-5 [19228676.001]
  • [Cites] Schizophr Res. 2009 Mar;108(1-3):297-8 [18829261.001]
  • [Cites] J Neuropathol Exp Neurol. 2009 Mar;68(3):262-73 [19225410.001]
  • [Cites] Science. 2009 Feb 27;323(5918):1205-8 [19251627.001]
  • [Cites] Science. 2009 Feb 27;323(5918):1208-11 [19251628.001]
  • [Cites] Acta Neuropathol. 2009 Apr;117(4):429-44 [19194716.001]
  • [Cites] J Biol Chem. 2009 Mar 20;284(12):8083-92 [19112176.001]
  • [Cites] Neuropathol Appl Neurobiol. 2009 Apr;35(2):222-5 [18986339.001]
  • [Cites] J Biol Chem. 2009 Mar 27;284(13):8516-24 [19164285.001]
  • [Cites] Hum Mutat. 2009 Apr;30(4):688-94 [19224587.001]
  • [Cites] Science. 2008 Mar 21;319(5870):1668-72 [18309045.001]
  • [Cites] J Neuropathol Exp Neurol. 2008 Apr;67(4):271-9 [18379440.001]
  • [Cites] Lancet Neurol. 2008 May;7(5):409-16 [18396105.001]
  • [Cites] J Neurochem. 2008 May;105(3):797-806 [18088371.001]
  • [Cites] Nat Genet. 2008 May;40(5):572-4 [18372902.001]
  • [Cites] Acta Neuropathol. 2008 Aug;116(2):193-203 [18560845.001]
  • [Cites] Acta Neuropathol. 2008 Aug;116(2):215-20 [18592255.001]
  • [Cites] Acta Neuropathol. 2008 Aug;116(2):205-13 [18607609.001]
  • [Cites] BMC Cell Biol. 2008;9:37 [18620564.001]
  • [Cites] Neuropathol Appl Neurobiol. 2008 Aug;34(4):446-56 [18657254.001]
  • [Cites] Ann Neurol. 2008 Jul;64(1):60-70 [18546284.001]
  • [Cites] Proc Natl Acad Sci U S A. 2009 May 5;106(18):7607-12 [19383787.001]
  • [Cites] Neurology. 2009 May 12;72(19):1669-76 [19433740.001]
  • [Cites] FEBS Lett. 2009 May 19;583(10):1586-92 [19379745.001]
  • [Cites] Eur J Neurol. 2009 Jun;16(6):727-32 [19236453.001]
  • [Cites] Nat Rev Mol Cell Biol. 2009 Jun;10(6):430-6 [19461665.001]
  • [Cites] Neurobiol Aging. 2009 Aug;30(8):1329-31 [18068872.001]
  • [Cites] Neurobiol Aging. 2009 Aug;30(8):1272-5 [19450904.001]
  • [Cites] Muscle Nerve. 2009 Jul;40(1):19-31 [19533646.001]
  • [Cites] Acta Neuropathol. 2009 Aug;118(2):303-11 [19283396.001]
  • [Cites] Nucleic Acids Res. 2009 Jul;37(12):4116-26 [19429692.001]
  • [Cites] J Biol Chem. 2009 Jul 24;284(30):20329-39 [19465477.001]
  • [Cites] J Neurochem. 2009 Aug;110(3):1082-94 [19522733.001]
  • [Cites] J Struct Biol. 2009 Sep;167(3):235-41 [19539030.001]
  • [Cites] Acta Neuropathol. 2009 Sep;118(3):359-69 [19330339.001]
  • [Cites] Acta Neuropathol. 2009 Sep;118(3):349-58 [19455346.001]
  • [Cites] Neurology. 2009 Oct 13;73(15):1176-9 [19741216.001]
  • [Cites] Mol Brain. 2009;2:30 [19781077.001]
  • [Cites] J Neurochem. 2009 Nov;111(4):1051-61 [19765185.001]
  • [Cites] Neuromuscul Disord. 2009 Nov;19(11):766-72 [19828315.001]
  • [Cites] Brain. 2009 Nov;132(Pt 11):2922-31 [19674978.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 2009 Nov;80(11):1283-5 [19864663.001]
  • [Cites] Nature. 2007 Jun 14;447(7146):859-63 [17568747.001]
  • [Cites] Acta Neuropathol. 2007 Jul;114(1):71-9 [17569066.001]
  • [Cites] Acta Neuropathol. 2007 Jul;114(1):5-22 [17579875.001]
  • [Cites] Am J Pathol. 2007 Jul;171(1):227-40 [17591968.001]
  • [Cites] Acta Neuropathol. 2007 Sep;114(3):221-9 [17653732.001]
  • [Cites] Mol Cell Biol. 2007 Sep;27(18):6469-83 [17562864.001]
  • [Cites] Genes Dev. 2007 Sep 1;21(17):2172-81 [17785525.001]
  • [Cites] Acta Neuropathol. 2007 Oct;114(4):335-45 [17639426.001]
  • [Cites] J Neurosci. 2007 Sep 26;27(39):10530-4 [17898224.001]
  • [Cites] J Neuropathol Exp Neurol. 2007 Oct;66(10):884-91 [17917582.001]
  • [Cites] Front Biosci. 2008;13:867-78 [17981595.001]
  • [Cites] Acta Neuropathol. 2008 Jan;115(1):133-45 [17713769.001]
  • [Cites] Acta Neuropathol. 2008 Jan;115(1):123-31 [18004574.001]
  • [Cites] Brain Res. 2007 Dec 12;1184:284-94 [17963732.001]
  • [Cites] J Biol Chem. 2007 Dec 14;282(50):36143-54 [17932037.001]
  • [Cites] J Neuropathol Exp Neurol. 2008 Jan;67(1):62-7 [18091558.001]
  • [Cites] Neurology. 2008 Jan 8;70(2):144-52 [18180444.001]
  • [Cites] Cell. 2008 Jan 11;132(1):27-42 [18191218.001]
  • [Cites] J Biol Chem. 2008 Jan 18;283(3):1744-53 [17984093.001]
  • [Cites] J Biol Chem. 2008 Mar 7;283(10):6489-500 [18167354.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3785-9 [18305152.001]
  • [Cites] Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18809-14 [19833869.001]
  • [Cites] J Neuropathol Exp Neurol. 2009 Nov;68(11):1167-76 [19816201.001]
  • [Cites] Neuroscience. 2009 Dec 29;164(4):1565-78 [19782731.001]
  • [Cites] J Mol Cell Biol. 2009 Dec;1(2):82-92 [19783543.001]
  • [Cites] Arch Neurol. 2009 Dec;66(12):1483-8 [20008652.001]
  • [Cites] J Cell Biol. 2009 Dec 14;187(6):761-72 [19951898.001]
  • [Cites] J Cell Biol. 2009 Dec 14;187(6):875-88 [20008565.001]
  • [Cites] Mol Cell Biol. 2010 Jan;30(1):186-96 [19841068.001]
  • [Cites] Hum Mol Genet. 2010 Jan 15;19(2):313-28 [19864493.001]
  • [Cites] J Biol Chem. 2010 Jan 1;285(1):608-19 [19887443.001]
  • [Cites] EMBO J. 2010 Jan 6;29(1):209-21 [19910924.001]
  • [Cites] Genesis. 2010 Jan;48(1):56-62 [20014337.001]
  • [Cites] J Neurosci. 2010 Jan 13;30(2):639-49 [20071528.001]
  • [Cites] Biochem Soc Trans. 2010 Feb;38(Pt 1):150-5 [20074050.001]
  • [Cites] Hum Mol Genet. 2010 Feb 15;19(4):671-83 [19959528.001]
  • [Cites] J Exp Med. 2010 Jan 18;207(1):117-28 [20026663.001]
  • [Cites] Acta Neuropathol. 2009 Nov;118(5):617-27 [19830439.001]
  • [Cites] Arch Neurol. 2008 Sep;65(9):1185-9 [18779421.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 2008 Oct;79(10):1186-9 [18796596.001]
  • [Cites] Biochem J. 2008 Oct 15;415(2):297-307 [18620545.001]
  • [Cites] PLoS Genet. 2008;4(9):e1000193 [18802454.001]
  • [Cites] BMC Neurol. 2008;8:32 [18755042.001]
  • [Cites] J Neurol Sci. 2010 Feb 15;289(1-2):149-54 [19732908.001]
  • [Cites] Neurosci Lett. 2010 Jan 18;469(1):112-6 [19944744.001]
  • [Cites] Neurosci Res. 2010 Jan;66(1):131-3 [19833157.001]
  • [Cites] Neurology. 2010 Feb 2;74(5):366-71 [20124201.001]
  • [Cites] J Proteome Res. 2010 Feb 5;9(2):1104-20 [20020773.001]
  • [Cites] Arch Neurol. 2010 Feb;67(2):224-30 [20142531.001]
  • [Cites] BMC Med Genet. 2010;11:8 [20082726.001]
  • [Cites] Intern Med. 2010;49(4):331-4 [20154440.001]
  • [Cites] Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3169-74 [20133767.001]
  • [Cites] J Biol Chem. 2010 Feb 26;285(9):6826-34 [20040602.001]
  • [Cites] Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3858-63 [20133711.001]
  • [Cites] Nucleic Acids Res. 2010 Mar;38(4):1353-66 [19965769.001]
  • [Cites] EMBO J. 2010 Mar 3;29(5):969-80 [20075865.001]
  • [Cites] Acta Neuropathol. 2010 Apr;119(4):409-19 [20198480.001]
  • [Cites] J Med Genet. 2010 Mar;47(3):190-4 [19861302.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6439-44 [18434538.001]
  • [Cites] Ann Neurol. 2008 Apr;63(4):535-8 [18288693.001]
  • [Cites] Ann Neurol. 2008 Apr;63(4):538-42 [18438952.001]
  • [Cites] Brain. 2008 May;131(Pt 5):1282-93 [18362096.001]
  • [Cites] J Biol Chem. 2008 May 9;283(19):13302-9 [18305110.001]
  • [Cites] J Neurol Sci. 2008 Jun 15;269(1-2):30-4 [18206910.001]
  • [Cites] Neurology. 2008 May 6;70(19 Pt 2):1850-7 [18401022.001]
  • [Cites] Arch Neurol. 2008 May;65(5):636-41 [18474740.001]
  • [Cites] J Neuropathol Exp Neurol. 2008 Jun;67(6):555-64 [18520774.001]
  • [Cites] PLoS One. 2008;3(6):e2450 [18545701.001]
  • [Cites] Expert Opin Biol Ther. 2008 Jul;8(7):969-78 [18549326.001]
  • [Cites] Am J Pathol. 2008 Jul;173(1):182-94 [18535185.001]
  • [Cites] Nature. 2008 Jul 3;454(7200):126-30 [18509338.001]
  • [Cites] Acta Neuropathol. 2008 Aug;116(2):169-82 [18481073.001]
  • [Cites] Acta Neuropathol. 2008 Aug;116(2):221-2 [18521613.001]
  • [Cites] Acta Neuropathol. 2008 Aug;116(2):147-57 [18536926.001]
  • [Cites] Acta Neuropathol. 2008 Aug;116(2):159-67 [18553091.001]
  • [Cites] J Cell Sci. 2008 Nov 15;121(Pt 22):3778-85 [18957508.001]
  • [Cites] Acta Neuropathol. 2008 Dec;116(6):625-37 [18843496.001]
  • [Cites] BMC Neurosci. 2008;9:104 [18957104.001]
  • [Cites] J Neural Transm (Vienna). 2008 Dec;115(12):1661-71 [18974920.001]
  • [Cites] Acta Neuropathol. 2009 Jan;117(1):45-53 [18923836.001]
  • [Cites] Acta Neuropathol. 2009 Jan;117(1):15-8 [19015862.001]
  • [Cites] Mamm Genome. 2008 May;19(5):299-305 [18592312.001]
  • [Cites] FEBS Lett. 2008 Aug 20;582(19):2899-904 [18656473.001]
  • [Cites] PLoS One. 2008;3(8):e2926 [18698352.001]
  • [Cites] Nucleic Acids Symp Ser (Oxf). 2008;(52):213-4 [18776329.001]
  • [Cites] Neuroscience. 2009 Jan 23;158(2):745-50 [19013502.001]
  • [Cites] Nat Rev Mol Cell Biol. 2009 Feb;10(2):126-39 [19165215.001]
  • [Cites] Acta Neuropathol. 2009 Feb;117(2):151-8 [19039597.001]
  • [Cites] Acta Neuropathol. 2009 Feb;117(2):209-11 [19066918.001]
  • [Cites] Acta Neuropathol. 2009 Feb;117(2):137-49 [19125255.001]
  • [Cites] Acta Neuropathol. 2009 Feb;117(2):125-36 [19139911.001]
  • [Cites] Nat Genet. 2009 Feb;41(2):163-5 [19136952.001]
  • [Cites] J Med Genet. 2009 Feb;46(2):112-4 [18931000.001]
  • [Cites] Mov Disord. 2009 Jan 15;24(1):32-9 [19006185.001]
  • [Cites] Nat Struct Mol Biol. 2009 Feb;16(2):130-7 [19136955.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 2010 Jun;81(6):639-45 [19965854.001]
  • [Cites] Acta Neurol Scand. 2010 Nov;122(5):367-72 [20175762.001]
  • [Cites] Neurobiol Aging. 2011 Mar;32(3):548.e1-4 [20018407.001]
  • [Cites] Neurobiol Aging. 2011 Mar;32(3):550.e1-4 [20138404.001]
  • [Cites] Acta Neuropathol. 2010 Mar;119(3):365-74 [19876635.001]
  • [Cites] Acta Neuropathol. 2010 Mar;119(3):355-64 [19967541.001]
  • [Cites] Eur J Neurol. 2010 May;17(5):754-6 [19922450.001]
  • [Cites] Int J Mol Sci. 2009 Jan;10(1):232-46 [19333444.001]
  • [Cites] Mol Ther. 2009 Apr;17(4):607-13 [19223871.001]
  • [Cites] Nucleic Acids Res. 2009 Apr;37(6):1799-808 [19174564.001]
  • [Cites] Parkinsonism Relat Disord. 2009 May;15(4):281-6 [18723384.001]
  • [Cites] Ann Neurol. 2009 Apr;65(4):470-3 [19350673.001]
  • [Cites] Genes Dev. 2000 Jun 15;14(12):1415-29 [10859161.001]
  • [Cites] Nat Neurosci. 2000 Jul;3(7):661-9 [10862698.001]
  • [Cites] J Neurol Sci. 2000 Nov 1;180(1-2):15-20 [11090859.001]
  • [Cites] J Biol Chem. 2001 Mar 2;276(9):6807-16 [11098054.001]
  • [Cites] EMBO J. 2001 Apr 2;20(7):1774-84 [11285240.001]
  • [Cites] EMBO J. 2001 Apr 2;20(7):1785-96 [11285241.001]
  • [Cites] J Biol Chem. 2001 Apr 20;276(16):13395-401 [11278855.001]
  • [Cites] Cancer Res. 2001 May 1;61(9):3586-90 [11325824.001]
  • [Cites] J Biol Chem. 2001 Sep 28;276(39):36337-43 [11470789.001]
  • [Cites] J Orthop Res. 2002 Jul;20(4):723-9 [12168660.001]
  • [Cites] Exp Cell Res. 2002 Aug 15;278(2):125-32 [12169268.001]
  • [Cites] Genome Res. 2002 Aug;12(8):1231-45 [12176931.001]
  • [Cites] Nature. 2002 Sep 12;419(6903):182-5 [12226669.001]
  • [Cites] Neurology. 2002 Oct 8;59(7):1077-9 [12370467.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13583-8 [12361981.001]
  • [Cites] Acta Neuropathol. 2009 Sep;118(3):407-13 [19557423.001]
  • [Cites] J Neurol Sci. 2009 Sep 15;284(1-2):69-71 [19411082.001]
  • [Cites] Neuropathology. 2009 Aug;29(4):466-71 [18715271.001]
  • [Cites] J Biol Chem. 2009 Aug 14;284(33):22059-66 [19535326.001]
  • [Cites] Neurosci Lett. 2009 Sep 29;463(1):87-92 [19539703.001]
  • [Cites] Neurology. 2009 Aug 18;73(7):511-7 [19687452.001]
  • [Cites] Hum Mol Genet. 2009 Sep 15;18(18):3353-64 [19515851.001]
  • [Cites] J Neurochem. 2009 Sep;110(5):1457-68 [19558455.001]
  • [Cites] Acta Neuropathol. 2009 Oct;118(4):561-73 [19449021.001]
  • [Cites] Acta Neuropathol. 2009 Oct;118(4):553-60 [19526244.001]
  • [Cites] Nucleic Acids Symp Ser (Oxf). 2009;(53):247-8 [19749353.001]
  • [Cites] Mov Disord. 2009 Sep 15;24(12):1843-7 [19609911.001]
  • [Cites] Brain Res. 2009 Nov 3;1296:176-86 [19619516.001]
  • [Cites] Neuromuscul Disord. 2009 Oct;19(10):696-700 [19695877.001]
  • [Cites] Neuropathology. 2009 Oct;29(5):566-73 [19422539.001]
  • [Cites] J Biol Chem. 2009 Oct 2;284(40):27416-24 [19651785.001]
  • [Cites] Neurology. 2009 Oct 13;73(15):1180-5 [19741215.001]
  • [Cites] Nat Genet. 1993 Jun;4(2):175-80 [7503811.001]
  • [Cites] Genes Dev. 1994 Nov 1;8(21):2513-26 [7958914.001]
  • [Cites] Oncogene. 1994 Dec;9(12):3717-29 [7970732.001]
  • [Cites] J Virol. 1995 Jun;69(6):3584-96 [7745706.001]
  • [Cites] RNA. 1995 Sep;1(7):724-33 [7585257.001]
  • [Cites] EMBO J. 1996 Sep 16;15(18):5022-31 [8890175.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 2009 Nov;80(11):1286-8 [19864664.001]
  • [Cites] Acta Neuropathol. 2009 Nov;118(5):633-45 [19618195.001]
  • [Cites] Acta Neuropathol. 2009 Nov;118(5):605-16 [19669651.001]
  • [Cites] Hum Mutat. 2009 Nov;30(11):E974-83 [19655382.001]
  • [Cites] Mol Endocrinol. 1998 Jan;12(1):4-18 [9440806.001]
  • [Cites] Mol Cell Biol. 1998 Mar;18(3):1489-97 [9488465.001]
  • [Cites] J Biol Chem. 1998 Feb 27;273(9):4838-42 [9478924.001]
  • [Cites] Neuron. 1998 Mar;20(3):589-602 [9539131.001]
  • [Cites] EMBO J. 1998 Aug 3;17(15):4442-55 [9687511.001]
  • [Cites] Gene. 1998 Oct 23;221(2):191-8 [9795213.001]
  • [Cites] Neurology. 1998 Dec;51(6):1546-54 [9855500.001]
  • [Cites] Oncogene. 1999 Aug 5;18(31):4515-21 [10442642.001]
  • [Cites] Nature. 2004 Nov 11;432(7014):235-40 [15531877.001]
  • [Cites] Mol Biol Cell. 2004 Dec;15(12):5383-98 [15371533.001]
  • [Cites] Curr Biol. 2005 Mar 29;15(6):587-93 [15797031.001]
  • [Cites] J Mol Biol. 2005 May 6;348(3):575-88 [15826655.001]
  • [Cites] Neurosci Lett. 2005 May 13;379(3):152-7 [15843054.001]
  • [Cites] Neurology. 2005 Aug 23;65(4):586-90 [16116120.001]
  • [Cites] Gastroenterology. 2005 Oct;129(4):1225-36 [16230076.001]
  • [Cites] Nucleic Acids Res. 2005;33(18):6000-10 [16254078.001]
  • [Cites] J Biol Chem. 2005 Nov 11;280(45):37572-84 [16157593.001]
  • [Cites] Acta Neuropathol. 2009 Nov;118(5):629-31 [19844730.001]
  • [Cites] Acta Neuropathol. 2009 Nov;118(5):719-20 [19844732.001]
  • [Cites] Acta Neuropathol. 2010 Jan;119(1):1-4 [19924424.001]
  • [Cites] J Neurosci Res. 2010 Mar;88(4):784-97 [19798749.001]
  • [Cites] J Am Chem Soc. 2010 Feb 3;132(4):1186-7 [20055380.001]
  • [Cites] Nature. 2006 Jun 15;441(7095):880-4 [16625205.001]
  • [Cites] Mol Cell. 2006 Jun 23;22(6):713-7 [16793541.001]
  • [Cites] Dev Biol. 2006 Jul 15;295(2):781-90 [16730344.001]
  • [Cites] EMBO J. 2006 Jul 26;25(14):3357-66 [16810319.001]
  • [Cites] Nat Rev Neurosci. 2006 Sep;7(9):710-23 [16924260.001]
  • [Cites] Nature. 2006 Aug 24;442(7105):920-4 [16862115.001]
  • [Cites] Nature. 2006 Aug 24;442(7105):916-9 [16862116.001]
  • [Cites] J Mol Biol. 2006 Oct 13;363(1):27-38 [16965792.001]
  • [Cites] Am J Pathol. 2006 Oct;169(4):1343-52 [17003490.001]
  • [Cites] Neuron. 2006 Oct 5;52(1):39-59 [17015226.001]
  • [Cites] Science. 2006 Oct 6;314(5796):130-3 [17023659.001]
  • [Cites] Biochem Biophys Res Commun. 2006 Dec 22;351(3):602-11 [17084815.001]
  • [Cites] Proteomics. 2006 Nov;6(22):5962-72 [17106916.001]
  • [Cites] Curr Biol. 2006 Dec 5;16(23):2345-51 [17141617.001]
  • [Cites] Curr Alzheimer Res. 2006 Dec;3(5):485-91 [17168647.001]
  • [Cites] PLoS Genet. 2010 Mar;6(3):e1000887 [20361056.001]
  • [Cites] J Biol Chem. 2010 Apr 9;285(15):11068-72 [20154090.001]
  • [Cites] Hum Mol Genet. 2010 May 1;19(9):1741-55 [20147319.001]
  • [Cites] Autophagy. 2010 Feb;6(2):217-27 [20104022.001]
  • [Cites] Neurogenetics. 2010 May;11(2):217-25 [19760257.001]
  • [Cites] J Hum Genet. 2010 Apr;55(4):252-4 [20224596.001]
  • [Cites] Hum Mutat. 2010 May;31(5):E1377-89 [20232451.001]
  • [Cites] Amyotroph Lateral Scler. 2010;11(1-2):240-3 [19306141.001]
  • [Cites] Amyotroph Lateral Scler. 2010;11(1-2):223-7 [19714537.001]
  • [Cites] Brain Pathol. 2010 Mar;20(2):351-60 [19338576.001]
  • [Cites] J Neurol. 2010 May;257(5):747-53 [19946779.001]
  • [Cites] Neuropathology. 2009 Dec;29(6):689-96 [19170893.001]
  • [Cites] Neuropathology. 2009 Dec;29(6):672-83 [19496940.001]
  • [Cites] Neuropathology. 2010 Apr;30(2):170-81 [20102522.001]
  • [Cites] Cell Mol Neurobiol. 2010 May;30(4):641-52 [20043239.001]
  • [Cites] Brain Pathol. 2010 May;20(3):589-97 [19832837.001]
  • [Cites] Trends Mol Med. 2008 Nov;14(11):479-85 [18929508.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16719-24 [12477934.001]
  • [Cites] Exp Cell Res. 2003 Feb 15;283(2):184-95 [12581738.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 2003 May;74(5):683-6 [12700323.001]
  • [Cites] Anal Chem. 2003 Jul 1;75(13):3107-14 [12964758.001]
  • [Cites] Annu Rev Neurosci. 2003;26:267-98 [12704221.001]
  • [Cites] Genomics. 2004 Jan;83(1):130-9 [14667816.001]
  • [Cites] Nature. 2008 Nov 27;456(7221):464-9 [18978773.001]
  • [Cites] J Neuropathol Exp Neurol. 2008 Dec;67(12):1159-65 [19018245.001]
  • [Cites] Brain Res. 2009 Jan 16;1249:202-11 [19046946.001]
  • [Cites] Neurosci Lett. 2009 Jan 30;450(2):163-6 [19103256.001]
  • [Cites] J Biol Chem. 1999 Nov 26;274(48):34337-42 [10567410.001]
  • [Cites] Oncogene. 1999 Dec 23;18(56):8000-10 [10637511.001]
  • [Cites] Nat Genet. 2000 Feb;24(2):175-9 [10655065.001]
  • [Cites] EMBO J. 2000 Feb 1;19(3):453-62 [10654943.001]
  • [Cites] Mol Cell Biol. 2000 May;20(10):3345-54 [10779324.001]
  • [Cites] Cell. 2003 Dec 12;115(6):727-38 [14675537.001]
  • [Cites] Cell Signal. 2004 Apr;16(4):515-20 [14709340.001]
  • [Cites] Nature. 2004 Feb 26;427(6977):801 [14985749.001]
  • [Cites] Nat Genet. 2004 Apr;36(4):377-81 [15034582.001]
  • [Cites] EMBO J. 2004 Apr 21;23(8):1782-91 [15057275.001]
  • [Cites] Cell. 2004 May 28;117(5):649-62 [15163412.001]
  • [Cites] Neuron. 2004 Aug 19;43(4):513-25 [15312650.001]
  • [Cites] J Biol Chem. 2004 Oct 22;279(43):44834-40 [15299008.001]
  • [Cites] Ann Neurol. 1993 Feb;33(2):200-7 [8257465.001]
  • [Cites] Nature. 1993 Mar 4;362(6415):59-62 [8446170.001]
  • [Cites] Nature. 1993 Jun 17;363(6430):640-4 [8510758.001]
  • [Cites] J Neuropathol Exp Neurol. 2007 Feb;66(2):152-7 [17279000.001]
  • [Cites] J Neuropathol Exp Neurol. 2007 Mar;66(3):177-83 [17356379.001]
  • [Cites] Acta Neuropathol. 2007 May;113(5):521-33 [17219193.001]
  • [Cites] Acta Neuropathol. 2007 May;113(5):535-42 [17333220.001]
  • [Cites] Acta Neuropathol. 2007 May;113(5):543-8 [17415574.001]
  • [Cites] Brain. 2007 May;130(Pt 5):1375-85 [17360763.001]
  • [Cites] Brain. 2007 May;130(Pt 5):1360-74 [17439980.001]
  • [Cites] Brain. 2007 May;130(Pt 5):1386-94 [17439983.001]
  • [Cites] Ann Neurol. 2007 May;61(5):427-34 [17469116.001]
  • [Cites] Ann Neurol. 2007 May;61(5):435-45 [17469117.001]
  • [Cites] Neurosci Lett. 2007 Jun 13;420(2):128-32 [17543992.001]
  • [Cites] Mol Cell Neurosci. 2007 Jun;35(2):320-7 [17481916.001]
  • [Cites] Genomics. 1996 Oct 1;37(1):1-8 [8921363.001]
  • [Cites] Oncogene. 1997 Jan 30;14(4):451-61 [9053842.001]
  • [Cites] EMBO J. 1997 Jul 16;16(14):4421-32 [9250686.001]
  • [Cites] J Cell Sci. 1997 Aug;110 ( Pt 15):1741-50 [9264461.001]
  • [Cites] J Cell Sci. 2005 Dec 15;118(Pt 24):5755-65 [16317045.001]
  • [Cites] FEBS Lett. 2006 Feb 20;580(5):1339-44 [16458894.001]
  • [Cites] Mol Cell Proteomics. 2006 Apr;5(4):635-51 [16352523.001]
  • [Cites] Brief Funct Genomic Proteomic. 2006 Mar;5(1):8-14 [16769671.001]
  • [Cites] Nature. 2006 Jun 15;441(7095):885-9 [16625204.001]
  • (PMID = 20400460.001).
  • [ISSN] 1460-2083
  • [Journal-full-title] Human molecular genetics
  • [ISO-abbreviation] Hum. Mol. Genet.
  • [Language] eng
  • [Grant] United Kingdom / Wellcome Trust / / 089701; United States / NINDS NIH HHS / NS / R37 NS027036
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA-Binding Proteins; 0 / RNA-Binding Protein FUS
  • [Number-of-references] 295
  • [Other-IDs] NLM/ PMC3167692
  •  go-up   go-down


10. Carroll KD, Bu W, Palmeri D, Spadavecchia S, Lynch SJ, Marras SA, Tyagi S, Lukac DM: Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway. J Virol; 2006 Oct;80(19):9697-709
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway.
  • Kaposi's sarcoma-associated herpesvirus (KSHV) lytic switch protein, Rta, is a ligand-independent inducer of the Notch signal transduction pathway, and KSHV cannot reactivate from latency in cells null for the Notch target protein RBP-Jk.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nucleic Acids Res. 1994 Aug 11;22(15):2938-44 [8065905.001]
  • [Cites] J Virol. 1995 Jan;69(1):253-62 [7983717.001]
  • [Cites] J Virol. 1995 Mar;69(3):1944-50 [7853539.001]
  • [Cites] Science. 1995 Apr 28;268(5210):560-3 [7725102.001]
  • [Cites] Lancet. 1995 Sep 23;346(8978):799-802 [7674745.001]
  • [Cites] Nature. 1995 Sep 28;377(6547):355-8 [7566092.001]
  • [Cites] Genes Dev. 1995 Nov 1;9(21):2598-608 [7590238.001]
  • [Cites] Mol Cell Biol. 1996 Mar;16(3):952-9 [8622698.001]
  • [Cites] Development. 2004 Mar;131(5):965-73 [14973298.001]
  • [Cites] J Virol. 2004 Apr;78(8):3941-52 [15047810.001]
  • [Cites] J Virol. 2004 Apr;78(8):4248-67 [15047839.001]
  • [Cites] Immunity. 2004 May;20(5):611-22 [15142529.001]
  • [Cites] J Virol. 2004 Jul;78(13):6818-26 [15194757.001]
  • [Cites] Semin Cancer Biol. 2004 Oct;14(5):317-9 [15288256.001]
  • [Cites] EMBO J. 2004 Sep 1;23(17):3441-51 [15297877.001]
  • [Cites] Science. 2004 Oct 8;306(5694):269-71 [15472075.001]
  • [Cites] J Virol. 1987 May;61(5):1310-7 [3033261.001]
  • [Cites] Gene Anal Tech. 1988 Mar-Apr;5(2):22-31 [3192155.001]
  • [Cites] Nature. 1989 Aug 3;340(6232):393-7 [2547164.001]
  • [Cites] Proc Natl Acad Sci U S A. 1989 Dec;86(23):9558-62 [2556717.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Oct;87(19):7390-4 [2170976.001]
  • [Cites] J Virol. 1991 May;65(5):2164-9 [1850003.001]
  • [Cites] J Virol. 1991 May;65(5):2545-54 [1850028.001]
  • [Cites] J Virol. 1991 Aug;65(8):4101-6 [1649318.001]
  • [Cites] Annu Rev Immunol. 2005;23:945-74 [15771590.001]
  • [Cites] J Virol. 2005 May;79(9):5640-52 [15827179.001]
  • [Cites] J Virol. 2005 Jul;79(14):8750-63 [15994769.001]
  • [Cites] Cancer Cell. 2005 Jul;8(1):13-23 [16023595.001]
  • [Cites] Oncogene. 2005 Sep 22;24(42):6333-44 [15940249.001]
  • [Cites] J Virol. 2005 Nov;79(22):14371-82 [16254371.001]
  • [Cites] FEBS Lett. 1996 Oct 21;395(2-3):221-4 [8898100.001]
  • [Cites] J Virol. 2000 Feb;74(4):1939-47 [10644367.001]
  • [Cites] Mol Cell Biol. 2000 Apr;20(7):2400-10 [10713164.001]
  • [Cites] J Biol Chem. 2000 Jun 2;275(22):17211-20 [10747963.001]
  • [Cites] Genes Dev. 2000 Jun 1;14(11):1343-52 [10837027.001]
  • [Cites] J Virol. 2000 Jul;74(13):6207-12 [10846108.001]
  • [Cites] J Virol. 2000 Sep;74(18):8623-34 [10954564.001]
  • [Cites] Blood. 2000 Sep 1;96(5):1906-13 [10961893.001]
  • [Cites] Nat Genet. 2000 Dec;26(4):484-9 [11101851.001]
  • [Cites] J Virol Methods. 2001 Feb;91(2):109-17 [11164492.001]
  • [Cites] J Virol. 2001 Mar;75(5):2033-40 [11160707.001]
  • [Cites] J Virol. 2001 Jul;75(13):5899-912 [11390591.001]
  • [Cites] Development. 1996 May;122(5):1373-83 [8625826.001]
  • [Cites] J Exp Med. 1996 May 1;183(5):2283-91 [8642337.001]
  • [Cites] Genes Dev. 1996 Aug 1;10(15):1930-44 [8756350.001]
  • [Cites] J Clin Invest. 1997 May 1;99(9):2082-6 [9151779.001]
  • [Cites] Mol Cell Biol. 1997 Sep;17(9):5620-8 [9271437.001]
  • [Cites] Development. 1997 Oct;124(20):4133-41 [9374409.001]
  • [Cites] Mol Cell Biol. 1998 Jan;18(1):644-54 [9418910.001]
  • [Cites] Mol Cell Biol. 1998 Apr;18(4):2077-88 [9528780.001]
  • [Cites] Cell. 1998 May 15;93(4):649-60 [9604939.001]
  • [Cites] Nature. 1998 May 28;393(6683):382-6 [9620803.001]
  • [Cites] Genes Dev. 1998 Aug 1;12(15):2269-77 [9694793.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10866-71 [9724796.001]
  • [Cites] Leukemia. 1998 Oct;12(10):1507-17 [9766492.001]
  • [Cites] Genes Dev. 1998 Dec 1;12(23):3728-40 [9851979.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):23-8 [9874765.001]
  • [Cites] Virology. 1998 Dec 20;252(2):304-12 [9878608.001]
  • [Cites] N Engl J Med. 1999 Apr 8;340(14):1063-70 [10194235.001]
  • [Cites] Hum Mol Genet. 1999 May;8(5):723-30 [10196361.001]
  • [Cites] Dev Biol. 1999 Sep 1;213(1):33-53 [10452845.001]
  • [Cites] J Virol. 1999 Nov;73(11):9348-61 [10516043.001]
  • [Cites] Mol Cell. 2004 Nov 19;16(4):509-20 [15546612.001]
  • [Cites] Curr Opin Hematol. 2004 Nov;11(6):426-33 [15548998.001]
  • [Cites] Immunity. 2005 Jan;22(1):59-70 [15664159.001]
  • [Cites] J Virol. 2005 Mar;79(6):3468-78 [15731241.001]
  • [Cites] J Virol. 2005 Mar;79(6):3479-87 [15731242.001]
  • [Cites] Cancer Cell. 2003 Jun;3(6):551-64 [12842084.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8490-5 [12832621.001]
  • [Cites] J Virol. 2003 Sep;77(17):9399-411 [12915555.001]
  • [Cites] J Virol. 2003 Sep;77(17):9590-612 [12915572.001]
  • [Cites] Annu Rev Pharmacol Toxicol. 2004;44:219-38 [14744245.001]
  • [Cites] Mol Cell Biol. 2001 Jul;21(13):4337-46 [11390662.001]
  • [Cites] J Virol. 2001 Aug;75(15):6786-99 [11435557.001]
  • [Cites] J Virol. 2001 Aug;75(15):6894-900 [11435569.001]
  • [Cites] Mol Cell Biol. 2001 Sep;21(18):6222-32 [11509665.001]
  • [Cites] Semin Cancer Biol. 2001 Dec;11(6):423-34 [11669604.001]
  • [Cites] Differentiation. 2001 Dec;69(2-3):135-44 [11798067.001]
  • [Cites] Methods. 2001 Dec;25(4):402-8 [11846609.001]
  • [Cites] J Virol. 2002 Apr;76(7):3168-78 [11884541.001]
  • [Cites] J Virol. 2002 May;76(10):5000-13 [11967316.001]
  • [Cites] Nat Immunol. 2002 May;3(5):443-50 [11967543.001]
  • [Cites] Mol Cell Biol. 2002 Jun;22(11):3927-41 [11997524.001]
  • [Cites] J Virol. 2002 Jun;76(12):6185-96 [12021352.001]
  • [Cites] Genes Dev. 2002 Jun 1;16(11):1397-411 [12050117.001]
  • [Cites] Dev Cell. 2002 Jul;3(1):127-36 [12110173.001]
  • [Cites] J Virol. 2002 Aug;76(16):8252-64 [12134031.001]
  • [Cites] Genes Dev. 2002 Aug 1;16(15):1977-89 [12154127.001]
  • [Cites] Blood. 2002 Sep 1;100(5):1919-21 [12176919.001]
  • [Cites] Mol Cell Biol. 2002 Nov;22(22):7812-9 [12391150.001]
  • [Cites] J Virol. 2002 Dec;76(23):12044-54 [12414946.001]
  • [Cites] Mol Cell Biol. 2003 Jan;23(1):14-25 [12482957.001]
  • [Cites] Methods Mol Biol. 2003;212:111-28 [12491906.001]
  • [Cites] Cancer Biol Ther. 2002 Sep-Oct;1(5):466-76 [12496471.001]
  • [Cites] Mol Cell Biol. 2003 Mar;23(6):2055-67 [12612078.001]
  • [Cites] J Biol Chem. 2003 Jun 6;278(23):21232-9 [12644465.001]
  • [Cites] Cell. 1991 Aug 23;66(4):649-61 [1831692.001]
  • [Cites] J Virol. 1991 Nov;65(11):5880-5 [1656076.001]
  • [Cites] J Virol. 1991 Dec;65(12):6765-71 [1658373.001]
  • [Cites] J Virol. 1992 May;66(5):2846-52 [1313905.001]
  • [Cites] J Virol. 2003 Jan;77(1):600-23 [12477864.001]
  • [Cites] EMBO J. 1993 Jan;12(1):167-75 [8381349.001]
  • [Cites] Genomics. 1993 Aug;17(2):306-15 [8406481.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9237-41 [8415684.001]
  • [Cites] Mol Cell Biol. 1994 May;14(5):3310-9 [8164682.001]
  • [Cites] J Virol. 1994 Aug;68(8):5184-93 [8035517.001]
  • (PMID = 16973574.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; 0 / Immediate-Early Proteins; 0 / Immunoglobulin J Recombination Signal Sequence-Binding Protein; 0 / Lectins; 0 / Receptors, Notch; 0 / Rta protein, Human herpesvirus 8; 0 / Trans-Activators; 0 / Viral Proteins; 0 / cerebellar soluble lectin
  • [Other-IDs] NLM/ PMC1617261
  •  go-up   go-down


11. Pepek JM, Willett CG, Wu QJ, Yoo S, Clough RW, Czito BG: Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis. Int J Radiat Oncol Biol Phys; 2010 Dec 1;78(5):1413-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis.
  • PURPOSE: Intensity-modulated radiation therapy (IMRT) has the potential to reduce toxicities associated with chemoradiotherapy in the treatment of anal cancer.
  • This study reports the results of using IMRT in the treatment of anal cancer.
  • METHODS AND MATERIALS: Records of patients with anal malignancies treated with IMRT at Duke University were reviewed.
  • RESULTS: Forty-seven patients with anal malignancy (89% canal, 11% perianal skin) were treated with IMRT between August 2006 and September 2008.
  • CONCLUSIONS: IMRT-based chemoradiotherapy for anal cancer results in significant reductions in normal tissue dose and acute toxicities versus historic controls treated without IMRT, leading to reduced rates of toxicity-related treatment interruption.
  • IMRT is emerging as a standard therapy for anal cancer.
  • [MeSH-major] Anus Neoplasms / radiotherapy. Radiotherapy, Intensity-Modulated / adverse effects
  • [MeSH-minor] Adenocarcinoma / radiotherapy. Adolescent. Adult. Aged. Aged, 80 and over. Anemia / etiology. Carcinoma, Squamous Cell / radiotherapy. Diarrhea / etiology. Female. Humans. Leukopenia / etiology. Male. Melanoma / radiotherapy. Middle Aged. Neuroendocrine Tumors / radiotherapy. Radiotherapy Dosage. Rhabdomyosarcoma / radiotherapy. Sarcoma / radiotherapy. Thrombocytopenia / etiology. Treatment Outcome. Young Adult

  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20231064.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


12. Erkizan HV, Kong Y, Merchant M, Schlottmann S, Barber-Rotenberg JS, Yuan L, Abaan OD, Chou TH, Dakshanamurthy S, Brown ML, Uren A, Toretsky JA: A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma. Nat Med; 2009 Jul;15(7):750-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma.
  • Ewing's sarcoma family tumors (ESFTs) contain a characteristic t(11;22) translocation leading to expression of the oncogenic fusion protein EWS-FLI1.
  • [MeSH-major] Antineoplastic Agents / pharmacology. DEAD-box RNA Helicases / metabolism. Indoles / pharmacology. Neoplasm Proteins / metabolism. Oncogene Proteins, Fusion / antagonists & inhibitors. Sarcoma, Ewing / drug therapy. Transcription Factors / antagonists & inhibitors

  • Genetic Alliance. consumer health - Ewing's Sarcoma.
  • COS Scholar Universe. author profiles.
  • Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Protein Sci. 2000 Sep;9(9):1753-73 [11045621.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10149-54 [18626011.001]
  • [Cites] J Biol Chem. 2001 Jun 22;276(25):22317-22 [11301318.001]
  • [Cites] Anal Biochem. 2002 Sep 15;308(2):364-72 [12419351.001]
  • [Cites] N Engl J Med. 2003 Feb 20;348(8):694-701 [12594313.001]
  • [Cites] J Biol Chem. 2003 Apr 25;278(17):15105-15 [12560328.001]
  • [Cites] Nat Rev Cancer. 2003 Sep;3(9):685-94 [12951587.001]
  • [Cites] Semin Cancer Biol. 2003 Aug;13(4):275-81 [14563122.001]
  • [Cites] Biochemistry. 2003 Dec 2;42(47):13787-99 [14636045.001]
  • [Cites] Blood. 2004 Jan 1;103(1):229-35 [12946992.001]
  • [Cites] J Biol Chem. 2004 Apr 23;279(17):17134-41 [14769796.001]
  • [Cites] Eur J Biochem. 2004 Sep;271(18):3741-51 [15355351.001]
  • [Cites] J Clin Oncol. 2004 Oct 15;22(20):4135-9 [15483023.001]
  • [Cites] Biochemistry. 2004 Oct 26;43(42):13579-89 [15491164.001]
  • [Cites] Nature. 1992 Sep 10;359(6391):162-5 [1522903.001]
  • [Cites] J Cell Sci. 1993 Jun;105 ( Pt 2):481-8 [8408279.001]
  • [Cites] N Engl J Med. 1994 Aug 4;331(5):294-9 [8022439.001]
  • [Cites] J Clin Invest. 1997 Jan 15;99(2):239-47 [9005992.001]
  • [Cites] Cell. 1997 Sep 19;90(6):1107-12 [9323138.001]
  • [Cites] Blood. 1997 Dec 15;90(12):4947-52 [9389713.001]
  • [Cites] Nat Genet. 1998 Jul;19(3):254-6 [9662397.001]
  • [Cites] Oncogene. 1998 Aug 6;17(5):603-10 [9704926.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13709-13 [9811865.001]
  • [Cites] Nature. 1998 Dec 10;396(6711):580-4 [9859993.001]
  • [Cites] Cancer Cell. 2005 May;7(5):457-68 [15894266.001]
  • [Cites] Cancer Res. 2005 Jul 15;65(14):6199-206 [16024621.001]
  • [Cites] Cancer Res. 2005 Oct 1;65(19):8984-92 [16204072.001]
  • [Cites] J Comput Chem. 2005 Dec;26(16):1668-88 [16200636.001]
  • [Cites] Cancer Res. 2006 Jun 1;66(11):5574-81 [16740692.001]
  • [Cites] Nat Struct Mol Biol. 2006 Jun;13(6):509-16 [16680162.001]
  • [Cites] Mol Cell Proteomics. 2006 Jul;5(7):1212-23 [16571897.001]
  • [Cites] Nucleic Acids Res. 2006;34(14):3938-46 [16914450.001]
  • [Cites] Trends Biotechnol. 2006 Oct;24(10):435-42 [16876893.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):479-84 [17202261.001]
  • [Cites] Nat Rev Cancer. 2007 Apr;7(4):233-45 [17361217.001]
  • [Cites] J Proteome Res. 2007 May;6(5):1882-98 [17391014.001]
  • [Cites] Cancer Cell. 2007 May;11(5):421-9 [17482132.001]
  • [Cites] Mol Cell. 2007 May 25;26(4):523-37 [17531811.001]
  • [Cites] Nat Rev Drug Discov. 2007 Nov;6(11):881-90 [17971784.001]
  • [Cites] Leuk Res. 2008 Apr;32(4):633-42 [17875318.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):6004-9 [18413612.001]
  • [Cites] J Biol Chem. 2001 Jan 12;276(2):1634-42 [11038348.001]
  • (PMID = 19584866.001).
  • [ISSN] 1546-170X
  • [Journal-full-title] Nature medicine
  • [ISO-abbreviation] Nat. Med.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R01 CA088004-08; United States / NCI NIH HHS / CA / R01CA138212; United States / NCI NIH HHS / CA / R01CA133662; United States / NCI NIH HHS / CA / R01 CA133662; United States / NCI NIH HHS / CA / P01 CA47179; United States / NCI NIH HHS / CA / R01 CA138212; United States / NCI NIH HHS / CA / P30 CA051008; United States / NCI NIH HHS / CA / R01 CA138212-01; United States / NCI NIH HHS / CA / R01 CA088004; United States / NCI NIH HHS / CA / T32 CA009686; United States / NCI NIH HHS / CA / R01 CA133662-01A2; United States / NCI NIH HHS / CA / P01 CA047179
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / EWS-FLI fusion protein; 0 / Indoles; 0 / Neoplasm Proteins; 0 / Oncogene Proteins, Fusion; 0 / Proto-Oncogene Protein c-fli-1; 0 / RNA-Binding Protein EWS; 0 / Transcription Factors; 0 / YK 4-279; EC 3.4.22.- / Caspase 3; EC 3.6.1.- / DHX9 protein, human; EC 3.6.4.13 / DEAD-box RNA Helicases
  • [Other-IDs] NLM/ NIHMS116382; NLM/ PMC2777681
  •  go-up   go-down


13. Dittrich C, Zandvliet AS, Gneist M, Huitema AD, King AA, Wanders J: A phase I and pharmacokinetic study of indisulam in combination with carboplatin. Br J Cancer; 2007 Feb 26;96(4):559-66
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Carboplatin / pharmacokinetics. Carcinoma / drug therapy. Neoplasms / drug therapy. Sarcoma / drug therapy. Sulfonamides / pharmacokinetics

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • Hazardous Substances Data Bank. CARBOPLATIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 2000 Mar 15;88(6):1336-46 [10717614.001]
  • [Cites] Clin Cancer Res. 2006 Nov 1;12(21):6502-8 [17085665.001]
  • [Cites] Invest New Drugs. 2001;19(3):219-27 [11561678.001]
  • [Cites] N Engl J Med. 2002 Jan 10;346(2):92-8 [11784875.001]
  • [Cites] J Clin Oncol. 2002 Aug 15;20(16):3508-21 [12177112.001]
  • [Cites] Cancer Chemother Pharmacol. 2002 Sep;50(3):243-50 [12203107.001]
  • [Cites] J Clin Oncol. 2002 Oct 1;20(19):4065-73 [12351604.001]
  • [Cites] Anal Chem. 2003 May 1;75(9):2159-65 [12720356.001]
  • [Cites] Nephron. 1976;16(1):31-41 [1244564.001]
  • [Cites] Cancer Chemother Pharmacol. 1982;9(3):140-7 [6761010.001]
  • [Cites] J Clin Oncol. 1989 Nov;7(11):1748-56 [2681557.001]
  • [Cites] Cancer Chemother Pharmacol. 1991;27(5):409-12 [1999004.001]
  • [Cites] J Clin Oncol. 1992 Mar;10(3):433-7 [1740682.001]
  • [Cites] J Clin Oncol. 1993 Nov;11(11):2112-7 [8229125.001]
  • [Cites] Eur J Cancer. 1994;30A(5):710-3 [8080692.001]
  • [Cites] J Clin Oncol. 1995 Aug;13(8):1860-70 [7543559.001]
  • [Cites] Semin Oncol. 1995 Aug;22(4 Suppl 9):63-6 [7644931.001]
  • [Cites] J Clin Oncol. 1996 Jul;14(7):2054-60 [8683236.001]
  • [Cites] Semin Oncol. 1996 Oct;23(5 Suppl 12):19-21 [8941406.001]
  • [Cites] Rapid Commun Mass Spectrom. 2004;18(23):2839-48 [15517526.001]
  • [Cites] Arch Toxicol. 2005 Jul;79(7):406-13 [15798913.001]
  • [Cites] J Pharmacokinet Pharmacodyn. 2006 Oct;33(5):543-70 [16946998.001]
  • [Cites] N Engl J Med. 2006 Oct 5;355(14):1502-3; author reply 1503 [17021330.001]
  • [Cites] Clin Pharmacol Ther. 2000 Jun;67(6):621-30 [10872644.001]
  • (PMID = 17285128.001).
  • [ISSN] 0007-0920
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide; 0 / Sulfonamides; BG3F62OND5 / Carboplatin
  • [Other-IDs] NLM/ PMC2360043
  •  go-up   go-down


14. Meşină C, Vasile I, Vîlcea ID, Paşalega M, Pârvănescu H, Calotă F, Georgescu CV, Ghiluşi M, Dumitrescu T, Mirea C, Mogoanţă S, Moraru E: [Soft tissue sarcoma--problems of diagnosis and treatment]. Chirurgia (Bucur); 2010 Mar-Apr;105(2):257-66
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Soft tissue sarcoma--problems of diagnosis and treatment].
  • We present 3 cases of soft tissue sarcomas (the tumors were located to the right axilary region, perianal and dorsale face of the left leg) hospitalized in 2nd Surgical Clinic of Emergency Hospital of Craiova and we discuss the difficulties of diagnosis and treatment.
  • In conclusion surgical treatment is mainstay of treatment for soft-tissue sarcomas and is usefull the prompt diagnosis for decrease the risk of local recurrence and metastatic disease.
  • [MeSH-major] Sarcoma / diagnosis. Sarcoma / surgery
  • [MeSH-minor] Aged. Anal Canal / pathology. Anal Canal / surgery. Axilla / pathology. Axilla / surgery. Female. Humans. Leg / pathology. Leg / surgery. Male. Middle Aged. Treatment Outcome

  • Genetic Alliance. consumer health - Soft tissue sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20540243.001).
  • [ISSN] 1221-9118
  • [Journal-full-title] Chirurgia (Bucharest, Romania : 1990)
  • [ISO-abbreviation] Chirurgia (Bucur)
  • [Language] rum
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Romania
  •  go-up   go-down


15. van Leeuwen MT, Vajdic CM, Middleton MG, McDonald AM, Law M, Kaldor JM, Grulich AE: Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy. AIDS; 2009 Oct 23;23(16):2183-90
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Incidence of Kaposi sarcoma and non-Hodgkin lymphoma declined significantly (Ptrend < 0.001).
  • Incidence of anal cancer was unchanged (Ptrend = 0.451) and remained raised more than 30-fold.
  • CONCLUSION: Incidence of Kaposi sarcoma and non-Hodgkin lymphoma has continued to decline among people with HIV in Australia, though it remains very substantially elevated.
  • Incidence of anal cancer has remained stable, and it is now the third most common cancer in HIV-infected Australians.


16. Randall RL, Schabel KL, Hitchcock Y, Joyner DE, Albritton KH: Diagnosis and management of synovial sarcoma. Curr Treat Options Oncol; 2005 Nov;6(6):449-59
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnosis and management of synovial sarcoma.
  • Synovial sarcoma is a unique tumor with substantial promise for biologically targeted therapy.
  • Research should be directed at understanding the fusion protein of the X,18 translocation and further validating the role of overexpressed proteins in synovial sarcoma.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Sarcoma, Synovial

  • Genetic Alliance. consumer health - Synovial sarcoma.
  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Genes Chromosomes Cancer. 2001 Aug;31(4):362-72 [11433527.001]
  • [Cites] J Clin Oncol. 1996 Mar;14(3):859-68 [8622034.001]
  • [Cites] J Clin Oncol. 2001 Mar 1;19(5):1238-47 [11230464.001]
  • [Cites] Cancer Res. 2002 Jul 1;62(13):3861-7 [12097301.001]
  • [Cites] Cancer. 2002 May 15;94(10):2712-8 [12173341.001]
  • [Cites] Orthopedics. 2004 Feb;27(2):209-12 [14992389.001]
  • [Cites] Mod Pathol. 2000 May;13(5):482-8 [10824918.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):265-74 [15337565.001]
  • [Cites] N Engl J Med. 1998 Jan 15;338(3):153-60 [9428816.001]
  • [Cites] Lancet. 2002 Apr 13;359(9314):1301-7 [11965276.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):83-8 [12694826.001]
  • [Cites] Am J Surg Pathol. 1998 Jun;22(6):673-82 [9630174.001]
  • [Cites] J Clin Oncol. 2004 Oct 15;22(20):4040-50 [15364967.001]
  • [Cites] Oncogene. 2003 Oct 23;22(48):7628-31 [14576825.001]
  • [Cites] Radiother Oncol. 1996 Dec;41(3):209-14 [9027935.001]
  • [Cites] Lab Invest. 2000 Jun;80(6):805-13 [10879732.001]
  • [Cites] Orthopedics. 1996 Aug;19(8):657-64 [8856775.001]
  • [Cites] Br J Cancer. 1999 Aug;80(11):1809-14 [10468301.001]
  • [Cites] Am J Surg Pathol. 2002 Nov;26(11):1434-40 [12409719.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1993 Sep 30;27(2):259-65 [8407399.001]
  • [Cites] Hum Pathol. 2003 Jul;34(7):639-45 [12874758.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1596-606 [15050341.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):752-9 [15183478.001]
  • [Cites] Anal Cell Pathol. 1998;16(1):45-62 [9584899.001]
  • [Cites] Pathol Int. 1997 Dec;47(12):854-61 [9503467.001]
  • [Cites] Oncology. 1999;56(1):13-23 [9885372.001]
  • [Cites] J Clin Oncol. 2000 Nov 15;18(22):3794-803 [11078492.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1991 Apr;20(4):787-90 [1848542.001]
  • [Cites] J Clin Oncol. 2000 May;18(10):2087-94 [10811674.001]
  • [Cites] Oncogene. 2004 Jul 15;23(32):5551-7 [15077175.001]
  • [Cites] Br J Surg. 1997 Dec;84(12):1692-6 [9448617.001]
  • [Cites] J Transl Med. 2005 Jan 12;3(1):1 [15647119.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2001 May 1;50(1):127-31 [11316555.001]
  • [Cites] Clin Cancer Res. 2004 Feb 1;10(3):938-43 [14871970.001]
  • [Cites] Cancer. 2004 Dec 1;101(11):2491-502 [15503311.001]
  • [Cites] Cancer. 2004 Aug 1;101(3):627-34 [15274077.001]
  • [Cites] Cancer. 2005 Feb 15;103(4):830-8 [15641030.001]
  • [Cites] Lancet. 2002 Jun 29;359(9325):2235-41 [12103287.001]
  • [Cites] Hum Pathol. 1996 Oct;27(10):1060-5 [8892591.001]
  • [Cites] Ann Oncol. 2005 Mar;16(3):437-44 [15653701.001]
  • [Cites] Jpn J Clin Oncol. 1998 Feb;28(2):86-91 [9544821.001]
  • [Cites] Clin Orthop Relat Res. 2004 Feb;(419):155-61 [15021147.001]
  • [Cites] Lancet. 1997 Dec 6;350(9092):1647-54 [9400508.001]
  • [Cites] Am J Pathol. 2003 Oct;163(4):1449-56 [14507652.001]
  • [Cites] Radiother Oncol. 1994 Oct;33(1):23-30 [7878206.001]
  • [Cites] J Immunol. 2002 Aug 1;169(3):1611-8 [12133991.001]
  • [Cites] Histol Histopathol. 2005 Jan;20(1):83-9 [15578426.001]
  • [Cites] J Am Coll Surg. 2001 Mar;192(3):305-13 [11245372.001]
  • [Cites] Am J Pathol. 2002 Nov;161(5):1587-95 [12414507.001]
  • [Cites] Cancer Control. 2005 Jan-Feb;12(1):27-35 [15668650.001]
  • [Cites] Am J Clin Oncol. 2004 Apr;27(2):122-7 [15057149.001]
  • [Cites] Cancer Treat Res. 2004;120:151-67 [15217223.001]
  • [Cites] Histopathology. 2002 May;40(5):464-71 [12010367.001]
  • [Cites] Cancer Treat Rep. 1984 Sep;68(9):1067-78 [6383604.001]
  • [Cites] J Clin Oncol. 1998 Jan;16(1):197-203 [9440743.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):3843-8 [11274403.001]
  • [Cites] J Cancer Res Clin Oncol. 2002 Nov;128(11):610-6 [12458341.001]
  • [Cites] J Clin Oncol. 2004 Aug 15;22(16):3375-80 [15310783.001]
  • [Cites] Am J Pathol. 2000 Mar;156(3):977-83 [10702413.001]
  • [Cites] Diagn Mol Pathol. 2000 Mar;9(1):1-8 [10718206.001]
  • [Cites] Arkh Patol. 2002 May-Jun;64(3):39-47 [15338724.001]
  • [Cites] J Clin Oncol. 1988 Sep;6(9):1491-500 [3047339.001]
  • (PMID = 16242050.001).
  • [ISSN] 1527-2729
  • [Journal-full-title] Current treatment options in oncology
  • [ISO-abbreviation] Curr Treat Options Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Biomarkers, Tumor; 0 / Oncogene Proteins, Fusion; 0 / SYT-SSX fusion protein; 80168379AG / Doxorubicin; UM20QQM95Y / Ifosfamide
  • [Number-of-references] 64
  •  go-up   go-down


17. Li X, Uchimura T, Kawanabe S, Imasaka T: Use of a fluorescence lifetime imaging microscope in an apoptosis assay of Ewing's sarcoma cells with a vital fluorescent probe. Anal Biochem; 2007 Aug 15;367(2):219-24
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Use of a fluorescence lifetime imaging microscope in an apoptosis assay of Ewing's sarcoma cells with a vital fluorescent probe.
  • [MeSH-major] Apoptosis. Microscopy, Fluorescence / methods. Sarcoma, Ewing / pathology

  • Genetic Alliance. consumer health - Ewing's Sarcoma.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17543878.001).
  • [ISSN] 0003-2697
  • [Journal-full-title] Analytical biochemistry
  • [ISO-abbreviation] Anal. Biochem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Fluorescent Dyes; 0 / Organic Chemicals; 0 / SYTO 13; 80168379AG / Doxorubicin
  •  go-up   go-down


18. Butler LM, Neilands TB, Mosam A, Mzolo S, Martin JN: A population-based study of how children are exposed to saliva in KwaZulu-Natal Province, South Africa: implications for the spread of saliva-borne pathogens to children. Trop Med Int Health; 2010 Apr;15(4):442-53
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: In sub-Saharan Africa, many viral infections, including Epstein-Barr virus, cytomegalovirus, Kaposi's sarcoma-associated herpesvirus and hepatitis B are acquired in childhood.
  • RESULTS: We identified 12 caregiving practices that expose a child's oral-respiratory mucosa, cutaneous surfaces or anal-rectal mucosa to saliva.

  • MedlinePlus Health Information. consumer health - Child Care.
  • MedlinePlus Health Information. consumer health - Viral Infections.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Cancer. 2000 Jan 1;85(1):54-9 [10585583.001]
  • [Cites] Pediatrics. 2009 Aug;124(2):658-66 [19620190.001]
  • [Cites] J Med Virol. 2000 Aug;61(4):433-8 [10897060.001]
  • [Cites] Lancet. 2000 Sep 23;356(9235):1062-5 [11009141.001]
  • [Cites] Parassitologia. 2002 Jun;44(1-2):123-9 [12404820.001]
  • [Cites] J Infect Dis. 2003 Jun 1;187(11):1780-5 [12751036.001]
  • [Cites] Br J Cancer. 2003 Nov 17;89(10):2016-7 [14612917.001]
  • [Cites] J Infect Dis. 2004 Sep 15;190(6):1068-75 [15319855.001]
  • [Cites] Nature. 1978 Aug 24;274(5673):756-61 [210392.001]
  • [Cites] Int J Cancer. 1978 Sep 15;22(3):239-43 [212369.001]
  • [Cites] Lancet. 1981 Nov 21;2(8256):1129-33 [6118576.001]
  • [Cites] Bull World Health Organ. 1981;59(4):605-10 [6274535.001]
  • [Cites] Lancet. 1983 May 28;1(8335):1203-6 [6133999.001]
  • [Cites] J Clin Pathol. 1991 May;44(5):366-9 [1646236.001]
  • [Cites] Epidemiol Rev. 1991;13:42-59 [1765119.001]
  • [Cites] J Pediatr. 1992 Apr;120(4 Pt 1):563-4 [1552394.001]
  • [Cites] New Microbiol. 1993 Jan;16(1):83-5 [8385733.001]
  • [Cites] Science. 1994 Dec 16;266(5192):1865-9 [7997879.001]
  • [Cites] Am J Epidemiol. 1998 Mar 1;147(5):478-87 [9525535.001]
  • [Cites] Int J Cancer. 1998 Sep 11;77(6):817-20 [9714046.001]
  • [Cites] Int J Cancer. 1999 Apr 12;81(2):189-92 [10188717.001]
  • [Cites] Lancet Infect Dis. 2004 Dec;4(12):725-38 [15567122.001]
  • [Cites] J Infect Dis. 2006 Feb 1;193(3):422-6 [16388490.001]
  • [Cites] Trop Med Int Health. 2007 Jan;12(1):150-5 [17207159.001]
  • [Cites] PLoS Med. 2007 Dec;4(12):e334 [18052600.001]
  • [Cites] J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):162-7 [19131893.001]
  • [Cites] J Infect Dis. 2009 Aug 1;200(3):430-8 [19534596.001]
  • [Cites] Int J STD AIDS. 2009 Aug;20(8):553-6 [19625587.001]
  • [Cites] Br J Cancer. 2000 May;82(9):1585-92 [10789729.001]
  • (PMID = 20149165.001).
  • [ISSN] 1365-3156
  • [Journal-full-title] Tropical medicine & international health : TM & IH
  • [ISO-abbreviation] Trop. Med. Int. Health
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / K01 HD052020
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Other-IDs] NLM/ NIHMS582774; NLM/ PMC4104610
  •  go-up   go-down


19. Dalton AK, Ako-Adjei D, Murray PS, Murray D, Vogt VM: Electrostatic interactions drive membrane association of the human immunodeficiency virus type 1 Gag MA domain. J Virol; 2007 Jun;81(12):6434-45
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Myristoylation increases the barely detectable intrinsic affinity of the apo-protein for liposomes by only 10-fold, and the resulting affinity is still weak, similar to that of the naturally nonmyristoylated MA of Rous sarcoma virus.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. MYRISTIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2003 Apr;77(8):4805-17 [12663787.001]
  • [Cites] J Biol Chem. 2003 Jul 25;278(30):27923-9 [12761222.001]
  • [Cites] J Cell Biol. 2003 Aug 4;162(3):443-55 [12885763.001]
  • [Cites] Traffic. 2003 Nov;4(11):785-801 [14617360.001]
  • [Cites] J Virol. 2004 Jan;78(1):52-60 [14671087.001]
  • [Cites] J Virol. 2004 Feb;78(3):1552-63 [14722309.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):517-22 [14699046.001]
  • [Cites] J Mol Biol. 1998 Mar 27;277(2):161-9 [9514761.001]
  • [Cites] J Virol. 1998 Apr;72(4):2723-32 [9525590.001]
  • [Cites] EMBO J. 1998 May 1;17(9):2699-708 [9564051.001]
  • [Cites] Biophys J. 1998 Aug;75(2):769-76 [9675178.001]
  • [Cites] J Virol. 1998 Sep;72(9):7659-63 [9696871.001]
  • [Cites] Protein Eng. 1998 Sep;11(9):739-47 [9796821.001]
  • [Cites] J Virol. 1999 Mar;73(3):1902-8 [9971769.001]
  • [Cites] J Virol. 1999 Apr;73(4):2604-12 [10074105.001]
  • [Cites] J Virol. 1999 May;73(5):4136-44 [10196310.001]
  • [Cites] J Virol. 1999 Oct;73(10):8527-40 [10482606.001]
  • [Cites] Cell. 2005 Mar 11;120(5):663-74 [15766529.001]
  • [Cites] J Virol. 2005 May;79(10):6227-38 [15858007.001]
  • [Cites] Structure. 2005 Oct;13(10):1521-31 [16216583.001]
  • [Cites] Virology. 2005 Nov 25;342(2):190-200 [16139856.001]
  • [Cites] Biophys Chem. 2006 Jan 1;119(1):23-32 [16183191.001]
  • [Cites] Biochemistry. 2006 Apr 4;45(13):4077-83 [16566581.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11364-9 [16840558.001]
  • [Cites] Biochim Biophys Acta. 2006 Aug;1761(8):812-26 [16928468.001]
  • [Cites] J Mol Biol. 2007 Jan 19;365(3):799-811 [17098251.001]
  • [Cites] PLoS Biol. 2006 Dec;4(12):e435 [17147474.001]
  • [Cites] Virology. 1980 Apr 15;102(1):205-10 [6245502.001]
  • [Cites] J Biol Chem. 1980 Oct 10;255(19):9044-50 [6251073.001]
  • [Cites] Proc Natl Acad Sci U S A. 1989 Aug;86(15):5781-5 [2788277.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Jan;87(2):523-7 [2405382.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5181-5 [8389472.001]
  • [Cites] Biochemistry. 1993 Oct 5;32(39):10436-43 [8399188.001]
  • [Cites] J Virol. 1993 Nov;67(11):6387-94 [8411340.001]
  • [Cites] J Virol. 1994 Apr;68(4):2556-69 [8139035.001]
  • [Cites] J Virol. 1994 May;68(5):3232-42 [8151785.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 May 10;91(10):4594-8 [8183954.001]
  • [Cites] J Virol. 1994 Aug;68(8):5311-20 [8035531.001]
  • [Cites] J Virol. 1994 Oct;68(10):6644-54 [7521919.001]
  • [Cites] Biochemistry. 1994 Nov 8;33(44):13093-101 [7947714.001]
  • [Cites] Science. 1995 May 26;268(5214):1144-9 [7761829.001]
  • [Cites] Trends Biochem Sci. 1995 Jul;20(7):272-6 [7667880.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3099-104 [8610175.001]
  • [Cites] Biochemistry. 1996 Apr 2;35(13):3933-43 [8672424.001]
  • [Cites] Biophys J. 1996 Aug;71(2):561-75 [8842196.001]
  • [Cites] J Virol. 1996 Dec;70(12):8540-8 [8970978.001]
  • [Cites] J Virol. 1997 Sep;71(9):6582-92 [9261380.001]
  • [Cites] Biophys J. 1997 Oct;73(4):1717-27 [9336168.001]
  • [Cites] Science. 1997 Oct 31;278(5339):849-53 [9346481.001]
  • [Cites] J Mol Biol. 2007 Feb 16;366(2):574-85 [17188710.001]
  • [Cites] PLoS Pathog. 2007 Mar;3(3):e36 [17381240.001]
  • [Cites] Biochemistry. 1998 Feb 24;37(8):2145-59 [9485361.001]
  • [Cites] J Virol. 2000 Mar;74(6):2855-66 [10684302.001]
  • [Cites] J Virol. 2000 Apr;74(7):3264-72 [10708443.001]
  • [Cites] J Virol. 2000 Jun;74(11):5142-50 [10799589.001]
  • [Cites] J Virol. 2000 Jul;74(13):5845-55 [10846064.001]
  • [Cites] J Virol. 2000 Sep;74(18):8670-9 [10954568.001]
  • [Cites] J Virol. 2001 Sep;75(17):7913-24 [11483736.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10875-9 [11526217.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13925-30 [11717449.001]
  • [Cites] Traffic. 2002 Oct;3(10):718-29 [12230470.001]
  • [Cites] J Virol. 2002 Nov;76(22):11177-85 [12388677.001]
  • [Cites] J Virol. 2003 Feb;77(3):1916-26 [12525626.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):672-5 [15208690.001]
  • [Cites] J Virol. 2004 Sep;78(17):9560-3 [15308748.001]
  • [Cites] J Mol Biol. 2004 Oct 29;343(4):903-16 [15476809.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Oct 12;101(41):14889-94 [15465916.001]
  • [Cites] Virology. 1971 Oct;46(1):106-16 [4108030.001]
  • [Cites] Anal Biochem. 1972 Jun;47(2):614-9 [4338619.001]
  • [Cites] Virology. 1972 Nov;50(2):550-7 [4344196.001]
  • [Cites] J Virol. 2003 Apr;77(7):3973-84 [12634357.001]
  • (PMID = 17392361.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / R01 GM066147; United States / NCI NIH HHS / CA / CA20087; United States / NIGMS NIH HHS / GM / GM66147; United States / NIAID NIH HHS / AI / AI54167; United States / NCI NIH HHS / CA / CA20087-S1
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Fatty Acids; 0 / Gene Products, gag; 0 / Phospholipids; 0I3V7S25AW / Myristic Acid
  • [Other-IDs] NLM/ PMC1900125
  •  go-up   go-down


20. Aldo S, Salmaso L, El Barmi H, Pesarin F: Conditional tests in a competing risks model. Lifetime Data Anal; 2008 Jun;14(2):154-66
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Animals. Computer Simulation. Lymphoma, T-Cell / mortality. Male. Mice. Sarcoma / mortality

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lifetime Data Anal. 2002 Sep;8(3):277-88 [12182123.001]
  • [Cites] Lifetime Data Anal. 2002 Dec;8(4):401-12 [12471948.001]
  • [Cites] Biometrics. 1972 Jun;28(2):475-88 [4556703.001]
  • (PMID = 17943442.001).
  • [ISSN] 1380-7870
  • [Journal-full-title] Lifetime data analysis
  • [ISO-abbreviation] Lifetime Data Anal
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


21. Dalton AK, Murray PS, Murray D, Vogt VM: Biochemical characterization of rous sarcoma virus MA protein interaction with membranes. J Virol; 2005 May;79(10):6227-38
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Biochemical characterization of rous sarcoma virus MA protein interaction with membranes.
  • We have used an in vitro flotation assay to directly measure Rous sarcoma virus (RSV) MA-membrane interaction in the absence of host cell factors.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 1996 Apr;70(4):2664-8 [8642704.001]
  • [Cites] Biochemistry. 1996 Apr 2;35(13):3933-43 [8672424.001]
  • [Cites] Biophys J. 1996 Aug;71(2):561-75 [8842196.001]
  • [Cites] J Virol. 1996 Dec;70(12):8540-8 [8970978.001]
  • [Cites] Virology. 1972 Nov;50(2):550-7 [4344196.001]
  • [Cites] J Mol Biol. 1979 Jul 15;131(4):819-37 [229234.001]
  • [Cites] J Biol Chem. 1980 Oct 10;255(19):9044-50 [6251073.001]
  • [Cites] Biochim Biophys Acta. 1982 Jul 28;689(2):393-402 [6288099.001]
  • [Cites] Protein Eng. 1998 Sep;11(9):739-47 [9796821.001]
  • [Cites] Cell. 1998 Dec 11;95(6):847-58 [9865702.001]
  • [Cites] J Virol. 1999 Mar;73(3):1902-8 [9971769.001]
  • [Cites] J Virol. 1999 Apr;73(4):2604-12 [10074105.001]
  • [Cites] J Virol. 1999 May;73(5):4136-44 [10196310.001]
  • [Cites] Biochemistry. 1999 Jun 22;38(25):8056-63 [10387050.001]
  • [Cites] J Virol. 1999 Aug;73(8):7050-5 [10400808.001]
  • [Cites] Biophys J. 1999 Dec;77(6):3176-88 [10585939.001]
  • [Cites] Virology. 2000 Feb 15;267(2):289-98 [10662624.001]
  • [Cites] J Mol Biol. 2000 Feb 25;296(3):887-98 [10677289.001]
  • [Cites] J Virol. 2000 Mar;74(6):2855-66 [10684302.001]
  • [Cites] J Virol. 2000 Apr;74(7):3264-72 [10708443.001]
  • [Cites] J Virol. 2000 Jun;74(11):5142-50 [10799589.001]
  • [Cites] J Virol. 1997 May;71(5):3474-83 [9094619.001]
  • [Cites] J Virol. 1997 Jun;71(6):4425-35 [9151833.001]
  • [Cites] J Virol. 1997 Sep;71(9):6582-92 [9261380.001]
  • [Cites] Structure. 1997 Aug 15;5(8):985-9 [9309215.001]
  • [Cites] Biophys J. 1997 Oct;73(4):1717-27 [9336168.001]
  • [Cites] Science. 1997 Oct 31;278(5339):849-53 [9346481.001]
  • [Cites] Pac Symp Biocomput. 1996;:53-72 [9390223.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2580-5 [9482929.001]
  • [Cites] Biochemistry. 1998 Feb 24;37(8):2145-59 [9485361.001]
  • [Cites] J Mol Biol. 1998 Mar 27;277(2):161-9 [9514761.001]
  • [Cites] J Virol. 1998 Apr;72(4):2723-32 [9525590.001]
  • [Cites] EMBO J. 1998 May 1;17(9):2699-708 [9564051.001]
  • [Cites] J Mol Biol. 1998 Jun 19;279(4):921-8 [9642071.001]
  • [Cites] Biophys J. 1998 Aug;75(2):769-76 [9675178.001]
  • [Cites] J Virol. 1998 Sep;72(9):7659-63 [9696871.001]
  • [Cites] J Virol. 2003 Apr;77(8):4805-17 [12663787.001]
  • [Cites] Traffic. 2003 Apr;4(4):201-13 [12694559.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 May 13;100(10):5795-800 [12721375.001]
  • [Cites] J Biol Chem. 2003 Jul 25;278(30):27923-9 [12761222.001]
  • [Cites] J Cell Biol. 2003 Sep 29;162(7):1233-44 [14517204.001]
  • [Cites] Proteins. 2003;53 Suppl 6:430-5 [14579332.001]
  • [Cites] Traffic. 2003 Nov;4(11):785-801 [14617360.001]
  • [Cites] Traffic. 2003 Dec;4(12):902-10 [14617353.001]
  • [Cites] Cell. 2003 Nov 14;115(4):377-88 [14622593.001]
  • [Cites] J Mol Biol. 2004 Jan 2;335(1):275-82 [14659756.001]
  • [Cites] J Virol. 2004 Feb;78(3):1552-63 [14722309.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):517-22 [14699046.001]
  • [Cites] Physiol Rev. 2004 Jul;84(3):699-730 [15269334.001]
  • [Cites] J Virol. 2004 Sep;78(17):9560-3 [15308748.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Oct 12;101(41):14889-94 [15465916.001]
  • [Cites] Virology. 1971 Oct;46(1):106-16 [4108030.001]
  • [Cites] Anal Biochem. 1972 Jun;47(2):614-9 [4338619.001]
  • [Cites] J Mol Biol. 2000 May 19;298(5):841-57 [10801353.001]
  • [Cites] J Mol Biol. 2000 Jun 2;299(2):499-520 [10860755.001]
  • [Cites] J Mol Biol. 2000 Jun 30;300(1):103-12 [10864502.001]
  • [Cites] Bioinformatics. 2000 Apr;16(4):404-5 [10869041.001]
  • [Cites] J Mol Biol. 2000 Aug 4;301(1):173-90 [10926500.001]
  • [Cites] J Virol. 2000 Dec;74(23):11222-9 [11070020.001]
  • [Cites] J Virol. 2001 Mar;75(6):2753-64 [11222698.001]
  • [Cites] Virus Res. 2001 Jul;76(1):103-13 [11376850.001]
  • [Cites] J Mol Biol. 2001 Jun 29;310(1):243-57 [11419950.001]
  • [Cites] J Virol. 2001 Sep;75(17):7913-24 [11483736.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10875-9 [11526217.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13925-30 [11717449.001]
  • [Cites] J Virol. 2002 Feb;76(4):1876-83 [11799182.001]
  • [Cites] Mol Cell. 2002 Jan;9(1):145-54 [11804593.001]
  • [Cites] Proteins. 2002 May 1;47(2):228-35 [11933069.001]
  • [Cites] J Clin Invest. 2002 Sep;110(5):597-603 [12208858.001]
  • [Cites] Structure. 2002 Dec;10(12):1627-36 [12467570.001]
  • [Cites] J Virol. 2003 Mar;77(5):3058-66 [12584331.001]
  • [Cites] Methods Biochem Anal. 2003;44:427-40 [12647398.001]
  • [Cites] J Virol. 1984 Oct;52(1):145-53 [6090691.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Jan;87(2):523-7 [2405382.001]
  • [Cites] AIDS. 1991 Jun;5(6):639-54 [1883539.001]
  • [Cites] Proteins. 1991;11(4):281-96 [1758883.001]
  • [Cites] Biochemistry. 1992 Feb 18;31(6):1767-73 [1737030.001]
  • [Cites] Nature. 1992 Mar 5;356(6364):83-5 [1538787.001]
  • [Cites] Proteins. 1992 Apr;13(2):112-9 [1620693.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5181-5 [8389472.001]
  • [Cites] J Virol. 1993 Sep;67(9):5550-61 [8394460.001]
  • [Cites] Biochemistry. 1993 Oct 5;32(39):10436-43 [8399188.001]
  • [Cites] J Virol. 1993 Nov;67(11):6387-94 [8411340.001]
  • [Cites] J Virol. 1993 Nov;67(11):6487-98 [8411352.001]
  • [Cites] J Virol. 1994 Apr;68(4):2556-69 [8139035.001]
  • [Cites] J Virol. 1994 May;68(5):3232-42 [8151785.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 May 10;91(10):4594-8 [8183954.001]
  • [Cites] J Virol. 1994 Aug;68(8):5311-20 [8035531.001]
  • [Cites] J Virol. 1994 Oct;68(10):6644-54 [7521919.001]
  • [Cites] Biochemistry. 1994 Nov 8;33(44):13093-101 [7947714.001]
  • [Cites] J Mol Biol. 1994 Nov 25;244(2):198-223 [7966331.001]
  • [Cites] Virology. 1994 Nov 15;205(1):336-44 [7975229.001]
  • [Cites] Science. 1995 May 26;268(5214):1144-9 [7761829.001]
  • [Cites] Trends Biochem Sci. 1995 Jul;20(7):272-6 [7667880.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3099-104 [8610175.001]
  • [Cites] J Virol. 1996 Apr;70(4):2269-76 [8642653.001]
  • (PMID = 15858007.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA020081; United States / NIAID NIH HHS / AI / AI54167
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Liposomes; 0 / MA protein, Rous sarcoma virus; 0 / Phosphoproteins; 0 / Viral Matrix Proteins
  • [Other-IDs] NLM/ PMC1091718
  •  go-up   go-down


22. Malone VS, Dobin SM, Jones KA, Donner LR: CD99-positive large cell neuroendocrine carcinoma with rearranged EWSR1 gene in an infant: a case of prognostically favorable tumor. Virchows Arch; 2010 Sep;457(3):389-95
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The tumor arose at the anal verge of a 1-year-old girl.
  • The diagnosis of this CD99-positive tumor was supported by expression of epithelial (keratins, EMA, and Ep-CAM) and neuroendocrine (chromogranin A, synaptophysin, and neuron-specific enolase) markers and absence of immunoreactivity for Fli-1.
  • Because the tumor was initially misclassified as an extraskeletal Ewing's sarcoma, the patient was treated according to the Ewing's sarcoma treatment protocol.
  • She remains free of tumor 8 years after initial diagnosis.
  • [MeSH-major] Antigens, CD / biosynthesis. Anus Neoplasms / pathology. Calmodulin-Binding Proteins / genetics. Carcinoma, Large Cell / pathology. Carcinoma, Neuroendocrine / pathology. Cell Adhesion Molecules / biosynthesis. RNA-Binding Proteins / genetics
  • [MeSH-minor] Antigens, CD99. Biomarkers, Tumor / analysis. Bone Neoplasms / pathology. Diagnostic Errors. Female. Humans. Immunohistochemistry. In Situ Hybridization, Fluorescence. Infant. Prognosis. Reverse Transcriptase Polymerase Chain Reaction. Sarcoma, Ewing / pathology

  • Genetic Alliance. consumer health - Pancreatic islet cell tumors.
  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Neuroendocrinology. 2004;80(6):394-424 [15838182.001]
  • [Cites] Histopathology. 1992 May;20(5):437-9 [1587495.001]
  • [Cites] J Child Neurol. 2001 Aug;16(8):548-52 [11510923.001]
  • [Cites] Virchows Arch. 2006 Oct;449(4):395-401 [16967267.001]
  • [Cites] Genes Chromosomes Cancer. 2009 Dec;48(12):1051-6 [19760602.001]
  • [Cites] Cancer Genet Cytogenet. 2009 Oct;194(1):53-7 [19737655.001]
  • [Cites] Am J Surg Pathol. 2005 Aug;29(8):1025-33 [16006796.001]
  • [Cites] Appl Immunohistochem Mol Morphol. 2005 Sep;13(3):265-7 [16082253.001]
  • [Cites] Am J Surg. 1995 Dec;170(6):606-8 [7492010.001]
  • [Cites] J Pediatr Surg. 2000 Sep;35(9):1282-6 [10999679.001]
  • [Cites] Curr Top Pathol. 1995;89:31-45 [7882716.001]
  • [Cites] Virchows Arch. 2010 Feb;456(2):219-34 [19936782.001]
  • [Cites] Virchows Arch. 1998 Jul;433(1):35-40 [9692823.001]
  • [Cites] Am J Surg Pathol. 2008 Nov;32(11):1742-8 [18769338.001]
  • [Cites] Am J Surg Pathol. 2006 Dec;30(12 ):1588-94 [17122516.001]
  • [Cites] Clin Cancer Res. 2009 Apr 1;15(7):2259-68 [19318479.001]
  • [Cites] Cancer Genet Cytogenet. 2009 Nov;195(1):12-8 [19837262.001]
  • [Cites] Neuroendocrinology. 2008;87(1):40-6 [17940332.001]
  • [Cites] Int J Surg Pathol. 2005 Jan;13(1):43-50 [15735854.001]
  • [Cites] J Pathol. 2008 May;215(1):78-86 [18338330.001]
  • [Cites] Dis Colon Rectum. 2004 Feb;47(2):163-9 [15043285.001]
  • [Cites] Am J Surg Pathol. 2000 Mar;24(3):410-6 [10716155.001]
  • [Cites] Histopathology. 2007 Jan;50(1):163-74 [17204029.001]
  • [Cites] Pediatr Blood Cancer. 2008 Mar;50(3):588-93 [17405155.001]
  • [Cites] Genes Chromosomes Cancer. 2008 Jul;47(7):558-64 [18383210.001]
  • [Cites] Int J Surg Pathol. 2000 Jan;8(1):59-65 [11493965.001]
  • [Cites] Cancer. 1991 Jul 15;68(2):227-32 [1712661.001]
  • [Cites] Am J Surg Pathol. 2000 Dec;24(12 ):1657-62 [11117787.001]
  • [Cites] Adv Anat Pathol. 2009 Nov;16(6):383-91 [19851129.001]
  • [Cites] Appl Immunohistochem Mol Morphol. 2008 Jul;16(4):344-8 [18528283.001]
  • [Cites] Cancer Genet Cytogenet. 2000 Nov;123(1):1-26 [11120329.001]
  • [Cites] Am J Surg Pathol. 2001 Feb;25(2):273-4 [11176079.001]
  • [Cites] Arch Pathol Lab Med. 2003 Sep;127(9):1200-3 [12946222.001]
  • [Cites] Cancer Res. 2003 Aug 1;63(15):4568-76 [12907633.001]
  • [Cites] Oncogene. 2000 Aug 3;19(33):3799-804 [10949935.001]
  • [Cites] Semin Diagn Pathol. 2000 Aug;17(3):194-203 [10968705.001]
  • [Cites] J Pediatr Surg. 1990 Oct;25(10):1073-5 [2262861.001]
  • [Cites] Virchows Arch. 2000 Sep;437(3):270-4 [11037347.001]
  • (PMID = 20617339.001).
  • [ISSN] 1432-2307
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, CD99; 0 / Biomarkers, Tumor; 0 / CD99 protein, human; 0 / Calmodulin-Binding Proteins; 0 / Cell Adhesion Molecules; 0 / EWSR1 protein, human; 0 / RNA-Binding Proteins
  •  go-up   go-down


23. Morton LM, Curtis RE, Linet MS, Bluhm EC, Tucker MA, Caporaso N, Ries LA, Fraumeni JF Jr: Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype. J Clin Oncol; 2010 Nov 20;28(33):4935-44
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Patients with HIV/AIDS-related lymphoma (n = 932) were predominantly diagnosed with DLBCL and had significantly and substantially elevated risks for second anal cancer (SIR = 120.50) and Kaposi's sarcoma (SIR = 138.90).

  • Genetic Alliance. consumer health - Chronic Lymphocytic Leukemia.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):925-33 [15824165.001]
  • [Cites] Am J Epidemiol. 2010 Feb 1;171(3):267-76 [20047977.001]
  • [Cites] Br J Cancer. 2005 Jul 11;93(1):159-66 [15970927.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2402-6 [16214923.001]
  • [Cites] N Engl J Med. 2005 Nov 17;353(20):2135-47 [16291983.001]
  • [Cites] Lung Cancer. 2005 Dec;50(3):419-20 [16125820.001]
  • [Cites] J Clin Oncol. 2006 Apr 1;24(10):1568-74 [16520465.001]
  • [Cites] Cancer. 2006 Jul 1;107(1):108-15 [16708354.001]
  • [Cites] Haematologica. 2006 Nov;91(11):1481-8 [17043014.001]
  • [Cites] Leuk Lymphoma. 2006 Nov;47(11):2314-20 [17107903.001]
  • [Cites] AIDS. 2007 Jan 11;21(2):207-13 [17197812.001]
  • [Cites] Int J Cancer. 2007 Mar 1;120(5):1099-102 [17131330.001]
  • [Cites] Cancer Causes Control. 2007 Mar;18(2):135-42 [17235495.001]
  • [Cites] Int J Cancer. 2007 Jul 1;121(1):151-6 [17351903.001]
  • [Cites] Blood. 2007 Jun 1;109(11):4617-26 [17311989.001]
  • [Cites] Blood. 2007 Jul 15;110(2):695-708 [17389762.001]
  • [Cites] Lancet. 2007 Jul 7;370(9581):59-67 [17617273.001]
  • [Cites] Int J Cancer. 2008 Jan 1;122(1):144-54 [17708556.001]
  • [Cites] Cancer Causes Control. 2008 Feb;19(1):43-50 [17906957.001]
  • [Cites] Haematologica. 2008 Mar;93(3):398-404 [18268277.001]
  • [Cites] Clin Gastroenterol Hepatol. 2008 Apr;6(4):451-8 [18387498.001]
  • [Cites] Blood. 2008 Apr 15;111(8):4029-38 [18263783.001]
  • [Cites] J Clin Oncol. 2008 Apr 10;26(11):1850-7 [18347006.001]
  • [Cites] Expert Rev Anticancer Ther. 2008 Apr;8(4):605-15 [18402527.001]
  • [Cites] Int J Cancer. 2008 Jul 1;123(1):187-94 [18435450.001]
  • [Cites] Expert Opin Pharmacother. 2008 Jun;9(9):1481-94 [18518779.001]
  • [Cites] Hematol Oncol Clin North Am. 2008 Oct;22(5):941-52, ix [18954744.001]
  • [Cites] Blood. 2008 Dec 15;112(13):5150-60 [18796628.001]
  • [Cites] Blood. 2009 Jan 29;113(5):1175-83 [18971419.001]
  • [Cites] J Clin Oncol. 1999 Aug;17(8):2454-60 [10561309.001]
  • [Cites] Cancer. 2001 Feb 15;91(4):874-80 [11241258.001]
  • [Cites] J Clin Oncol. 2001 Mar 15;19(6):1610-8 [11250989.001]
  • [Cites] J Natl Cancer Inst. 2002 Feb 6;94(3):182-92 [11830608.001]
  • [Cites] Semin Oncol. 2002 Feb;29(1 Suppl 2):10-24 [11842384.001]
  • [Cites] J Clin Oncol. 2002 Sep 15;20(18):3878-84 [12228208.001]
  • [Cites] Br J Cancer. 2003 Jan 13;88(1):74-8 [12556962.001]
  • [Cites] Med Oncol. 2003;20(3):211-20 [14514970.001]
  • [Cites] Eur J Cancer. 2004 Feb;40(3):383-9 [14746857.001]
  • [Cites] Blood. 2004 Feb 15;103(4):1222-8 [14576060.001]
  • [Cites] Cancer. 2004 May 1;100(9):1902-8 [15112271.001]
  • [Cites] J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1083-91 [15247562.001]
  • [Cites] J Natl Cancer Inst. 1992 Sep 16;84(18):1422-7 [1512794.001]
  • [Cites] Eur J Haematol. 1994 Oct;53(4):218-22 [7957806.001]
  • [Cites] J Natl Cancer Inst. 1995 Apr 5;87(7):524-30 [7707439.001]
  • [Cites] J Clin Oncol. 1996 Feb;14(2):565-71 [8636772.001]
  • [Cites] Int J Cancer. 1997 Nov 27;73(5):645-50 [9398040.001]
  • [Cites] Cancer. 2005 Jan 15;103(2):216-28 [15578683.001]
  • [Cites] N Engl J Med. 2009 Feb 12;360(7):659-67 [19213679.001]
  • [Cites] J Natl Cancer Inst. 2009 Feb 18;101(4):248-55 [19211444.001]
  • [Cites] J Clin Oncol. 2009 Feb 20;27(6):904-10 [19114699.001]
  • [Cites] Nat Genet. 2009 Aug;41(8):873-5 [19620980.001]
  • [Cites] J Natl Cancer Inst. 2009 Aug 19;101(16):1120-30 [19648510.001]
  • [Cites] Blood. 2005 Jun 15;105(12):4573-5 [15741224.001]
  • (PMID = 20940199.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] ENG
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3020697
  •  go-up   go-down


24. Guiguet M, Boué F, Cadranel J, Lang JM, Rosenthal E, Costagliola D, Clinical Epidemiology Group of the FHDH-ANRS CO4 cohort: Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol; 2009 Dec;10(12):1152-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: We investigated the incidence of both AIDS-defining cancers (Kaposi's sarcoma, non-Hodgkin lymphoma, and cervical cancer) and non-AIDS-defining cancers (Hodgkin's lymphoma, lung cancer, liver cancer, and anal cancer) in 52 278 patients followed up in the French Hospital Database on HIV cohort during 1998-2006 (median follow-up 4.9 years, IQR 2.1-7.9; 255 353 person-years).
  • FINDINGS: Current CD4 cell count was the most predictive risk factor for all malignancies apart from anal cancer.
  • Compared with patients with CD4 count greater than 500 cells per microL, rate ratios (RR) ranged from 1.9 (95% CI 1.3-2.7) for CD4 counts 350-499 cells per microL to 25.2 (17.1-37.0) for counts less than 50 cells per microL for Kaposi's sarcoma (p<0.0001), from 1.3 (0.9-2.0) to 14.8 (9.7-22.6) for non-Hodgkin lymphoma (p<0.0001), from 1.2 (0.7-2.2) to 5.4 (2.4-12.1) for Hodgkin's lymphoma (p<0.0001), from 2.2 (1.3-3.6) to 8.5 (4.3-16.7) for lung cancer (p<0.0001), and from 2.0 (0.9-4.5) to 7.6 (2.7-20.8) for liver cancer (p<0.0001).
  • The risk of Kaposi's sarcoma and non-Hodgkin lymphoma increased for current plasma HIV RNA greater than 100 000 copies per mL compared with patients with controlled viral load (RR 3.1, 95% CI 2.3-4.2, p<0.0001; and 2.9, 2.1-3.9, p<0.0001, respectively), whereas cART was independently associated with a decreased incidence (0.3, 0.2-0.4, p<0.0001; and 0.8, 0.6-1.0, p=0.07, respectively).
  • The risk of anal cancer increased with the time during which the CD4 count was less than 200 cells per microL (1.3 per year, 1.2-1.5; p=0.0001), and viral load was greater than 100 000 copies per mL (1.2 per year, 1.1-1.4, p=0.005).
  • INTERPRETATION: cART would be most beneficial if it restores or maintains CD4 count above 500 cells per microL, thereby indicating an earlier diagnosis of HIV infection and an earlier treatment initiation.


25. Rajwanshi A, Srinivas R, Upasana G: Malignant small round cell tumors. J Cytol; 2009 Jan;26(1):1-10
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • They generally include Ewing's sarcoma, peripheral neuroectodermal tumor, rhabdomyosarcoma, synovial sarcoma, non-Hodgkin's lymphoma, retinoblastoma, neuroblastoma, hepatoblastoma, and nephroblastoma or Wilms' tumor.
  • Other differential diagnoses of small round cell tumors include small cell osteogenic sarcoma, undifferentiated hepatoblastoma, granulocytic sarcoma, and intraabdominal desmoplastic small round cell tumor.
  • Differential diagnosis of small round cell tumors is particularly difficult due to their undifferentiated or primitive character.
  • Tumors that show good differentiation are generally easy to diagnose, but when a tumor is poorly differentiated, identification of the diagnostic, morphological features is difficult and therefore, no definitive diagnosis may be possible.
  • As seen in several study reports, fine needle aspiration cytology (FNAC) has become an important modality of diagnosis for these tumors.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1992 Feb 15;69(4):1067-73 [1370916.001]
  • [Cites] Cancer Res. 1992 Sep 1;52(17):4701-5 [1380888.001]
  • [Cites] Diagn Cytopathol. 1992;8(5):465-74 [1396025.001]
  • [Cites] Diagn Cytopathol. 2003 Dec;29(6):341-3 [14648792.001]
  • [Cites] Diagn Cytopathol. 2004 Jan;30(1):19-23 [14696140.001]
  • [Cites] Neuroscience. 1992 Aug;49(3):497-528 [1501763.001]
  • [Cites] Diagn Cytopathol. 2004 Sep;31(3):147-54 [15349982.001]
  • [Cites] Diagn Cytopathol. 2004 Sep;31(3):159-63 [15349984.001]
  • [Cites] Diagn Cytopathol. 2005 May;32(5):281-6 [15830360.001]
  • [Cites] J Histochem Cytochem. 2005 Dec;53(12):1433-40 [15956022.001]
  • [Cites] Indian J Pathol Microbiol. 2004 Jul;47(3):309-18 [16295413.001]
  • [Cites] Eur J Cancer. 1991;27(6):762-5 [1676900.001]
  • [Cites] Am J Surg Pathol. 2006 Aug;30(8):962-8 [16861966.001]
  • [Cites] Acta Cytol. 1990 Jan-Feb;34(1):79-83 [1688679.001]
  • [Cites] Cytojournal. 2006;3:24 [17069647.001]
  • [Cites] Am J Surg Pathol. 1991 Jun;15(6):499-513 [1709557.001]
  • [Cites] Cancer. 2007 Feb 25;111(1):41-6 [17173322.001]
  • [Cites] Br J Cancer. 1991 Dec;64(6):1039-42 [1764365.001]
  • [Cites] Hum Mol Genet. 1997 Sep;6(9):1549-58 [9285793.001]
  • [Cites] Pathol Int. 1997 Sep;47(9):637-41 [9311017.001]
  • [Cites] N Engl J Med. 1998 Jan 15;338(3):153-60 [9428816.001]
  • [Cites] Am J Clin Pathol. 1998 May;109(5):625-30 [9576583.001]
  • [Cites] J Korean Med Sci. 1998 Aug;13(4):395-9 [9741544.001]
  • [Cites] Diagn Cytopathol. 1998 Nov;19(5):382-4 [9812236.001]
  • [Cites] Clin Cancer Res. 1998 Nov;4(11):2801-5 [9829745.001]
  • [Cites] Nature. 1978 Dec 21-28;276(5690):834-6 [31568.001]
  • [Cites] Acta Cytol. 1988 May-Jun;32(3):367-76 [3287819.001]
  • [Cites] Acta Cytol. 1988 Jan-Feb;32(1):1-10 [3336946.001]
  • [Cites] Am J Pathol. 1986 Mar;122(3):433-42 [3513600.001]
  • [Cites] Cancer. 1986 Feb 15;57(4):797-803 [3943013.001]
  • [Cites] Cancer. 1985 Sep 15;56(6):1490-2 [4027884.001]
  • [Cites] Am J Pathol. 1995 Dec;147(6):1584-91 [7495283.001]
  • [Cites] Am J Pathol. 1995 Dec;147(6):1799-810 [7495304.001]
  • [Cites] EMBO J. 1995 May 15;14(10):2333-40 [7539744.001]
  • [Cites] Am J Surg Pathol. 1995 Jun;19(6):659-65 [7755152.001]
  • [Cites] J Pathol. 1995 Apr;175(4):391-6 [7790992.001]
  • [Cites] Ann Clin Lab Sci. 1994 Jan-Feb;24(1):6-11 [8147568.001]
  • [Cites] Pathol Res Pract. 1993 Dec;189(10):111-36 [8183732.001]
  • [Cites] Acta Cytol. 1994 May-Jun;38(3):355-60 [8191824.001]
  • [Cites] Am J Pathol. 1994 Jun;144(6):1121-34 [8203453.001]
  • [Cites] Am J Surg Pathol. 1993 Jan;17(1):1-13 [8383465.001]
  • [Cites] Histopathology. 1993 Jul;23(1):93-7 [8396065.001]
  • [Cites] Diagn Cytopathol. 1995 Nov;13(4):310-5 [8599914.001]
  • [Cites] Int J Gynecol Pathol. 1995 Jul;14(3):260-5 [8600079.001]
  • [Cites] Cancer. 1996 Mar 15;77(6):1214-9 [8635146.001]
  • [Cites] J Pediatr Hematol Oncol. 1996 Aug;18(3):293-8 [8689345.001]
  • [Cites] Acta Cytol. 1997 Jul-Aug;41(4):1035-47 [9250296.001]
  • [Cites] Arch Pathol Lab Med. 1999 Mar;123(3):206-12 [10086508.001]
  • [Cites] Histopathology. 1999 Mar;34(3):205-10 [10217560.001]
  • [Cites] Diagn Cytopathol. 1999 May;20(5):271-7 [10319227.001]
  • [Cites] Diagn Cytopathol. 1999 May;20(5):278-84 [10319228.001]
  • [Cites] Am J Pathol. 1999 Jul;155(1):17-21 [10393831.001]
  • [Cites] Diagn Cytopathol. 1999 Aug;21(2):81-91 [10425044.001]
  • [Cites] Hum Pathol. 2000 Feb;31(2):246-50 [10685642.001]
  • [Cites] Diagn Cytopathol. 2000 Aug;23(2):118-23 [10888758.001]
  • [Cites] Acta Cytol. 2000 Jul-Aug;44(4):524-32 [10934943.001]
  • [Cites] Am J Surg Pathol. 2001 Jun;25(6):776-81 [11395555.001]
  • [Cites] Biol Pharm Bull. 2004 Mar;27(3):315-8 [14993794.001]
  • [Cites] Cytometry B Clin Cytom. 2005 Mar;64(1):34-42 [15669024.001]
  • [Cites] Diagn Cytopathol. 2005 Apr;32(4):211-6 [15754373.001]
  • [Cites] Diagn Cytopathol. 2005 Jun;32(6):330-5 [15880716.001]
  • [Cites] Cytopathology. 2007 Aug;18(4):234-40 [17559565.001]
  • [Cites] Diagn Mol Pathol. 1995 Sep;4(3):162-73 [7493135.001]
  • [Cites] Acta Cytol. 1993 Jul-Aug;37(4):477-82 [8392251.001]
  • [Cites] Am J Surg Pathol. 1996 Apr;20(4):406-12 [8604806.001]
  • [Cites] Cancer. 1991 Apr 1;67(7):1886-93 [1848471.001]
  • [Cites] Am J Pathol. 1991 Aug;139(2):317-25 [1867320.001]
  • [Cites] Diagn Cytopathol. 1991;7(5):451-61 [1954821.001]
  • [Cites] Cell. 1990 Feb 9;60(3):509-20 [2154335.001]
  • [Cites] Am J Pathol. 1990 Dec;137(6):1283-91 [2260621.001]
  • [Cites] Hum Pathol. 1986 Oct;17(10):996-1008 [2428727.001]
  • [Cites] Diagn Cytopathol. 1989;5(4):378-82 [2612314.001]
  • [Cites] Cancer. 1985 Apr 15;55(8):1805-17 [2983864.001]
  • [Cites] Diagn Cytopathol. 1997 Jun;16(6):513-7 [9181317.001]
  • [Cites] Am J Pathol. 1998 Dec;153(6):1807-12 [9846971.001]
  • [Cites] Diagn Cytopathol. 1998 Dec;19(6):410-6 [9839129.001]
  • [Cites] J Surg Oncol. 1999 Aug;71(4):269-72 [10440769.001]
  • [Cites] Mod Pathol. 2000 May;13(5):482-8 [10824918.001]
  • [Cites] Acta Cytol. 2000 May-Jun;44(3):332-6 [10833987.001]
  • [Cites] Arch Pathol Lab Med. 2000 Dec;124(12):1792-9 [11100059.001]
  • [Cites] Diagn Cytopathol. 2001 Apr;24(4):233-9 [11285617.001]
  • [Cites] Appl Immunohistochem Mol Morphol. 2001 Sep;9(3):255-60 [11556754.001]
  • [Cites] Anal Quant Cytol Histol. 2001 Dec;23(6):405-12 [11777275.001]
  • [Cites] Cancer Res. 2002 Jan 1;62(1):135-40 [11782370.001]
  • [Cites] Cancer. 2002 Feb 25;96(1):21-31 [11836699.001]
  • [Cites] Am J Surg Pathol. 2002 Aug;26(8):965-77 [12170083.001]
  • [Cites] Am J Surg Pathol. 2002 Sep;26(9):1175-83 [12218574.001]
  • [Cites] Diagn Cytopathol. 2003 May;28(5):232-8 [12722117.001]
  • [Cites] Acta Cytol. 1992 Jul-Aug;36(4):541-50 [1321999.001]
  • (PMID = 21938141.001).
  • [ISSN] 0970-9371
  • [Journal-full-title] Journal of cytology
  • [ISO-abbreviation] J Cytol
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3167982
  • [Keywords] NOTNLM ; Fine needle aspiration cytology / ancillary techniques / malignant small round cell tumors
  •  go-up   go-down


26. Spano JP, Costagliola D, Katlama C, Mounier N, Oksenhendler E, Khayat D: AIDS-related malignancies: state of the art and therapeutic challenges. J Clin Oncol; 2008 Oct 10;26(29):4834-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although the advent of cART has resulted in reductions in the incidence of Kaposi's sarcoma and non-Hodgkin's lymphoma, non-AIDS-defining malignancies present an increased risk for HIV-infected patients, characterized by some common clinical features, generally with a more aggressive behavior and a more advanced disease at diagnosis, which is responsible for poorer patient outcomes.
  • Specific therapeutic recommendations are lacking for these new nonopportunistic malignancies, such as Hodgkin's lymphoma, anal cancer, lung cancer, hepatocarcinoma, and many others.

  • Genetic Alliance. consumer health - AIDS-HIV.
  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • HIV InSite. treatment guidelines - Human Herpesvirus-8 .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18591544.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 99
  •  go-up   go-down


27. Bozzi F, Ferrari A, Negri T, Conca E, Luca da R, Losa M, Casieri P, Orsenigo M, Lampis A, Meazza C, Casanova M, Pierotti MA, Tamborini E, Pilotti S: Molecular characterization of synovial sarcoma in children and adolescents: evidence of akt activation. Transl Oncol; 2008 Jul;1(2):95-101
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Molecular characterization of synovial sarcoma in children and adolescents: evidence of akt activation.
  • Synovial sarcoma (SS) is the most frequent nonrhabdomyosarcomatous soft tissue sarcoma encountered in adolescents and young adults, and despite advances in the treatment of local disease, metastases remain the main cause of death.


28. Katona TM, Lopez-Beltran A, MacLennan GT, Cheng L, Montironi R, Cheng L: Soft tissue tumors of the penis: a review. Anal Quant Cytol Histol; 2006 Aug;28(4):193-206
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The purpose of this review is to aid the practicing surgical pathologist in distinguishing penile soft tissue tumors, such as sarcomatoid squamous cell carcinoma, from other prognostically and therapeutically important entities in the differential diagnosis.
  • Among reported cases, the most frequent malignant penile soft tissue tumors are Kaposi sarcoma and leiomyosarcoma.
  • Accurate diagnosis is best facilitated by consideration of all available aspects of the case, including clinical information, histopathologic findings and immunohistochemical results.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16927639.001).
  • [ISSN] 0884-6812
  • [Journal-full-title] Analytical and quantitative cytology and histology
  • [ISO-abbreviation] Anal. Quant. Cytol. Histol.
  • [Language] ENG
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 63
  •  go-up   go-down


29. Ang D, Luman W, Ooi CJ: Early experience with double balloon enteroscopy: a leap forward for the gastroenterologist. Singapore Med J; 2007 Jan;48(1):50-60
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: DBE was carried out via the oral approach (19 patients), anal approach (eight patients), and both approaches (three patients).
  • A positive diagnosis was achieved in 19 patients: jejunal gastrointestinal stromal tumour (GIST) (one), jejunal sarcoma (one), jejunal adenocarcinoma (one), duodenal adenocarcinoma (one), malignant lymphangioma (one), eosinophilic enteritis (one), pseudomembranous ileitis (one), tuberculous ileitis (one), jejunitis/ileitis (seven), lymphangiectasia attributed to relapsed Non-Hodgkins lymphoma (one), combination of angiodysplastic lesions and apthous jejunal/ileal lesions (one), and focal villous atrophy (two).
  • [MeSH-major] Endoscopes, Gastrointestinal / standards. Endoscopy, Gastrointestinal / methods. Intestinal Diseases / diagnosis. Intestine, Small / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17245517.001).
  • [ISSN] 0037-5675
  • [Journal-full-title] Singapore medical journal
  • [ISO-abbreviation] Singapore Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Singapore
  •  go-up   go-down


30. Chen W, Jarzyna PA, van Tilborg GA, Nguyen VA, Cormode DP, Klink A, Griffioen AW, Randolph GJ, Fisher EA, Mulder WJ, Fayad ZA: RGD peptide functionalized and reconstituted high-density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probe. FASEB J; 2010 Jun;24(6):1689-99
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] RGD peptide functionalized and reconstituted high-density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probe.
  • High density lipoprotein (HDL), an endogenous nanoparticle, transports fat throughout the body and is capable of transferring cholesterol from atheroma in the vessel wall to the liver.
  • In the present study, we utilized HDL as a multimodal nanoparticle platform for tumor targeting and imaging via nonspecific accumulation and specific binding to angiogenically activated blood vessels.
  • We reconstituted HDL (rHDL) with amphiphilic gadolinium chelates and fluorescent dyes.
  • To target angiogenic endothelial cells, rHDL was functionalized with alphavbeta3-integrin-specific RGD peptides (rHDL-RGD).
  • Nonspecific RAD peptides were conjugated to rHDL nanoparticles as a control (rHDL-RAD).
  • It was observed in vitro that all 3 nanoparticles were phagocytosed by macrophages, while alphavbeta3-integrin-specific rHDL-RGD nanoparticles were preferentially taken up by endothelial cells.
  • The uptake of nanoparticles in mouse tumors was evaluated in vivo using near infrared (NIR) and MR imaging.
  • All nanoparticles accumulated in tumors but with very different accumulation/binding kinetics as observed by NIR imaging.
  • Moreover, confocal microscopy revealed rHDL-RGD to be associated with tumor endothelial cells, while rHDL and rHDL-RAD nanoparticles were mainly found in the interstitial space.
  • This study demonstrates the ability to reroute HDL from its natural targets to tumor blood vessels and its potential for multimodal imaging of tumor-associated processes.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nature. 2000 Sep 14;407(6801):249-57 [11001068.001]
  • [Cites] Magn Reson Med. 2009 May;61(5):1022-32 [19235908.001]
  • [Cites] Pathobiology. 2001;69(4):225-9 [12007282.001]
  • [Cites] Mol Imaging. 2002 Oct;1(4):365-77 [12940233.001]
  • [Cites] Technol Cancer Res Treat. 2003 Dec;2(6):553-62 [14640766.001]
  • [Cites] Nat Biotechnol. 2004 Jan;22(1):93-7 [14661026.001]
  • [Cites] N Engl J Med. 1971 Nov 18;285(21):1182-6 [4938153.001]
  • [Cites] Anal Biochem. 1976 May 7;72:248-54 [942051.001]
  • [Cites] Atherosclerosis. 1994 Feb;105(2):145-57 [8003090.001]
  • [Cites] J Lipid Res. 1999 Sep;40(9):1647-54 [10484611.001]
  • [Cites] J Am Chem Soc. 2004 Dec 22;126(50):16316-7 [15600321.001]
  • [Cites] J Am Coll Cardiol. 2005 Sep 20;46(6):937-54 [16168274.001]
  • [Cites] Mol Imaging. 2005 Jul-Sep;4(3):143-64 [16194447.001]
  • [Cites] J Am Coll Cardiol. 2005 Oct 4;46(7):1209-18 [16198833.001]
  • [Cites] FASEB J. 2005 Dec;19(14):2008-10 [16204353.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17757-62 [16306263.001]
  • [Cites] Nano Lett. 2006 Jan;6(1):1-6 [16402777.001]
  • [Cites] Magn Reson Med. 2006 Mar;55(3):491-7 [16450336.001]
  • [Cites] Nat Clin Pract Cardiovasc Med. 2006 Mar;3(3):144-53 [16505860.001]
  • [Cites] Nano Lett. 2006 Oct;6(10):2220-4 [17034087.001]
  • [Cites] J Lipid Res. 2006 Nov;47(11):2408-21 [16926440.001]
  • [Cites] Am J Cardiol. 2006 Dec 1;98(11):1542-9 [17126667.001]
  • [Cites] Int J Cancer. 2007 May 1;120(9):1951-7 [17278104.001]
  • [Cites] NMR Biomed. 2007 Apr;20(2):77-89 [16952123.001]
  • [Cites] Bioconjug Chem. 2007 Mar-Apr;18(2):379-88 [17298029.001]
  • [Cites] J Am Chem Soc. 2007 May 9;129(18):5798-9 [17428054.001]
  • [Cites] Curr Opin Lipidol. 2007 Aug;18(4):443-50 [17620862.001]
  • [Cites] Expert Opin Drug Deliv. 2007 Nov;4(6):665-75 [17970668.001]
  • [Cites] Int J Nanomedicine. 2007;2(4):767-74 [18203443.001]
  • [Cites] Nutr Metab Cardiovasc Dis. 2008 May;18(4):329-35 [18378129.001]
  • [Cites] Curr Opin Cardiol. 2008 Jul;23(4):370-8 [18520722.001]
  • [Cites] FASEB J. 2008 Aug;22(8):2758-67 [18362202.001]
  • [Cites] Small. 2008 Sep;4(9):1437-44 [18712752.001]
  • [Cites] Nano Lett. 2008 Nov;8(11):3715-23 [18939808.001]
  • [Cites] Neoplasia. 2008 Dec;10(12):1459-69 [19048124.001]
  • [Cites] Clin Sci (Lond). 2009 Jan;116(2):87-98 [19076062.001]
  • [Cites] Bioconjug Chem. 2008 Dec;19(12):2471-9 [19035793.001]
  • [Cites] Contrast Media Mol Imaging. 2008 Nov-Dec;3(6):233-42 [19072768.001]
  • [Cites] Angiogenesis. 2009;12(1):17-24 [19067197.001]
  • [Cites] Magn Reson Med. 2009 May;61(5):1049-58 [19215042.001]
  • [Cites] Bioconjug Chem. 2002 Jan-Feb;13(1):128-35 [11792188.001]
  • (PMID = 20075195.001).
  • [ISSN] 1530-6860
  • [Journal-full-title] FASEB journal : official publication of the Federation of American Societies for Experimental Biology
  • [ISO-abbreviation] FASEB J.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / 5R24 CA-095823-04; United States / PHS HHS / / R01 H-71021; United States / NIBIB NIH HHS / EB / EB-009638; United States / PHS HHS / / R01 H-78667; United States / NIBIB NIH HHS / EB / R01 EB009638; United States / NCI NIH HHS / CA / R24 CA095823; United States / NCRR NIH HHS / RR / 1 S10 RR-09145-01
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Integrin alphaVbeta3; 0 / Lipoproteins, HDL; 0 / Molecular Probes; 0 / Oligopeptides; 99896-85-2 / arginyl-glycyl-aspartic acid
  • [Other-IDs] NLM/ PMC2874482
  •  go-up   go-down


31. Chatelain D, Mokrani N, Fléjou JF: [Anal and anal margin tumors]. Ann Pathol; 2007 Dec;27(6):459-75
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Anal and anal margin tumors].
  • Tumors of the anal canal and anal margin are rare.
  • [MeSH-major] Anus Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma / epidemiology. Adenocarcinoma / pathology. Carcinoma, Squamous Cell / epidemiology. Carcinoma, Squamous Cell / pathology. Endocrine Gland Neoplasms / epidemiology. Endocrine Gland Neoplasms / pathology. France / epidemiology. Humans. Incidence. Leiomyosarcoma / pathology. Lymphoma / pathology. Melanoma / epidemiology. Melanoma / pathology. Papilloma / pathology. Sarcoma, Kaposi / pathology

  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18554556.001).
  • [ISSN] 0242-6498
  • [Journal-full-title] Annales de pathologie
  • [ISO-abbreviation] Ann Pathol
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 110
  •  go-up   go-down


32. Rivero Fernández M, García Martos M, Sanz Moya P, Vázquez Romero M, Fernández Amago MT, García Benayas MT, Sánchez-Pobre Bejarano P: [Kaposi's sarcoma with colorectal and anal canal involvement]. Gastroenterol Hepatol; 2010 Aug-Sep;33(7):508-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Kaposi's sarcoma with colorectal and anal canal involvement].
  • [Transliterated title] Sarcoma de Kaposi con afectación colorrectal y del canal anal.
  • Kaposi's sarcoma (KS) is a low-grade vascular tumor, with four main variants, one of which is fairly prevalent in HIV-infected patients.
  • The gastrointestinal tract is involved in 40% of patients, but rectal and anal canal involvement is exceptional.
  • We report the case of a 39-year-old HIV-infected man with an unusual presentation of KS with colorectal and anal canal involvement in the absence of cutaneous disease.
  • [MeSH-major] Anus Neoplasms. Colorectal Neoplasms. Neoplasms, Multiple Primary. Sarcoma, Kaposi

  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Kaposi's Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] .
  • (PMID = 20630624.001).
  • [ISSN] 0210-5705
  • [Journal-full-title] Gastroenterología y hepatología
  • [ISO-abbreviation] Gastroenterol Hepatol
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


33. Sápi Z, Pápai Z, Hruska A, Antal I, Bodó M, Orosz Z: Her-2 oncogene amplification, chromosome 17 and DNA ploidy status in synovial sarcoma. Pathol Oncol Res; 2005;11(3):133-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Her-2 oncogene amplification, chromosome 17 and DNA ploidy status in synovial sarcoma.
  • The treatment options for synovial sarcoma (SS) are very limited, though this type of sarcoma seems to be more heterogeneous than it has been traditionally considered.
  • [MeSH-major] Chromosomes, Human, Pair 17. DNA, Neoplasm / genetics. Genes, erbB-2. Sarcoma, Synovial / genetics

  • Genetic Alliance. consumer health - Synovial sarcoma.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Genes Chromosomes Cancer. 2001 Aug;31(4):362-72 [11433527.001]
  • [Cites] Histopathology. 1994 Nov;25(5):455-61 [7868086.001]
  • [Cites] Clin Endocrinol (Oxf). 1998 Nov;49(5):629-37 [10197079.001]
  • [Cites] Hum Pathol. 2003 Jul;34(7):639-45 [12874758.001]
  • [Cites] Anal Cell Pathol. 2001;23(2):89-95 [11904464.001]
  • [Cites] Cancer. 1999 Jun 15;85(12):2596-607 [10375108.001]
  • [Cites] Br J Cancer. 1991 Apr;63(4):601-8 [1673627.001]
  • [Cites] J Clin Oncol. 2000 Nov 15;18(22):3794-803 [11078492.001]
  • [Cites] J Clin Oncol. 2000 May;18(10):2087-94 [10811674.001]
  • [Cites] Am J Clin Pathol. 1997 Oct;108(4):456-63 [9322600.001]
  • [Cites] Cancer. 2005 Feb 15;103(4):830-8 [15641030.001]
  • [Cites] Mod Pathol. 2001 Dec;14(12):1277-83 [11743051.001]
  • [Cites] Cancer. 1996 Apr 15;77(8):1419-26 [8608524.001]
  • [Cites] Ann Oncol. 2005 Mar;16(3):437-44 [15653701.001]
  • [Cites] Cancer. 1990 May 15;65(10):2295-300 [2161280.001]
  • [Cites] Am J Pathol. 2002 Nov;161(5):1587-95 [12414507.001]
  • [Cites] Anal Cell Pathol. 1994 Feb;6(2):165-80 [8167099.001]
  • [Cites] J Cancer Res Clin Oncol. 2002 Nov;128(11):610-6 [12458341.001]
  • (PMID = 16195766.001).
  • [ISSN] 1219-4956
  • [Journal-full-title] Pathology oncology research : POR
  • [ISO-abbreviation] Pathol. Oncol. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / DNA, Neoplasm
  •  go-up   go-down


34. Cook MB, Dawsey SM, Freedman ND, Inskip PD, Wichner SM, Quraishi SM, Devesa SS, McGlynn KA: Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev; 2009 Apr;18(4):1174-82
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: The 10 cancers with the largest male-to-female IRR were Kaposi sarcoma (28.73), lip (7.16), larynx (5.17), mesothelioma (4.88), hypopharynx (4.13), urinary bladder (3.92), esophagus (3.49), tonsil (3.07), oropharynx (3.06), and other urinary organs (2.92).
  • Only 5 cancers had a higher incidence in females compared with males: breast (0.01), peritoneum, omentum, and mesentery (0.18), thyroid (0.39), gallbladder (0.57), and anus, anal canal, and anorectum (0.81).

  • MedlinePlus Health Information. consumer health - Cancer in Children.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Environ Res. 2007 May;104(1):128-34 [17084838.001]
  • [Cites] Environ Res. 2007 May;104(1):85-95 [16996054.001]
  • [Cites] Am J Epidemiol. 2007 Jun 15;165(12):1424-33 [17420181.001]
  • [Cites] Gastroenterology. 2007 Jun;132(7):2557-76 [17570226.001]
  • [Cites] Verh K Acad Geneeskd Belg. 2007;69(3):105-30 [17580814.001]
  • [Cites] Science. 2007 Jul 6;317(5834):121-4 [17615358.001]
  • [Cites] Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4365-70 [17671117.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2007 Nov 9;56(44):1157-61 [17989644.001]
  • [Cites] Cell Prolif. 2007 Dec;40(6):921-35 [18021179.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):352-8 [18268119.001]
  • [Cites] Adv Exp Med Biol. 2008;624:104-16 [18348451.001]
  • [Cites] Aging Clin Exp Res. 2008 Apr;20(2):91-102 [18431075.001]
  • [Cites] Br J Cancer. 2008 Nov 4;99(9):1506-10 [18841152.001]
  • [Cites] Eur J Cancer. 2008 Nov;44(16):2397-403 [18755583.001]
  • [Cites] Nat Rev Genet. 2008 Dec;9(12):911-22 [19002143.001]
  • [Cites] Eur J Endocrinol. 2008 Dec;159(6):659-73 [18713843.001]
  • [Cites] Soc Sci Med. 2000 May;50(10):1385-401 [10741575.001]
  • [Cites] Eur J Cancer Prev. 2000 Dec;9(6):433-7 [11201683.001]
  • [Cites] J Gend Specif Med. 2000 Mar-Apr;3(2):42-4 [11253245.001]
  • [Cites] J Gastroenterol Hepatol. 2001 Feb;16(2):132-6 [11207891.001]
  • [Cites] J Womens Health Gend Based Med. 2001 Jun;10(5):433-9 [11445042.001]
  • [Cites] Indian J Cancer. 2000 Jun-Sep;37(2-3):114-22 [11876609.001]
  • [Cites] Tumori. 2002 Jan-Feb;88(1):13-7 [12004843.001]
  • [Cites] Thyroid. 2002 Oct;12(10):889-96 [12487771.001]
  • [Cites] J Gastroenterol. 2003 Mar;38 Suppl 15:3-6 [12698863.001]
  • [Cites] N Engl J Med. 2003 Apr 24;348(17):1625-38 [12711737.001]
  • [Cites] Int J Cancer. 2004 Feb 20;108(5):766-72 [14696105.001]
  • [Cites] Urol Clin North Am. 2004 May;31(2):237-47 [15123404.001]
  • [Cites] Cancer. 2004 Jul 15;101(2):281-8 [15241824.001]
  • [Cites] Br J Cancer. 1969 Mar;23(1):26-30 [4181296.001]
  • [Cites] World Health Stat Q. 1978;31(4):360-83 [735114.001]
  • [Cites] Annu Rev Public Health. 1984;5:433-58 [6372818.001]
  • [Cites] Ann N Y Acad Sci. 1990;609:290-7; discussion 297-9 [2264652.001]
  • [Cites] World Health Stat Q. 1992;45(1):117-64 [1413853.001]
  • [Cites] Int J Epidemiol. 1995 Aug;24(4):720-9 [8550269.001]
  • [Cites] J Intern Med. 1997 Jan;241(1):71-9 [9042096.001]
  • [Cites] Acta Biotheor. 1998 Jun;46(2):157-60 [9691260.001]
  • [Cites] J Natl Cancer Inst. 1998 Nov 4;90(21):1626-36 [9811312.001]
  • [Cites] Int J Cancer. 2005 Mar 10;114(1):101-8 [15523697.001]
  • [Cites] Am J Gastroenterol. 2005 Mar;100(3):560-7 [15743352.001]
  • [Cites] Hum Reprod Update. 2005 Jul-Aug;11(4):411-23 [15817524.001]
  • [Cites] Ann Epidemiol. 2005 Aug;15(7):545-50 [16029848.001]
  • [Cites] Br J Nutr. 2005 Aug;94(2):139-40 [16115345.001]
  • [Cites] Br J Cancer. 2005 Oct 17;93(8):859-61 [16189516.001]
  • [Cites] Am J Epidemiol. 2005 Dec 1;162(11):1050-61 [16221805.001]
  • [Cites] Br J Cancer. 2006 Jan 16;94(1):136-41 [16404367.001]
  • [Cites] Clin Gastroenterol Hepatol. 2006 Mar;4(3):369-80 [16527702.001]
  • [Cites] Ann Intern Med. 2006 May 16;144(10):705-14 [16702586.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):872-8 [16702363.001]
  • [Cites] Cancer Detect Prev. 2006;30(2):152-7 [16647226.001]
  • [Cites] Br J Cancer. 2006 Jul 3;95(1):87-90 [16721368.001]
  • [Cites] Clin Otolaryngol. 2006 Aug;31(4):259-66 [16911640.001]
  • [Cites] Mayo Clin Proc. 2007 Mar;82(3):364-80 [17352373.001]
  • [Cites] N Engl J Med. 2007 May 10;356(19):1944-56 [17494927.001]
  • (PMID = 19293308.001).
  • [ISSN] 1055-9965
  • [Journal-full-title] Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • [ISO-abbreviation] Cancer Epidemiol. Biomarkers Prev.
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / ZIA CP010126-15
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS160092; NLM/ PMC2793271
  •  go-up   go-down


35. Abbott DE, Halverson AL, Wayne JD, Kim JY, Talamonti MS, Dumanian GA: The oblique rectus abdominal myocutaneous flap for complex pelvic wound reconstruction. Dis Colon Rectum; 2008 Aug;51(8):1237-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Indications for flap reconstruction included abdominal perineal resection for anal/rectal cancer, pelvic sarcoma/sacral resection/exenteration, small bowel/colonic fistula resection, and total proctocolectomy with vaginal reconstruction.

  • MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18481146.001).
  • [ISSN] 1530-0358
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


36. Gatta G, Ciccolallo L, Kunkler I, Capocaccia R, Berrino F, Coleman MP, De Angelis R, Faivre J, Lutz JM, Martinez C, Möller T, Sankila R, EUROCARE Working Group: Survival from rare cancer in adults: a population-based study. Lancet Oncol; 2006 Feb;7(2):132-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • FINDINGS: Overall 5-year relative survival was good (ie, >65%) for placental choriocarcinoma (85.4% [95% CI 81.4-89.5]), thyroid medullary carcinoma (72.4% [69.2-75.5]), ovarian germ-cell cancer (73.0% [70.0-76.0]), lung carcinoid (70.1% [67.3-72.9]), and cervical adenocarcinoma (65.5% [64.3-66.6]); intermediate (ie, 35-65%) for testicular cancer at age 65 years or older (64.0% [59.3-68.7]), sarcoma of extremities (60.0% [58.9-61.2]), digestive-system endocrine cancers (55.6% [54.9-56.3]), anal squamous-cell carcinoma (53.1% [51.5-54.8]), and uterine sarcoma (43.5% [42.0-44.9]); low for carcinoma of adrenal-gland cortex (32.7% [28.3-37.2]) and bladder squamous-cell carcinoma (20.4% [18.8-22.0]); and poor for angiosarcoma of liver (6.4% [1.8-11.0]) and mesothelioma (4.7% [4.3-5.2]).
  • Survival significantly improved over time for ovarian germ-cell cancer, sarcomas of extremities, digestive-system endocrine tumours, anal squamous-cell carcinoma, and angiosarcoma of liver.

  • MedlinePlus Health Information. consumer health - Rare Diseases.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16455477.001).
  • [ISSN] 1470-2045
  • [Journal-full-title] The Lancet. Oncology
  • [ISO-abbreviation] Lancet Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


37. Kalt I, Borodianskiy-Shteinberg T, Schachor A, Sarid R: GLTSCR2/PICT-1, a putative tumor suppressor gene product, induces the nucleolar targeting of the Kaposi's sarcoma-associated herpesvirus KS-Bcl-2 protein. J Virol; 2010 Mar;84(6):2935-45
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] GLTSCR2/PICT-1, a putative tumor suppressor gene product, induces the nucleolar targeting of the Kaposi's sarcoma-associated herpesvirus KS-Bcl-2 protein.
  • KS-Bcl-2, encoded by Kaposi's sarcoma-associated herpesvirus (KSHV), is a structural and functional homologue of the Bcl-2 family of apoptosis regulators.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2001 May;75(10):4843-53 [11312356.001]
  • [Cites] J Pathol. 2008 Oct;216(2):218-24 [18729076.001]
  • [Cites] J Virol. 2002 Mar;76(5):2551-6 [11836434.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3428-33 [11904405.001]
  • [Cites] Genes Dev. 2002 Oct 1;16(19):2465-78 [12368257.001]
  • [Cites] Mol Biol Cell. 2002 Nov;13(11):4100-9 [12429849.001]
  • [Cites] Microbiol Mol Biol Rev. 2003 Jun;67(2):175-212, table of contents [12794189.001]
  • [Cites] Trends Cell Biol. 2003 Sep;13(9):478-83 [12946627.001]
  • [Cites] Brain Res. 2004 Mar 19;1001(1-2):133-42 [14972662.001]
  • [Cites] J Biol Chem. 2004 Oct 29;279(44):45300-3 [15355975.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):690-4 [9012846.001]
  • [Cites] Nat Med. 1997 Mar;3(3):293-8 [9055856.001]
  • [Cites] J Biol Chem. 1997 May 23;272(21):13829-34 [9153240.001]
  • [Cites] J Virol. 1999 May;73(5):3810-7 [10196275.001]
  • [Cites] Genomics. 2000 Feb 15;64(1):44-50 [10708517.001]
  • [Cites] J Virol. 2000 Jun;74(11):5024-31 [10799576.001]
  • [Cites] Mol Cell. 2000 Jul;6(1):31-40 [10949025.001]
  • [Cites] Nat Cell Biol. 2000 Nov;2(11):819-25 [11056537.001]
  • [Cites] Genes Dev. 1999 Aug 1;13(15):1899-911 [10444588.001]
  • [Cites] Anal Biochem. 2005 Jan 1;336(1):138-40 [15582570.001]
  • [Cites] Nature. 2005 Jan 6;433(7021):77-83 [15635413.001]
  • [Cites] Biochem J. 2005 May 1;387(Pt 3):659-67 [15554878.001]
  • [Cites] Cell Cycle. 2005 Apr;4(4):590-6 [15876860.001]
  • [Cites] Crit Rev Clin Lab Sci. 2005;42(2):101-53 [15941082.001]
  • [Cites] Cell. 2005 Sep 23;122(6):927-39 [16179260.001]
  • [Cites] Arch Virol. 2005 Nov;150(11):2387-95 [15883654.001]
  • [Cites] Nat Cell Biol. 2006 Jul;8(7):688-99 [16799551.001]
  • [Cites] Cell Death Differ. 2006 Aug;13(8):1318-24 [16741528.001]
  • [Cites] Cell Death Differ. 2006 Aug;13(8):1339-50 [16763614.001]
  • [Cites] Mol Biol Cell. 2006 Nov;17(11):4888-95 [16971513.001]
  • [Cites] Nat Rev Mol Cell Biol. 2007 Jul;8(7):574-85 [17519961.001]
  • [Cites] Oncogene. 2007 Aug 30;26(40):5851-65 [17369848.001]
  • [Cites] Cell Death Differ. 2007 Nov;14(11):1872-9 [17657248.001]
  • [Cites] Virology. 2008 Feb 5;371(1):14-31 [17963810.001]
  • [Cites] Cell Death Differ. 2008 Mar;15(3):580-8 [18084238.001]
  • [Cites] Mol Cell. 2008 Jun 20;30(6):678-88 [18570871.001]
  • [Cites] Curr Biol. 2008 Jul 8;18(13):933-42 [18571408.001]
  • [Cites] FEBS J. 2008 Aug;275(16):4164-78 [18631361.001]
  • [Cites] J Virol. 2002 Mar;76(5):2469-79 [11836425.001]
  • (PMID = 20042497.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / GLTSCR2 protein, human; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / Recombinant Fusion Proteins; 0 / Tumor Suppressor Proteins; 0 / Viral Proteins
  • [Other-IDs] NLM/ PMC2826064
  •  go-up   go-down


38. Hunt DL, Cheng C, Pounds S: The Beta-Binomial Distribution for Estimating the Number of False Rejections in Microarray Gene Expression Studies. Comput Stat Data Anal; 2009 Mar 15;53(5):1688-1700
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • As an example, this method is also used to perform an analysis that compares the gene expression of soft tissue sarcoma samples to normal tissue samples.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20352014.001).
  • [ISSN] 0167-9473
  • [Journal-full-title] Computational statistics & data analysis
  • [ISO-abbreviation] Comput Stat Data Anal
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA021765-309003; United States / NCI NIH HHS / CA / P30 CA021765; United States / NIGMS NIH HHS / GM / U01 GM061374; United States / NIGMS NIH HHS / GM / U01 GM061393
  • [Publication-type] JOURNAL ARTICLE
  • [Publication-country] Netherlands
  •  go-up   go-down


39. Bonnet F, Chêne G: Evolving epidemiology of malignancies in HIV. Curr Opin Oncol; 2008 Sep;20(5):534-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Since the introduction of combination antiretroviral therapy, the incidence of Kaposi's sarcoma and cerebral lymphoma (among AIDS-defining cancers) decreased in parallel with AIDS-defining infections, whereas the incidence of systemic non-Hodgkin's lymphoma and cervical cancer decreased less than others and remains higher in HIV-infected patients than in the general population.
  • These malignancies include Hodgkin's disease, lung, anal, head and neck cancers, hemopathies, and conjunctival cancers.

  • Genetic Alliance. consumer health - HIV.
  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19106656.001).
  • [ISSN] 1531-703X
  • [Journal-full-title] Current opinion in oncology
  • [ISO-abbreviation] Curr Opin Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 75
  •  go-up   go-down


40. Bartee E, McCormack A, Früh K: Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog; 2006 Oct;2(10):e107
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • For instance, the K5 modulator of immune recognition (MIR2) from Kaposi sarcoma-associated herpesvirus prevents activation of cytotoxic T cells, natural killer cells, and natural killer T cells by downregulating major histocompatibility complex (MHC) class I molecules, the MHC-like molecule CD1, the cell adhesion molecules ICAM-1 and PECAM, and the co-stimulatory molecule B7.2.

  • Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).
  • GeneTex Inc. NCBI Redirect Page | Genetex Inc. (subscription/membership/fee required).
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Biol Cell. 2000 Jan;11(1):227-39 [10637304.001]
  • [Cites] J Virol. 1999 Aug;73(8):6892-902 [10400787.001]
  • [Cites] J Virol. 2000 Jun;74(11):5300-9 [10799607.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8051-6 [10859362.001]
  • [Cites] Cell. 2000 Sep 1;102(5):549-52 [11007473.001]
  • [Cites] Immunity. 2000 Sep;13(3):365-74 [11021534.001]
  • [Cites] J Clin Invest. 2001 Jun;107(12):1599-606 [11413168.001]
  • [Cites] Cell. 2001 Oct 5;107(1):55-65 [11595185.001]
  • [Cites] Virology. 2001 Sep 30;288(2):369-78 [11601908.001]
  • [Cites] Immunity. 2001 Oct;15(4):627-36 [11672544.001]
  • [Cites] J Cell Biol. 2001 Dec 24;155(7):1265-73 [11756476.001]
  • [Cites] J Biol Chem. 2002 Feb 22;277(8):6124-30 [11751860.001]
  • [Cites] J Virol. 2002 Mar;76(6):2912-23 [11861858.001]
  • [Cites] EMBO J. 2002 Apr 2;21(7):1638-49 [11927548.001]
  • [Cites] EMBO J. 2002 May 15;21(10):2418-29 [12006494.001]
  • [Cites] Mol Cell Proteomics. 2002 May;1(5):376-86 [12118079.001]
  • [Cites] Curr Top Microbiol Immunol. 2002;269:101-15 [12224504.001]
  • [Cites] J Biol Chem. 2002 Sep 20;277(38):35071-9 [12121982.001]
  • [Cites] Anal Chem. 2002 Oct 15;74(20):5383-92 [12403597.001]
  • [Cites] J Virol. 2003 Jan;77(2):1427-40 [12502858.001]
  • [Cites] Methods. 2003 Feb;29(2):124-30 [12606218.001]
  • [Cites] Nat Biotechnol. 2003 Mar;21(3):315-8 [12577067.001]
  • [Cites] J Biol Chem. 2003 Apr 25;278(17):14657-68 [12582153.001]
  • [Cites] J Exp Med. 2003 May 19;197(10):1245-53 [12756263.001]
  • [Cites] Nat Biotechnol. 2003 Aug;21(8):921-6 [12872131.001]
  • [Cites] Traffic. 2003 Oct;4(10):694-709 [12956872.001]
  • [Cites] J Biol Chem. 2003 Sep 19;278(38):36718-25 [12855681.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12735-40 [14557538.001]
  • [Cites] Anal Chem. 2003 Dec 1;75(23):6648-57 [14640741.001]
  • [Cites] J Virol. 2004 Feb;78(3):1109-20 [14722266.001]
  • [Cites] Eur J Immunol. 2004 Apr;34(4):930-40 [15048703.001]
  • [Cites] Mol Cell Proteomics. 2004 Jul;3(7):729-35 [15102926.001]
  • [Cites] Nat Biotechnol. 2004 Aug;22(8):985-92 [15258593.001]
  • [Cites] J Immunol. 2004 Aug 15;173(4):2262-70 [15294938.001]
  • [Cites] Biochim Biophys Acta. 2004 Aug 23;1693(2):81-9 [15313010.001]
  • [Cites] J Immunol. 1989 Oct 15;143(8):2439-47 [2794503.001]
  • [Cites] Res Virol. 1992 Jan-Feb;143(1):52-5 [1565858.001]
  • [Cites] J Virol. 1992 Dec;66(12):7193-200 [1433512.001]
  • [Cites] Anal Chem. 1995 Apr 15;67(8):1426-36 [7741214.001]
  • [Cites] Genomics. 1995 Apr 10;26(3):527-34 [7607676.001]
  • [Cites] Cell. 1996 Mar 8;84(5):769-79 [8625414.001]
  • [Cites] Anal Chem. 1995 Sep 15;67(18):3202-10 [8686885.001]
  • [Cites] J Exp Med. 1997 Apr 7;185(7):1295-305 [9104816.001]
  • [Cites] Eur J Immunol. 1997 Jun;27(6):1469-78 [9209500.001]
  • [Cites] Nature. 1998 Jan 22;391(6665):397-401 [9450757.001]
  • [Cites] Biochem Biophys Res Commun. 1999 May 19;258(3):583-91 [10329429.001]
  • [Cites] Nat Biotechnol. 1999 Jul;17(7):676-82 [10404161.001]
  • [Cites] Mol Biol Cell. 2005 Apr;16(4):1696-710 [15689499.001]
  • [Cites] J Proteome Res. 2005 Mar-Apr;4(2):400-9 [15822916.001]
  • [Cites] J Clin Invest. 2005 May;115(5):1369-78 [15864354.001]
  • [Cites] J Cell Biol. 2005 Jul 18;170(2):177-82 [16009722.001]
  • [Cites] Immunol Rev. 2005 Oct;207:112-25 [16181331.001]
  • [Cites] Mol Cell Proteomics. 2005 Nov;4(11):1697-709 [16088002.001]
  • [Cites] Trends Biotechnol. 2005 Dec;23(12):598-604 [16202464.001]
  • [Cites] Mol Cell Proteomics. 2006 Jan;5(1):157-71 [16215274.001]
  • [Cites] Nat Chem Biol. 2005 Oct;1(5):252-62 [16408053.001]
  • [Cites] J Biochem. 2006 Jan;139(1):137-45 [16428329.001]
  • [Cites] Blood. 2006 Apr 15;107(8):3212-20 [16352806.001]
  • [Cites] Mol Cell. 2006 Apr 21;22(2):193-204 [16630889.001]
  • [Cites] Blood. 2006 Sep 15;108(6):1932-40 [16601245.001]
  • [Cites] EMBO J. 2000 Mar 1;19(5):870-81 [10698929.001]
  • (PMID = 17238276.001).
  • [ISSN] 1553-7374
  • [Journal-full-title] PLoS pathogens
  • [ISO-abbreviation] PLoS Pathog.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / T32 AI007472; United States / NIAID NIH HHS / AI / T32AI007472; United States / NCI NIH HHS / CA / R21 CA109674; United States / NIAID NIH HHS / AI / R01 CA/AI 09401; United States / NCI NIH HHS / CA / R21 CA 109674-02
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / ALCAM protein, human; 0 / Antigens, CD; 0 / Antigens, Differentiation, T-Lymphocyte; 0 / BST2 protein, human; 0 / CD6 antigen; 0 / Cell Adhesion Molecules, Neuronal; 0 / Fetal Proteins; 0 / GPI-Linked Proteins; 0 / Immediate-Early Proteins; 0 / K5 protein, Human herpesvirus 8; 0 / Membrane Glycoproteins; 0 / Membrane Proteins; 0 / Qa-SNARE Proteins
  • [Other-IDs] NLM/ PMC1626102
  •  go-up   go-down


41. Fuchs B, Mahlum E, Halder C, Maran A, Yaszemski M, Bode B, Bolander M, Sarkar G: High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma. Gene; 2007 Sep 15;399(2):137-43
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma.
  • Our objective is to identify genes regulating metastasis of osteogenic sarcoma (OGS) since metastasis is the primary cause of mortality among patients with OGS.

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • The Lens. Cited by Patents in .
  • antibodies-online. View related products from antibodies-online.com (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Res. 2001 Sep 15;61(18):6649-55 [11559528.001]
  • [Cites] Cancer Res. 2001 May 1;61(9):3750-9 [11325848.001]
  • [Cites] Nat Rev Cancer. 2002 Apr;2(4):289-300 [12001990.001]
  • [Cites] Semin Cancer Biol. 2002 Apr;12(2):89-96 [12027580.001]
  • [Cites] Differentiation. 2002 Dec;70(9-10):498-505 [12492492.001]
  • [Cites] Nat Rev Cancer. 2003 Jan;3(1):55-63 [12509767.001]
  • [Cites] J Cell Biochem. 2003 Feb 1;88(2):408-17 [12520544.001]
  • [Cites] Nat Rev Cancer. 2003 Jun;3(6):411-21 [12778131.001]
  • [Cites] Cancer Cell. 2003 Jun;3(6):537-49 [12842083.001]
  • [Cites] Cancer Lett. 2003 Jul 30;198(1):1-20 [12893425.001]
  • [Cites] Oncogene. 2003 Sep 29;22(42):6524-36 [14528277.001]
  • [Cites] Cancer. 2003 Dec 1;98(11):2447-56 [14635080.001]
  • [Cites] Curr Opin Oncol. 2004 Jan;16(1):44-9 [14685092.001]
  • [Cites] Nat Rev Mol Cell Biol. 2003 Dec;4(12):915-25 [14685170.001]
  • [Cites] Chin Med J (Engl). 2004 Jan;117(1):94-8 [14733782.001]
  • [Cites] Nat Med. 2004 Feb;10(2):182-6 [14704791.001]
  • [Cites] Cancer. 1971 Feb;27(2):397-402 [5100401.001]
  • [Cites] N Engl J Med. 1986 Jun 19;314(25):1600-6 [3520317.001]
  • [Cites] Pediatr Clin North Am. 1997 Aug;44(4):973-89 [9286295.001]
  • [Cites] Mol Biotechnol. 1997 Oct;8(2):135-7 [9406183.001]
  • [Cites] N Engl J Med. 1999 Jul 29;341(5):342-52 [10423470.001]
  • [Cites] Am J Pathol. 1999 Sep;155(3):739-52 [10487832.001]
  • [Cites] Cancer Res. 2004 Dec 1;64(23):8507-11 [15574754.001]
  • [Cites] Cell. 2000 Jan 7;100(1):57-70 [10647931.001]
  • [Cites] Science. 2000 Aug 18;289(5482):1197-202 [10947988.001]
  • [Cites] Anal Biochem. 2000 Nov 1;286(1):91-8 [11038279.001]
  • [Cites] Gene. 2000 Nov 27;258(1-2):155-63 [11111053.001]
  • [Cites] Semin Cancer Biol. 2001 Oct;11(5):327-37 [11562175.001]
  • (PMID = 17560052.001).
  • [ISSN] 0378-1119
  • [Journal-full-title] Gene
  • [ISO-abbreviation] Gene
  • [Language] ENG
  • [Grant] United States / NIAMS NIH HHS / AR / R01 AR047974-01A1; United States / NIAMS NIH HHS / AR / R01 AR047974-03; United States / NIAMS NIH HHS / AR / AR47974; United States / NIAMS NIH HHS / AR / R01 AR047974-02; United States / NIAMS NIH HHS / AR / AR047974-05; United States / NIAMS NIH HHS / AR / AR047974-03; United States / NIAMS NIH HHS / AR / R01 AR047974-05; United States / NIAMS NIH HHS / AR / AR047974-04; United States / NIAMS NIH HHS / AR / AR047974-02; United States / NIAMS NIH HHS / AR / R01 AR047974; United States / NIAMS NIH HHS / AR / AR047974-01A1; United States / NIAMS NIH HHS / AR / R01 AR047974-04
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Neoplasm Proteins; 0 / PLXDC1 protein, human; 0 / RNA, Messenger; 0 / RNA, Small Interfering; 0 / Receptors, Cell Surface
  • [Other-IDs] NLM/ NIHMS29184; NLM/ PMC2066185
  •  go-up   go-down


42. Oue T, Fukuzawa M, Okita H, Mugishima H, Horie H, Hata J, Saito M, Nozaki M, Chin M, Nakadate H, Hinotsu S, Koshinaga T, Kaneko Y, Kitano Y, Tanaka Y, Japan Wilms Tumor Study (JWiTS) Group: Outcome of pediatric renal tumor treated using the Japan Wilms Tumor Study-1 (JWiTS-1) protocol: a report from the JWiTS group. Pediatr Surg Int; 2009 Nov;25(11):923-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Central pathological diagnosis and follow-up data were available in 210 cases.
  • RESULTS: Five-year overall survival (OS) rate was 91.1% for nephroblastoma, 72.9% for clear cell sarcoma of the kidney (CCSK), and 22.2% for rhabdoid tumor of the kidney (RTK).
  • [MeSH-major] Kidney Neoplasms / therapy. Rhabdoid Tumor / therapy. Sarcoma, Clear Cell / therapy. Wilms Tumor / therapy

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Wilms Tumor.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hum Pathol. 1981 Jul;12(7):646-57 [7275104.001]
  • [Cites] Med Pediatr Oncol. 1994;22(4):221-7 [8107651.001]
  • [Cites] Eur J Cancer. 2006 Oct;42(15):2554-62 [16904312.001]
  • [Cites] Ann Oncol. 2001 Mar;12(3):311-9 [11332141.001]
  • [Cites] Lancet. 2004 Oct 2-8;364(9441):1229-35 [15464183.001]
  • [Cites] Am J Surg Pathol. 1989 Jun;13(6):439-58 [2543225.001]
  • [Cites] J Clin Oncol. 2001 Sep 1;19(17):3719-24 [11533093.001]
  • [Cites] Lifetime Data Anal. 2007 Dec;13(4):463-70 [18027087.001]
  • [Cites] J Urol. 1991 Aug;146(2 ( Pt 2)):514-8 [1650403.001]
  • [Cites] J Urol. 1987 Oct;138(4 Pt 2):968-73 [2821293.001]
  • [Cites] Cancer. 1984 Dec 15;54(12):2978-87 [6093989.001]
  • [Cites] Cancer. 1978 May;41(5):1937-48 [206343.001]
  • [Cites] Ann Surg. 1999 Feb;229(2):292-7 [10024113.001]
  • [Cites] Curr Probl Cancer. 2005 Sep-Oct;29(5):221-60 [16216623.001]
  • [Cites] Genes Chromosomes Cancer. 2008 Aug;47(8):712-27 [18464243.001]
  • [Cites] J Clin Oncol. 2005 Dec 20;23(36):9138-45 [16172460.001]
  • [Cites] J Pediatr Surg. 1977 Oct;12(5):631-8 [72143.001]
  • [Cites] Cancer. 1976 Aug;38(2):633-46 [184912.001]
  • [Cites] Mol Carcinog. 2008 Sep;47(9):660-6 [18286482.001]
  • [Cites] J Clin Oncol. 2005 Oct 10;23(29):7312-21 [16129848.001]
  • [Cites] J Clin Oncol. 1994 Oct;12(10):2132-7 [7931484.001]
  • [Cites] Genes Chromosomes Cancer. 2006 Jun;45(6):592-601 [16518847.001]
  • (PMID = 19701757.001).
  • [ISSN] 1437-9813
  • [Journal-full-title] Pediatric surgery international
  • [ISO-abbreviation] Pediatr. Surg. Int.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


43. Sánchez del Monte J, Hernández Guerrero A, Sobrino Cossio S, Lárraga Octavio A, Sánchez Benítez G, López Blanco P, Elguero Pineda E: [Clinical manifestations and endoscopic characteristics of Kaposi's sarcoma in patients with acquired immunodeficiency syndrome]. Rev Gastroenterol Mex; 2005 Oct-Dec;70(4):416-23
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinical manifestations and endoscopic characteristics of Kaposi's sarcoma in patients with acquired immunodeficiency syndrome].
  • [Transliterated title] Manifestaciones clinicas y características endoscópicas del sarcoma de Kaposi en pacientes con síndrome de inmunodeficiencia adquirida.
  • BACKGROUND: Kaposi sarcoma may be the initial manifestation of immunodeficiency acquired syndrome (AIDS )in 30% of patients.
  • METHOD: 12 consecutive cases with AIDS and Kaposi sarcoma.
  • The distribution of Kaposi sarcoma was as follows: hard palate 7, soft palate 2, larynx 3, esophagus 2, stomach 10, duodenum 2, colon 5 and anal conduct 1.
  • The biopsy was positive to Kaposi sarcoma in at least one lesion of each patient.
  • CONCLUSIONS: The Kaposi sarcoma appears as a multiple lesion with diverse aspect and colors that go from purple to blue or red.
  • There is correlation between a high number of Kaposi sarcoma lesions, affected organs, immunologic status and mortality.
  • [MeSH-major] Acquired Immunodeficiency Syndrome / complications. Gastrointestinal Neoplasms / etiology. Sarcoma, Kaposi / etiology

  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • MedlinePlus Health Information. consumer health - Kaposi's Sarcoma.
  • HIV InSite. treatment guidelines - Human Herpesvirus-8 .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17058981.001).
  • [ISSN] 0375-0906
  • [Journal-full-title] Revista de gastroenterología de México
  • [ISO-abbreviation] Rev Gastroenterol Mex
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Mexico
  •  go-up   go-down


44. Dhir AA, Sawant S, Dikshit RP, Parikh P, Srivastava S, Badwe R, Rajadhyaksha S, Dinshaw KA: Spectrum of HIV/AIDS related cancers in India. Cancer Causes Control; 2008 Mar;19(2):147-53
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: No case of Kaposi's sarcoma was observed.
  • In males, PIR was increased for anal cancer (PIR = 10.3, 95%CI 4.30-24.83), Hodgkin's disease, testicular cancer, colon cancer, and few head and neck cancer sites.
  • Among females, the PIRs for cervical cancer (PIR = 4.1, 95%CI 2.90-5.75), vaginal cancer (PIR = 7.7, 95%CI 2.48-23.85), and anal cancer (PIR = 6.5, 95%CI 0.91-45.88) were increased.
  • CONCLUSIONS: The absence of Kaposi's sarcoma and increased PIRs for certain non-AIDS defining cancers among HIV infected cancer cases indicates a different spectrum of HIV associated malignancies in this region.


45. Dresang LR, Vereide DT, Sugden B: Identifying sites bound by Epstein-Barr virus nuclear antigen 1 (EBNA1) in the human genome: defining a position-weighted matrix to predict sites bound by EBNA1 in viral genomes. J Virol; 2009 Apr;83(7):2930-40
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This PWM helped identify additional DNA-binding sites for EBNA1 in the genomes of EBV, Kaposi's sarcoma-associated herpesvirus, and cercopithecine herpesvirus 15 (CeHV-15) (also called herpesvirus papio 15).

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gastroenterology. 2000 Jun;118(6):1031-8 [10833477.001]
  • [Cites] Bioinformatics. 1998;14(1):48-54 [9520501.001]
  • [Cites] J Virol. 2001 Jul;75(13):5796-811 [11390581.001]
  • [Cites] J Virol. 2001 Nov;75(22):10603-11 [11602702.001]
  • [Cites] Intervirology. 2001;44(5):271-82 [11684888.001]
  • [Cites] J Virol. 2002 Jan;76(1):421-6 [11739708.001]
  • [Cites] Virology. 2003 Jul 5;311(2):263-74 [12842617.001]
  • [Cites] Mol Cell Biol. 2003 Oct;23(19):6901-8 [12972608.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14269-74 [14603034.001]
  • [Cites] Clin Cancer Res. 2004 Feb 1;10(3):803-21 [14871955.001]
  • [Cites] Genome Res. 2004 Jun;14(6):1188-90 [15173120.001]
  • [Cites] Trends Mol Med. 2004 Jul;10(7):331-6 [15242681.001]
  • [Cites] Biomedicine. 1975 Jul;22(4):276-84 [179629.001]
  • [Cites] Int J Cancer. 1977 Oct 15;20(4):486-94 [199543.001]
  • [Cites] Proc Natl Acad Sci U S A. 1980 Jul;77(7):4251-5 [6933474.001]
  • [Cites] Proc Natl Acad Sci U S A. 1984 Jun;81(12):3806-10 [6328526.001]
  • [Cites] Nature. 1984 Jul 19-25;310(5974):207-11 [6087149.001]
  • [Cites] Int J Cancer. 1985 Nov 15;36(5):545-7 [4055129.001]
  • [Cites] Mol Cell Biol. 1985 Oct;5(10):2533-42 [3016506.001]
  • [Cites] J Virol. 1986 Dec;60(3):1159-62 [3023667.001]
  • [Cites] Mol Cell Biol. 1986 Nov;6(11):3838-46 [3025615.001]
  • [Cites] Anal Biochem. 1987 Jul;164(1):44-52 [2823633.001]
  • [Cites] J Virol. 1989 Jun;63(6):2644-9 [2542577.001]
  • [Cites] J Virol. 1989 Jun;63(6):2657-66 [2542579.001]
  • [Cites] J Virol. 1990 May;64(5):2369-79 [2157891.001]
  • [Cites] J Virol. 1990 Jun;64(6):2876-83 [2159548.001]
  • [Cites] Nucleic Acids Res. 1990 Oct 25;18(20):6097-100 [2172928.001]
  • [Cites] J Biol Chem. 1991 Apr 25;266(12):7819-26 [1850421.001]
  • [Cites] J Virol. 1992 Jan;66(1):489-95 [1309258.001]
  • [Cites] J Virol. 1992 Aug;66(8):4654-61 [1321268.001]
  • [Cites] EMBO J. 1998 Nov 2;17(21):6394-403 [9799247.001]
  • [Cites] J Virol. 1999 Mar;73(3):1980-9 [9971778.001]
  • [Cites] Mol Cell Biol. 1999 May;19(5):3349-59 [10207059.001]
  • [Cites] J Clin Pathol. 1965 May;18:261-73 [14304234.001]
  • [Cites] Mol Cell Biol. 2006 Feb;26(3):1124-34 [16428463.001]
  • [Cites] Genome Res. 2006 Apr;16(4):466-76 [16533912.001]
  • [Cites] Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W369-73 [16845028.001]
  • [Cites] J Biol Chem. 2000 Jul 21;275(29):22273-7 [10801810.001]
  • [Cites] Oncogene. 2007 Jun 14;26(28):4135-47 [17486072.001]
  • [Cites] Blood. 2008 Jan 1;111(1):292-301 [17720884.001]
  • [Cites] J Virol. 2008 Feb;82(4):1679-87 [18077719.001]
  • [Cites] J Virol. 2008 Jun;82(12):5693-702 [18385243.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9639-44 [18621728.001]
  • [Cites] Cancer Res. 2008 Sep 1;68(17):6963-8 [18757410.001]
  • [Cites] Nature. 1992 Oct 8;359(6395):505-12 [1328886.001]
  • [Cites] J Virol. 1995 Apr;69(4):2633-6 [7884916.001]
  • [Cites] Cell. 1995 Oct 6;83(1):39-46 [7553871.001]
  • [Cites] Proc Int Conf Intell Syst Mol Biol. 1994;2:28-36 [7584402.001]
  • [Cites] Cell. 1996 Mar 8;84(5):791-800 [8625416.001]
  • [Cites] Intervirology. 1995;38(3-4):195-205 [8682617.001]
  • [Cites] J Virol. 1996 Sep;70(9):5758-68 [8709191.001]
  • [Cites] Virology. 1996 Aug 1;222(1):1-13 [8806482.001]
  • [Cites] Int J Cancer. 1997 Feb 7;70(4):375-82 [9033642.001]
  • [Cites] Nucleic Acids Res. 1997 Dec 15;25(24):4876-82 [9396791.001]
  • [Cites] J Virol. 1998 Jun;72(6):4657-66 [9573229.001]
  • [Cites] J Virol. 1998 Jul;72(7):6181-5 [9621086.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14188-93 [16966603.001]
  • (PMID = 19129441.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P01 CA022443; United States / NCI NIH HHS / CA / R01 CA133027
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; 0 / EBV-encoded nuclear antigen 1; 0 / Epstein-Barr Virus Nuclear Antigens; 9007-49-2 / DNA
  • [Other-IDs] NLM/ PMC2655553
  •  go-up   go-down


46. Potthoff A, Brockmeyer NH: [HIV-associated tumors]. Hautarzt; 2006 Nov;57(11):988, 990-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the beginning of the HIV epidemic, Kaposi sarcoma was a common stigma in AIDS patients and one of the leading causes of death.
  • While Kaposi sarcoma is seen less frequently since the introduction of antiretroviral therapy, lymphoma and other malignancies are an increasing therapeutic challenge.
  • The incidence of HPV-related anal carcinoma and its precursor lesions is rising so dramatically that screening programs as they are already established for cervical carcinoma should be implemented.
  • [MeSH-major] HIV Infections / complications. Neoplasms / etiology. Sarcoma, Kaposi / etiology
  • [MeSH-minor] AIDS-Related Opportunistic Infections / complications. Adult. Antiretroviral Therapy, Highly Active. Anus Neoplasms / etiology. Carcinoma, Hepatocellular / etiology. Female. HIV Seropositivity / complications. Humans. Liver Neoplasms / etiology. Lung Neoplasms / drug therapy. Lung Neoplasms / etiology. Lymphoma, AIDS-Related / diagnosis. Lymphoma, AIDS-Related / drug therapy. Lymphoma, AIDS-Related / etiology. Male. Middle Aged. Papillomavirus Infections / complications. Risk Factors. Skin Neoplasms / etiology. Smoking / adverse effects. Uterine Cervical Neoplasms / etiology


47. Clifford GM, Franceschi S: Cancer risk in HIV-infected persons: influence of CD4(+) count. Future Oncol; 2009 Jun;5(5):669-78
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Whereas Kaposi sarcoma and non-Hodgkin lymphoma were recognised as AIDS-defining illnesses early in the HIV epidemic, the influence of declining CD4(+) count on other infection-related cancers has taken longer to establish, undoubtedly because the association is weaker and the dose-response relationship is less steep.
  • However, following improved survival made possible by combined antiretroviral therapy, declining CD4(+) count starts showing an impact on the natural history of various carcinogenic infections and on the risk for an increasingly wide range of cancers, including Hodgkin lymphoma, cervical, anal and liver cancers.

  • Genetic Alliance. consumer health - HIV.
  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19519206.001).
  • [ISSN] 1744-8301
  • [Journal-full-title] Future oncology (London, England)
  • [ISO-abbreviation] Future Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 91
  •  go-up   go-down


48. Vidarsdóttir H, Möller PH, Tryggvason G, Kjartansson S, Jónasson JG: [Gastrointestinal Stromal Tumour (GIST). Case report]. Laeknabladid; 2005 Feb;91(2):177-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In 1987 a 73 year old man was diagnosed with a malignant sarcoma of the anus.
  • Fourteen years later the original diagnoses of the specimen was reviewed and the diagnosis was changed to GIST (gastrointestinal stromal tumour).
  • This diagnosis was confirmed with appropriate immunohistochemical staining on the tumour tissue.
  • This is the first case of GIST in the anus diagnosed in Iceland.
  • [MeSH-major] Anus Neoplasms / diagnosis. Gastrointestinal Stromal Tumors / diagnosis
  • [MeSH-minor] Aged. Diagnosis, Differential. Humans. Iceland. Immunohistochemistry. Leiomyosarcoma / diagnosis. Male

  • Genetic Alliance. consumer health - Gastrointestinal Stromal Tumors.
  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16155313.001).
  • [ISSN] 0023-7213
  • [Journal-full-title] Læknablađiđ
  • [ISO-abbreviation] Laeknabladid
  • [Language] ice
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Iceland
  •  go-up   go-down


49. Casper C, Carrell D, Miller KG, Judson FD, Meier AS, Pauk JS, Morrow RA, Corey L, Wald A, Celum C: HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: baseline data from the EXPLORE Study. Sex Transm Infect; 2006 Jun;82(3):229-35
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In a multivariate model, reporting more than the median number of lifetime sex partners (OR 2.2, p = 0.03) or lifetime sex partners of unknown HIV status (OR 1.7, p = 0.03), and the performance of oro-anal sex ("rimming") on partners whose HIV status is unknown (OR 2.7, p = 0.04) were independently associated with HHV-8 infection.

  • Genetic Alliance. consumer health - HIV.
  • MedlinePlus Health Information. consumer health - Kaposi's Sarcoma.
  • COS Scholar Universe. author profiles.
  • HIV InSite. treatment guidelines - Human Herpesvirus-8 .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] JAMA. 2002 Mar 13;287(10):1295-300 [11886321.001]
  • [Cites] Sex Transm Dis. 2001 Mar;28(3):176-83 [11289201.001]
  • [Cites] J Clin Microbiol. 2002 Oct;40(10):3822-5 [12354890.001]
  • [Cites] Am J Public Health. 2003 Jun;93(6):926-32 [12773357.001]
  • [Cites] AIDS. 2003 Aug 15;17(12):1717-30 [12891058.001]
  • [Cites] J Virol. 2004 Apr;78(8):4074-84 [15047824.001]
  • [Cites] J Acquir Immune Defic Syndr. 2004 Mar 1;35(3):233-8 [15076237.001]
  • [Cites] Lancet. 1992 Mar 14;339(8794):632-5 [1347337.001]
  • [Cites] Am J Epidemiol. 1993 Aug 15;138(4):256-65 [8356966.001]
  • [Cites] Science. 1994 Dec 16;266(5192):1865-9 [7997879.001]
  • [Cites] Nat Med. 1996 Aug;2(8):918-24 [8705863.001]
  • [Cites] J Leukoc Biol. 2001 Apr;69(4):639-44 [11310851.001]
  • [Cites] Rev Med Virol. 2002 Jan-Feb;12(1):47-63 [11787083.001]
  • [Cites] J Infect Dis. 2002 Apr 1;185(7):990-3 [11920325.001]
  • [Cites] Clin Infect Dis. 1996 Aug;23(2):406-7 [8842293.001]
  • [Cites] Lancet. 1996 Oct 26;348(9035):1133-8 [8888167.001]
  • [Cites] J Infect Dis. 1997 Jul;176(1):94-102 [9207354.001]
  • [Cites] J Virol. 1997 Sep;71(9):7083-7 [9261440.001]
  • [Cites] J Infect Dis. 1998 Jan;177(1):213-6 [9419191.001]
  • [Cites] Int J Cancer. 1998 Aug 12;77(4):543-8 [9679756.001]
  • [Cites] J Infect Dis. 1998 Dec;178(6):1610-5 [9815212.001]
  • [Cites] Adv Cancer Res. 1999;76:121-60 [10218100.001]
  • [Cites] Am J Epidemiol. 2000 Feb 1;151(3):213-24 [10670545.001]
  • [Cites] N Engl J Med. 2000 Nov 9;343(19):1369-77 [11070101.001]
  • [Cites] Epidemiol Infect. 2000 Dec;125(3):671-5 [11218216.001]
  • [Cites] J Infect Dis. 1999 Oct;180(4):1010-7 [10479125.001]
  • (PMID = 16731675.001).
  • [ISSN] 1368-4973
  • [Journal-full-title] Sexually transmitted infections
  • [ISO-abbreviation] Sex Transm Infect
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / U19 AI031448; United States / NIAID NIH HHS / AI / U19 AI31448; United States / NIAID NIH HHS / AI / P01 AI030731; United States / NIAID NIH HHS / AI / K23 AI054162; United States / NIAID NIH HHS / AI / P01 AI30731
  • [Publication-type] Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2564745
  •  go-up   go-down


50. Hayashi T, Nakamura T, Nakamura S, Kurachi K, Fukazawa A, Nakamura K, Nakajima A, Suzuki S, Konno H: Granulocytic sarcoma presenting as a thrombosed external hemorrhoid in a patient with myelodysplastic syndrome overt leukemia. Clin J Gastroenterol; 2008 Dec;1(4):145-147
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Granulocytic sarcoma presenting as a thrombosed external hemorrhoid in a patient with myelodysplastic syndrome overt leukemia.
  • A 67-year-old Japanese man complained of a painful lump in his anus.
  • A solid lump measuring 1.0 cm in diameter was detected in the anal verge.
  • Under a diagnosis of a thrombosed external hemorrhoid, thrombectomy was performed under local anesthesia.
  • Finally, the diagnosis of granulocytic sarcoma (GS) was made.
  • Though it is well known that perianal complications occur quite often in patients with leukemia, it is unusual for a diagnosis of GS of the anus to be definitely established.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1981 Sep 15;48(6):1426-37 [7023656.001]
  • [Cites] Cancer. 1986 Dec 15;58(12):2697-709 [3465429.001]
  • [Cites] Dis Colon Rectum. 2003 Sep;46(9):1226-31 [12972967.001]
  • [Cites] Cancer. 1973 Jan;31(1):149-52 [4509385.001]
  • [Cites] Cancer. 1973 Jun;31(6):1315-27 [4513690.001]
  • [Cites] Cancer Res. 1954 Mar;14(3):157-62 [13150326.001]
  • [Cites] Leuk Lymphoma. 1996 Mar;21(1-2):153-9 [8907283.001]
  • [Cites] Br J Surg. 2006 Mar;93(3):362-8 [16470713.001]
  • [Cites] J Clin Oncol. 1993 Apr;11(4):690-7 [8478662.001]
  • [Cites] Surg Gynecol Obstet. 1992 Apr;174(4):302-4 [1553609.001]
  • [Cites] Blood. 1973 Nov;42(5):721-8 [4518064.001]
  • (PMID = 26193692.001).
  • [ISSN] 1865-7257
  • [Journal-full-title] Clinical journal of gastroenterology
  • [ISO-abbreviation] Clin J Gastroenterol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Keywords] NOTNLM ; Acute myeloid leukemia (AML) / Granulocytic sarcoma (GS) / Hemorrhoid / Myelodysplastic syndromes (MDS)
  •  go-up   go-down


51. Yoo HJ, Yun BR, Kwon JH, Ahn HS, Seol MA, Lee MJ, Yu GR, Yu HC, Hong B, Choi K, Kim DG: Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells. Exp Mol Med; 2009 Feb 28;41(2):102-15
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Cholangiocarcinoma / genetics. Gene Expression Profiling. Sarcoma / genetics


52. Stewart-Maynard KM, Cruceanu M, Wang F, Vo MN, Gorelick RJ, Williams MC, Rouzina I, Musier-Forsyth K: Retroviral nucleocapsid proteins display nonequivalent levels of nucleic acid chaperone activity. J Virol; 2008 Oct;82(20):10129-42
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this work, complementary experimental approaches were used to characterize and compare the chaperone activities of NC proteins from four different retroviruses: HIV-1, Moloney murine leukemia virus (MLV), Rous sarcoma virus (RSV), and human T-cell lymphotropic virus type 1 (HTLV-1).

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Mol Biol. 2003 Feb 21;326(3):691-700 [12581633.001]
  • [Cites] J Mol Biol. 2003 Mar 28;327(3):571-8 [12634053.001]
  • [Cites] J Mol Biol. 2003 Apr 18;328(1):95-108 [12684000.001]
  • [Cites] Nucleic Acids Res. 2003 Jul 1;31(13):3406-15 [12824337.001]
  • [Cites] J Mol Biol. 2004 Mar 19;337(2):427-42 [15003457.001]
  • [Cites] J Mol Biol. 2004 Apr 2;337(4):951-68 [15033363.001]
  • [Cites] J Mol Biol. 2004 Feb 27;336(4):851-70 [15095865.001]
  • [Cites] J Mol Biol. 2004 May 7;338(4):711-23 [15099739.001]
  • [Cites] Annu Rev Biophys Biomol Struct. 2004;33:415-40 [15139820.001]
  • [Cites] J Mol Biol. 2004 Jul 30;341(1):27-36 [15312760.001]
  • [Cites] Q Rev Biophys. 1978 May;11(2):179-246 [353876.001]
  • [Cites] J Biol Chem. 1981 Aug 25;256(16):8400-6 [6267042.001]
  • [Cites] Science. 1986 Apr 25;232(4749):485-7 [2421409.001]
  • [Cites] J Biol Chem. 1987 Apr 15;262(11):4961-7 [2435721.001]
  • [Cites] J Virol. 1987 Oct;61(10):3004-12 [3041020.001]
  • [Cites] EMBO J. 1988 Jun;7(6):1777-83 [2458920.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Aug;87(16):6403-7 [2385599.001]
  • [Cites] J Mol Biol. 1990 Dec 5;216(3):689-99 [2124274.001]
  • [Cites] Nucleic Acids Res. 1991 Jul 11;19(13):3533-41 [1906602.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6472-6 [1631144.001]
  • [Cites] Protein Sci. 1993 Jan;2(1):3-19 [8443588.001]
  • [Cites] Protein Sci. 1993 Feb;2(2):231-43 [8443601.001]
  • [Cites] J Biol Chem. 1993 Aug 5;268(22):16519-27 [8344933.001]
  • [Cites] Annu Rev Biochem. 1993;62:255-87 [7688943.001]
  • [Cites] J Virol. 1994 Aug;68(8):5013-8 [8035501.001]
  • [Cites] J Virol. 1994 Sep;68(9):5863-70 [8057466.001]
  • [Cites] J Biol Chem. 1994 Sep 9;269(36):22538-46 [8077202.001]
  • [Cites] J Virol. 1995 Mar;69(3):1907-12 [7853532.001]
  • [Cites] Biopolymers. 1995 Sep;36(3):345-64 [7669919.001]
  • [Cites] J Biol Chem. 1995 Sep 8;270(36):20871-4 [7545662.001]
  • [Cites] J Mol Biol. 1995 Dec 8;254(4):523-37 [7500330.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7577-81 [8755517.001]
  • [Cites] J Virol. 1996 Aug;70(8):4996-5004 [8764006.001]
  • [Cites] Mol Endocrinol. 1996 Jun;10(6):607-12 [8776720.001]
  • [Cites] Curr Top Microbiol Immunol. 1996;214:177-218 [8791728.001]
  • [Cites] Nucleic Acids Res. 1997 Mar 1;25(5):1042-9 [9023116.001]
  • [Cites] Biopolymers. 1997 Mar;41(3):301-12 [9057495.001]
  • [Cites] J Mol Biol. 1997 May 2;268(2):250-60 [9159468.001]
  • [Cites] J Virol. 1997 Jul;71(7):5178-88 [9188585.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13530-5 [9391060.001]
  • [Cites] Science. 1998 Jan 16;279(5349):384-8 [9430589.001]
  • [Cites] Biopolymers. 1998 Mar;45(3):217-29 [9465785.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):459-64 [9892655.001]
  • [Cites] J Mol Biol. 1999 Mar 19;287(1):59-75 [10074407.001]
  • [Cites] Biochemistry. 1999 Mar 23;38(12):3821-30 [10090772.001]
  • [Cites] J Virol. 1999 May;73(5):4251-6 [10196321.001]
  • [Cites] J Virol. 1999 Aug;73(8):6670-9 [10400764.001]
  • [Cites] Nature. 2004 Sep 30;431(7008):586-90 [15457265.001]
  • [Cites] J Biol Chem. 2004 Oct 15;279(42):44154-65 [15271979.001]
  • [Cites] J Mol Biol. 1968 Feb 14;31(3):349-70 [5637197.001]
  • [Cites] Biopolymers. 1976 Jul;15(7):1345-75 [949539.001]
  • [Cites] J Mol Biol. 1976 Oct 25;107(2):145-58 [1003464.001]
  • [Cites] J Virol. 1998 Mar;72(3):1902-9 [9499042.001]
  • [Cites] J Mol Biol. 1998 Mar 27;277(2):225-35 [9514748.001]
  • [Cites] J Biol Chem. 1998 May 8;273(19):11463-71 [9565558.001]
  • [Cites] Biopolymers. 1997;44(3):269-82 [9591479.001]
  • [Cites] Trends Biochem Sci. 1998 Aug;23(8):297-301 [9757830.001]
  • [Cites] Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W577-81 [15980540.001]
  • [Cites] Nucleic Acids Res. 2005;33(14):4395-403 [16077025.001]
  • [Cites] Biophys J. 2005 Sep;89(3):1941-56 [15994897.001]
  • [Cites] Prog Nucleic Acid Res Mol Biol. 2005;80:217-86 [16164976.001]
  • [Cites] Phys Rev Lett. 2005 Oct 7;95(15):158102 [16241765.001]
  • [Cites] Biophys J. 2005 Nov;89(5):3470-9 [16100256.001]
  • [Cites] Nucleic Acids Res. 2006;34(2):472-84 [16434700.001]
  • [Cites] Nucleic Acids Res. 2006;34(2):593-605 [16449201.001]
  • [Cites] J Mol Biol. 2006 Oct 13;363(1):244-61 [16962137.001]
  • [Cites] Biochemistry. 2006 Oct 17;45(41):12617-28 [17029416.001]
  • [Cites] Anal Biochem. 2006 Nov 15;358(2):159-70 [17034752.001]
  • [Cites] J Mol Biol. 2006 Nov 10;363(5):867-77 [16997322.001]
  • [Cites] J Mol Biol. 2006 Dec 1;364(3):496-511 [17020765.001]
  • [Cites] J Biol Chem. 2006 Dec 15;281(50):38689-96 [17050544.001]
  • [Cites] J Mol Biol. 2007 Jan 12;365(2):453-67 [17070546.001]
  • [Cites] Biopolymers. 2007 Feb 5;85(2):154-68 [17080421.001]
  • [Cites] PLoS One. 2007;2(7):e669 [17712401.001]
  • [Cites] Biochemistry. 2007 Dec 18;46(50):14650-62 [18027912.001]
  • [Cites] J Mol Biol. 2002 May 3;318(3):749-64 [12054820.001]
  • [Cites] Biochem Biophys Res Commun. 2002 Jun 28;294(5):949-55 [12074568.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8614-9 [12084921.001]
  • [Cites] Curr Opin Struct Biol. 2002 Jun;12(3):330-6 [12127451.001]
  • [Cites] Prog Nucleic Acid Res Mol Biol. 2002;72:223-68 [12206453.001]
  • [Cites] J Mol Biol. 2003 Jan 3;325(1):1-10 [12473448.001]
  • [Cites] J Virol. 2003 Jan;77(2):1598-603 [12502875.001]
  • [Cites] Biophys J. 1999 Sep;77(3):1547-55 [10465765.001]
  • [Cites] Biochemistry. 2005 Mar 15;44(10):3735-44 [15751950.001]
  • [Cites] J Mol Biol. 2005 May 6;348(3):549-61 [15826653.001]
  • [Cites] J Mol Biol. 2005 May 20;348(5):1059-77 [15854644.001]
  • [Cites] J Mol Biol. 2005 May 20;348(5):1113-26 [15854648.001]
  • [Cites] J Mol Biol. 2005 Jun 3;349(2):317-30 [15890198.001]
  • [Cites] J Mol Biol. 2005 Jun 24;349(5):976-88 [15907938.001]
  • [Cites] Biochemistry. 1999 Dec 21;38(51):16816-25 [10606514.001]
  • [Cites] Nucleic Acids Res. 2000 Jan 15;28(2):634-40 [10606665.001]
  • [Cites] Biopolymers. 2000 Apr 5;53(4):329-41 [10685053.001]
  • [Cites] J Mol Biol. 2000 May 26;299(1):145-56 [10860728.001]
  • [Cites] J Mol Biol. 2000 Aug 11;301(2):491-511 [10926523.001]
  • [Cites] J Virol. 2000 Oct;74(19):8785-92 [10982320.001]
  • [Cites] J Virol. 2000 Oct;74(19):8980-8 [10982342.001]
  • [Cites] Biochim Biophys Acta. 2000 Sep 29;1481(2):381-94 [11018730.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 May 22;98(11):6121-6 [11344257.001]
  • [Cites] J Mol Biol. 2001 May 25;309(1):57-68 [11491301.001]
  • [Cites] J Mol Biol. 2001 Oct 5;312(5):985-97 [11580244.001]
  • [Cites] Biochemistry. 2001 Nov 13;40(45):13644-51 [11695913.001]
  • [Cites] J Mol Biol. 2001 Nov 23;314(2):217-32 [11718556.001]
  • [Cites] J Mol Biol. 2001 Dec 14;314(5):961-70 [11743714.001]
  • [Cites] Protein Eng. 2001 Dec;14(12):993-1000 [11809930.001]
  • [Cites] Acc Chem Res. 2002 Mar;35(3):159-66 [11900519.001]
  • [Cites] J Mol Biol. 2002 Mar 29;317(3):385-99 [11922672.001]
  • (PMID = 18684831.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / GM072396; United States / NIGMS NIH HHS / GM / F32 GM072396; United States / NIGMS NIH HHS / GM / R01 GM065056; United States / NIGMS NIH HHS / GM / GM073462; United States / NIGMS NIH HHS / GM / GM065056; United States / NCI NIH HHS / CA / N01CO12400; United States / NCI NIH HHS / CO / N01-CO-12400
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; 0 / Molecular Chaperones; 0 / Nucleic Acids; 0 / Nucleocapsid Proteins; 0 / RNA, Viral
  • [Other-IDs] NLM/ PMC2566285
  •  go-up   go-down


53. Aizawa J, Sakayama K, Kamei S, Kidani T, Yamamoto H, Norimatsu Y, Masuno H: Effect of troglitazone on tumor growth and pulmonary metastasis development of the mouse osteosarcoma cell line LM8. BMC Cancer; 2010;10:51
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Osteosarcoma often develops micrometastases in the lung prior to diagnosis, causing a fatal outcome.

  • Genetic Alliance. consumer health - Osteosarcoma.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Curr Biol. 1999 Oct 21;9(20):R776-8 [10531025.001]
  • [Cites] Int J Cancer. 2009 Dec 1;125(11):2576-85 [19551863.001]
  • [Cites] Cancer Res. 2001 Jan 15;61(2):589-93 [11212254.001]
  • [Cites] Cancer Invest. 2001;19(3):292-315 [11338887.001]
  • [Cites] Cancer Res. 2001 Oct 15;61(20):7647-53 [11606407.001]
  • [Cites] Biochem Biophys Res Commun. 2002 Jan 25;290(3):1123-7 [11798192.001]
  • [Cites] Cancer. 2002 Mar 1;94(5):1466-75 [11920503.001]
  • [Cites] Int J Cancer. 2002 Mar 20;98(3):344-51 [11920584.001]
  • [Cites] Clin Cancer Res. 2002 May;8(5):1288-94 [12006550.001]
  • [Cites] Clin Cancer Res. 2003 Jan;9(1):1-9 [12538445.001]
  • [Cites] Cancer Res. 2003 May 1;63(9):2172-8 [12727836.001]
  • [Cites] Toxicol Sci. 2003 Oct;75(2):314-20 [12883076.001]
  • [Cites] J Orthop Res. 2004 Nov;22(6):1168-74 [15475193.001]
  • [Cites] Clin Cancer Res. 2004 Oct 15;10(20):7022-30 [15501982.001]
  • [Cites] Anal Biochem. 1971 Jan;39(1):197-201 [5544593.001]
  • [Cites] Proc Natl Acad Sci U S A. 1985 May;82(10):3262-6 [2860667.001]
  • [Cites] Arch Pathol Lab Med. 1987 Sep;111(9):841-5 [2888448.001]
  • [Cites] Nature. 1993 Apr 29;362(6423):841-4 [7683111.001]
  • [Cites] Cell. 1995 Dec 15;83(6):835-9 [8521507.001]
  • [Cites] Cell. 1996 Nov 1;87(3):377-89 [8898192.001]
  • [Cites] Annu Rev Cell Dev Biol. 1996;12:335-63 [8970730.001]
  • [Cites] Eur J Cancer. 1996 Dec;32A(14):2474-84 [9059336.001]
  • [Cites] Int J Cancer. 1998 May 4;76(3):418-22 [9579581.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8806-11 [9671760.001]
  • [Cites] Diabet Med. 1999 Mar;16(3):179-92 [10227562.001]
  • [Cites] Cancer Chemother Pharmacol. 1999;43 Suppl:S42-51 [10357558.001]
  • [Cites] Br J Pharmacol. 2004 Dec;143(8):933-7 [15533890.001]
  • [Cites] Toxicol Sci. 2005 Apr;84(2):319-27 [15659569.001]
  • [Cites] Oncol Rep. 2005 Oct;14(4):847-52 [16142341.001]
  • [Cites] BMC Cancer. 2006;6:53 [16519808.001]
  • [Cites] Int J Cancer. 2007 Feb 1;120(3):702-13 [17096328.001]
  • [Cites] BMC Cancer. 2007;7:216 [18021457.001]
  • [Cites] BMC Cancer. 2008;8:47 [18261208.001]
  • [Cites] J Exp Clin Cancer Res. 2008;27:69 [19014499.001]
  • [Cites] Cancer Sci. 2009 Apr;100(4):770-7 [19469020.001]
  • [Cites] J Orthop Res. 2009 Jul;27(7):909-15 [19105229.001]
  • [Cites] Clin Cancer Res. 2000 Feb;6(2):572-7 [10690541.001]
  • (PMID = 20170548.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, CD34; 0 / Chromans; 0 / Hypoglycemic Agents; 0 / Thiazolidinediones; EC 3.4.24.24 / Matrix Metalloproteinase 2; I66ZZ0ZN0E / troglitazone
  • [Other-IDs] NLM/ PMC2838820
  •  go-up   go-down


54. Mathew SS, Bryant PW, Burch AD: Accumulation of oxidized proteins in Herpesvirus infected cells. Free Radic Biol Med; 2010 Aug 1;49(3):383-91
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here we show that oxidized proteins accumulate during infections with two distantly related herpesviruses, HSV-1 and Rhesus Rhadinovirus (RRV), a close relative of the Kaposi's sarcoma-associated herpesvirus (KSHV).

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Inc. All rights reserved.
  • [Cites] Free Radic Biol Med. 1999 Dec;27(11-12):1151-63 [10641706.001]
  • [Cites] Exp Eye Res. 2000 Feb;70(2):215-20 [10655147.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 May 23;97(11):5746-9 [10811907.001]
  • [Cites] Methods Mol Biol. 2000;99:15-24 [10909073.001]
  • [Cites] Drug Metab Rev. 2000 Aug-Nov;32(3-4):307-26 [11139131.001]
  • [Cites] Biochimie. 2001 Mar-Apr;83(3-4):301-10 [11295490.001]
  • [Cites] Free Radic Biol Med. 2001 May 15;30(10):1171-6 [11369508.001]
  • [Cites] EMBO J. 2001 Sep 17;20(18):5280-9 [11566891.001]
  • [Cites] IUBMB Life. 2001 Dec;52(6):303-7 [11895079.001]
  • [Cites] Free Radic Biol Med. 2002 May 1;32(9):790-6 [11978480.001]
  • [Cites] Biochem Pharmacol. 2002 Sep;64(5-6):1019-26 [12213601.001]
  • [Cites] Ann N Y Acad Sci. 2002 Nov;973:488-504 [12485918.001]
  • [Cites] Trends Mol Med. 2003 Apr;9(4):169-76 [12727143.001]
  • [Cites] Virology. 2003 Jul 20;312(1):122-34 [12890626.001]
  • [Cites] Circulation. 2004 Feb 3;109(4):500-5 [14732750.001]
  • [Cites] J Virol. 2004 Jul;78(13):7175-85 [15194794.001]
  • [Cites] Int J Biochem Cell Biol. 2004 Dec;36(12):2519-30 [15325589.001]
  • [Cites] J Virol. 1978 Sep;27(3):490-504 [212578.001]
  • [Cites] Free Radic Res Commun. 1986;1(6):361-7 [3505892.001]
  • [Cites] Methods Enzymol. 1990;186:464-78 [1978225.001]
  • [Cites] Methods Enzymol. 1994;233:346-57 [8015469.001]
  • [Cites] J Biol Chem. 1995 Feb 3;270(5):2344-51 [7836468.001]
  • [Cites] Ann Med. 1994 Dec;26(6):435-41 [7695870.001]
  • [Cites] J Neurochem. 1995 Nov;65(5):2146-56 [7595501.001]
  • [Cites] Antiviral Res. 1995 Jun;27(3):237-53 [8540746.001]
  • [Cites] J Biol Chem. 1996 Jun 28;271(26):15504-9 [8663134.001]
  • [Cites] Free Radic Biol Med. 1996;21(5):641-9 [8891667.001]
  • [Cites] FASEB J. 1997 Jun;11(7):526-34 [9212076.001]
  • [Cites] J Proteome Res. 2008 Sep;7(9):3868-78 [18652502.001]
  • [Cites] J Virol. 2009 Sep;83(18):9304-12 [19587060.001]
  • [Cites] PLoS Pathog. 2009 Oct;5(10):e1000619 [19816571.001]
  • [Cites] J Biol Chem. 1997 Aug 15;272(33):20313-6 [9252331.001]
  • [Cites] Anal Biochem. 1999 Jan 1;266(1):48-57 [9887212.001]
  • [Cites] Arch Biochem Biophys. 1999 Feb 15;362(2):211-6 [9989929.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 May 25;96(11):6223-8 [10339569.001]
  • [Cites] Free Radic Biol Med. 2004 Dec 15;37(12):2072-81 [15544925.001]
  • [Cites] Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):414-22 [15706088.001]
  • [Cites] J Biol Chem. 2005 Mar 25;280(12):11648-55 [15659387.001]
  • [Cites] EMBO J. 2005 Apr 6;24(7):1311-7 [15775985.001]
  • [Cites] J Virol. 2005 Aug;79(16):10740-9 [16051866.001]
  • [Cites] Free Radic Biol Med. 2005 Nov 1;39(9):1208-15 [16214036.001]
  • [Cites] Proteomics. 2006 Feb;6(4):1250-60 [16408314.001]
  • [Cites] J Virol. 2006 Apr;80(7):3567-81 [16537625.001]
  • [Cites] J Cell Mol Med. 2006 Apr-Jun;10(2):389-406 [16796807.001]
  • [Cites] Exp Cell Res. 2007 Jan 1;313(1):195-209 [17123510.001]
  • [Cites] J Neurovirol. 2007 Oct;13(5):416-25 [17994426.001]
  • [Cites] PLoS One. 2008;3(1):e1491 [18231578.001]
  • [Cites] J Virol. 2008 Apr;82(7):3381-90 [18234803.001]
  • [Cites] Mol Cell Biochem. 2008 Jun;313(1-2):179-86 [18414998.001]
  • [Cites] J Virol. 2008 Jul;82(13):6324-36 [18434395.001]
  • (PMID = 20441790.001).
  • [ISSN] 1873-4596
  • [Journal-full-title] Free radical biology & medicine
  • [ISO-abbreviation] Free Radic. Biol. Med.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / K22 AI062991; United States / NIAID NIH HHS / AI / K22AI062991
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / HSP27 Heat-Shock Proteins; 0 / Molecular Chaperones; 0 / Proteins; EC 3.4.25.1 / Proteasome Endopeptidase Complex
  • [Other-IDs] NLM/ NIHMS233650; NLM/ PMC3206308
  •  go-up   go-down


55. Wagner DG, Yao JL, di Sant'Agnese PA, Cheng L, Lopez-Beltran A, Montironi R, Huang J: Soft tissue tumors of the prostate: a review. Anal Quant Cytol Histol; 2007 Dec;29(6):341-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Diagnostic immunohistochemistry is an important adjunct to histopathology for proper diagnosis and tumor subclassification.

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18225389.001).
  • [ISSN] 0884-6812
  • [Journal-full-title] Analytical and quantitative cytology and histology
  • [ISO-abbreviation] Anal. Quant. Cytol. Histol.
  • [Language] ENG
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 90
  •  go-up   go-down


56. Kovaleva M, Bussmeyer I, Rabe B, Grötzinger J, Sudarman E, Ei